
<html lang="en"     class="pb-page"  data-request-id="f912a2fa-5e8b-4598-b3c1-e8b68cac1019"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2017.60.issue-19;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.7b00843"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer’s Disease" /></meta><meta name="dc.Creator" content="Snahel  Patel" /></meta><meta name="dc.Creator" content="William J.  Meilandt" /></meta><meta name="dc.Creator" content="Rebecca I.  Erickson" /></meta><meta name="dc.Creator" content="Jinhua  Chen" /></meta><meta name="dc.Creator" content="Gauri  Deshmukh" /></meta><meta name="dc.Creator" content="Anthony A.  Estrada" /></meta><meta name="dc.Creator" content="Reina N.  Fuji" /></meta><meta name="dc.Creator" content="Paul  Gibbons" /></meta><meta name="dc.Creator" content="Amy  Gustafson" /></meta><meta name="dc.Creator" content="Seth F.  Harris" /></meta><meta name="dc.Creator" content="Jose  Imperio" /></meta><meta name="dc.Creator" content="Wendy  Liu" /></meta><meta name="dc.Creator" content="Xingrong  Liu" /></meta><meta name="dc.Creator" content="Yichin  Liu" /></meta><meta name="dc.Creator" content="Joseph P.  Lyssikatos" /></meta><meta name="dc.Creator" content="Changyou  Ma" /></meta><meta name="dc.Creator" content="Jianping  Yin" /></meta><meta name="dc.Creator" content="Joseph W.  Lewcock" /></meta><meta name="dc.Creator" content="Michael  Siu" /></meta><meta name="dc.Description" content="Significant data exists to suggest that dual leucine zipper kinase (DLK, MAP3K12) is a conserved regulator of neuronal degeneration following neuronal injury and in chronic neurodegenerative diseas..." /></meta><meta name="Description" content="Significant data exists to suggest that dual leucine zipper kinase (DLK, MAP3K12) is a conserved regulator of neuronal degeneration following neuronal injury and in chronic neurodegenerative diseas..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 20, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00843" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00843" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00843" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00843" /></link>
        
    
    

<title>Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer’s Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00843" /></meta><meta property="og:title" content="Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer’s Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0017.jpeg" /></meta><meta property="og:description" content="Significant data exists to suggest that dual leucine zipper kinase (DLK, MAP3K12) is a conserved regulator of neuronal degeneration following neuronal injury and in chronic neurodegenerative disease. Consequently, there is considerable interest in the identification of DLK inhibitors with a profile compatible with development for these indications. Herein, we use structure-based drug design combined with a focus on CNS drug-like properties to generate compounds with superior kinase selectivity and metabolic stability as compared to previously disclosed DLK inhibitors. These compounds, exemplified by inhibitor 14, retain excellent CNS penetration and are well tolerated following multiple days of dosing at concentrations that exceed those required for DLK inhibition in the brain." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00843"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00843">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00843&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00843&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00843&amp;href=/doi/10.1021/acs.jmedchem.7b00843" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 8083-8102</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00813" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00856" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer’s Disease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Snahel++Patel">Snahel Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+J.++Meilandt">William J. Meilandt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rebecca+I.++Erickson">Rebecca I. Erickson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jinhua++Chen">Jinhua Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gauri++Deshmukh">Gauri Deshmukh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+A.++Estrada">Anthony A. Estrada</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reina+N.++Fuji">Reina N. Fuji</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Gibbons">Paul Gibbons</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amy++Gustafson">Amy Gustafson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seth+F.++Harris">Seth F. Harris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jose++Imperio">Jose Imperio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wendy++Liu">Wendy Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xingrong++Liu">Xingrong Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yichin++Liu">Yichin Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+P.++Lyssikatos">Joseph P. Lyssikatos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Changyou++Ma">Changyou Ma</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianping++Yin">Jianping Yin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+W.++Lewcock">Joseph W. Lewcock</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Siu">Michael Siu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-2822-6584" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Discovery Chemistry, <sup>∥</sup>Department of Safety Assessment, <sup>§</sup>Department of Structural Biology, <sup>‡</sup>Department of Neurosciences, <sup>⊥</sup>Department of Drug Metabolism and Pharmacokinetics, and <sup>∇</sup>Department of Biochemical and Cellular Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">#</span> <span class="aff-text">Department of Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div><div class="corresp-info"><strong>*</strong>M.S. Phone: 650-467-7764. E-mail: <a href="/cdn-cgi/l/email-protection#e6958f93c88b8f858e87838aa681838883c885898b"><span class="__cf_email__" data-cfemail="3c4f55491251555f545d59507c5b595259125f5351">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>J.W.L. Phone: 650-745-5247. E-mail: <a href="/cdn-cgi/l/email-protection#6f030a180c000c042f0b010306410c0002"><span class="__cf_email__" data-cfemail="670b02100408040c2703090b0e4904080a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00843&amp;href=/doi/10.1021%2Facs.jmedchem.7b00843" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 8083–8102</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 20, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 June 2017</li><li><span class="item_label"><b>Published</b> online</span>20 September 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 October 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00843" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00843</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8083%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSnahel%2BPatel%252C%2BWilliam%2BJ.%2BMeilandt%252C%2BRebecca%2BI.%2BErickson%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D19%26contentID%3Dacs.jmedchem.7b00843%26title%3DSelective%2BInhibitors%2Bof%2BDual%2BLeucine%2BZipper%2BKinase%2B%2528DLK%252C%2BMAP3K12%2529%2Bwith%2BActivity%2Bin%2Ba%2BModel%2Bof%2BAlzheimer%25E2%2580%2599s%2BDisease%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8102%26publicationDate%3DOctober%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00843"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3596</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">23</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00843" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer’s Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Snahel&quot;,&quot;last_name&quot;:&quot;Patel&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;J. Meilandt&quot;},{&quot;first_name&quot;:&quot;Rebecca&quot;,&quot;last_name&quot;:&quot;I. Erickson&quot;},{&quot;first_name&quot;:&quot;Jinhua&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Gauri&quot;,&quot;last_name&quot;:&quot;Deshmukh&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;A. Estrada&quot;},{&quot;first_name&quot;:&quot;Reina&quot;,&quot;last_name&quot;:&quot;N. Fuji&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Gibbons&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;Gustafson&quot;},{&quot;first_name&quot;:&quot;Seth&quot;,&quot;last_name&quot;:&quot;F. Harris&quot;},{&quot;first_name&quot;:&quot;Jose&quot;,&quot;last_name&quot;:&quot;Imperio&quot;},{&quot;first_name&quot;:&quot;Wendy&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Xingrong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Yichin&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;P. Lyssikatos&quot;},{&quot;first_name&quot;:&quot;Changyou&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Jianping&quot;,&quot;last_name&quot;:&quot;Yin&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;W. Lewcock&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Siu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;8083-8102&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00843&quot;},&quot;abstract&quot;:&quot;Significant data exists to suggest that dual leucine zipper kinase (DLK, MAP3K12) is a conserved regulator of neuronal degeneration following neuronal injury and in chronic neurodegenerative disease. Consequently, there is considerable interest in the identification of DLK inhibitors with a profile compatible with development for these indications. Herein, we use structure-based drug design combined with a focus on CNS drug-like properties to generate compounds with superior kinase selectivity and metabolic stability as compared to previously disclosed DLK inhibitors. These compounds, exemplified by inhibitor 14, retain excellent CNS penetration and are well tolerated following multiple days of dosing at concentrations that exceed those required for DLK inhibition in the brain.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00843&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00843" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00843&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00843" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00843&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00843" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00843&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00843&amp;href=/doi/10.1021/acs.jmedchem.7b00843" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00843" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00843" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00843%26sid%3Dliteratum%253Aachs%26pmid%3D28929759%26genre%3Darticle%26aulast%3DPatel%26date%3D2017%26atitle%3DSelective%2BInhibitors%2Bof%2BDual%2BLeucine%2BZipper%2BKinase%2B%2528DLK%252C%2BMAP3K12%2529%2Bwith%2BActivity%2Bin%2Ba%2BModel%2Bof%2BAlzheimer%25E2%2580%2599s%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D19%26spage%3D8083%26epage%3D8102%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/jmcmar.2017.60.issue-19/20171012/jmcmar.2017.60.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Significant data exists to suggest that dual leucine zipper kinase (DLK, MAP3K12) is a conserved regulator of neuronal degeneration following neuronal injury and in chronic neurodegenerative disease. Consequently, there is considerable interest in the identification of DLK inhibitors with a profile compatible with development for these indications. Herein, we use structure-based drug design combined with a focus on CNS drug-like properties to generate compounds with superior kinase selectivity and metabolic stability as compared to previously disclosed DLK inhibitors. These compounds, exemplified by inhibitor <b>14</b>, retain excellent CNS penetration and are well tolerated following multiple days of dosing at concentrations that exceed those required for DLK inhibition in the brain.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82272" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82272" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Dual leucine zipper kinase (DLK, MAP3K12) dependent activation of the JNK/c-Jun pathway in neurons is essential for induction of the neuronal stress response following insult.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> Abrogation of this stress response in DLK null animals results in potent protection of neurons from degeneration in multiple neuronal injury models.<a onclick="showRef(event, 'ref1 ref3 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref1 ref3 ref6 ref7 ref8">(1, 3, 6-8)</a> Although DLK also appears to be required for axon regeneration following peripheral nerve injury,<a onclick="showRef(event, 'ref1 ref2 ref5 ref9'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref5 ref9">(1, 2, 5, 9)</a> recent work has demonstrated that genetic deletion or pharmacological inhibition of DLK results in attenuation of synapse loss, neuronal degeneration, and functional decline in models of both Alzheimer’s Disease and Amyotrophic Lateral Sclerosis (ALS).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Based on these findings, the net effect of DLK inhibition would be expected to provide functional protection in the context of chronic neuronal degeneration, making DLK an attractive therapeutic target for the treatment of neurodegenerative disease.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a></div><div class="NLM_p last">Previously, we have disclosed two series of small molecule DLK inhibitors that effectively reduce c-Jun phosphorylation in nerve crush and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) based acute injury mouse models.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> These compounds have served as valuable tools to enable an improved understanding of the consequences of DLK inhibition <i>in vivo</i>, yet challenges remain in the development of DLK inhibitors for treatment of chronic neurodegenerative disease. For these indications, a good safety profile and large therapeutic window following chronic dosing are required, which are challenging attributes to achieve with CNS-penetrant kinase inhibitors.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Therefore, we used structure-based design to further evolve our pyrazole scaffold (represented by compound <b>1</b>) to address these challenges. Here we describe the discovery of a series of inhibitors with an improved potency, PK, kinase selectivity, and tolerability profile with potential for prolonged administration. These compounds appear more suitable than previously reported DLK inhibitors for use in chronic neurodegenerative indications.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72201" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72201" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In prior studies, compound <b>1</b> (DLK <i>K</i><sub>i</sub> = 0.042 μM, p-JNK cellular IC<sub>50</sub> = 0.536 μM, ClogP 3.7, tPSA 78 Å<sup>2</sup>, HBD 1, LipE 3.7) exhibited encouraging free drug exposure and DLK inhibition in an optic nerve crush model.<a onclick="showRef(event, 'ref14 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref16 ref17">(14, 16, 17)</a> Although promising, further optimization was necessary to improve potency, kinase selectivity, and drug-like properties befitting a brain-penetrant therapeutic (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Examination of the crystal structure of <b>1</b> bound to DLK<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> led us to explore alternative hydrogen bond donor/acceptor interactions of the 2-aminopyridine hinge binder, and we hypothesized that altering the hinge contacts could provide new leads for optimization. Initially, we targeted replacement of the 2-aminopyridine with a 7-azaindole<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (pyrrolo[2,3-<i>b</i>]pyridine) where the NH and C6–H could maintain polarized hydrogen bond interactions to the carbonyl moieties of Glu191 and Cys193, respectively (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). The 7-azaindole portion would also shift the central pyrazole core, changing the interactions of pyrazole N1 substituents with the P-loop.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Additionally, 7-azaindole C3-substituents would match the positioning of the C4-nitrile of compound <b>1</b> and provide interactions with both the P-loop and Met190 gatekeeper side chain.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Two-dimensional representation of the hydrogen bonds of compound <b>1</b> with the hinge residues of DLK (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CEQ">5CEQ</a>). Two-dimensional representation of proposed hydrogen bonds of 3-substituted-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Using the 4-(1-isopropyl-1<i>H</i>-pyrazol-5-yl)-1-(oxetan-3-yl)piperidine framework of compound <b>1</b> and targeting properties for brain penetration (HBD ≤ 1, tPSA ≤ 80 Å<sup>2</sup>), we initially evaluated the C3-substituted fluoro-, chloro-, methyl-, and trifluoromethyl-7-azaindoles (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). These compounds showed moderate biochemical and cellular potencies as measured by reduction of MKK4 phosphorylation and JNK phosphorylation (p-JNK) in HEK293 cells stably overexpressing DLK, respectively.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> The cellular assay was previously found to correlate well with potency against endogenous DLK.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Furthermore, these 7-azaindoles displayed increased lipophilic efficiencies when compared to <b>1</b> (LipE = 3.7). Unfortunately, the 7-azaindole analogs showed large efflux ratios in an MDR1 assay despite their low tPSA (3-fluoro-7-azaindole <b>2</b>, BA/AB = 3.9, tPSA = 58; 3-trifluoromethyl-7-azaindole <b>5</b>, BA/AB = 4.5, tPSA = 58); thus, balancing brain penetration with other properties proved to be difficult for this hinge binding motif.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 1. <a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0011.gif" alt="" id="GRAPHIC-d59e514-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">All assay results represent the geometric mean of a minimum of two determinations, and these assays generally produced results within 3-fold of the reported mean.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">MDCK-MDR1 human P-gp transfected cell line. BA/AB = Basolateral-to-apical/apical-to-basolateral ratio. AB = Apical-to-basolateral flux, Units = ×10<sup>–6</sup> cm s<sup>–1</sup>.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Liver microsome-predicted hepatic clearance.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">H/R/M = human/rat/mouse.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">LipE = −log <i>K</i>i – ClogP.</p></div></div><div></div></div><div class="NLM_p">Accordingly, we examined a 3-substituted 2-aminopyridine (with C5 connectivity to the pyrazole scaffold) as an isostere of the 7-azaindole. Specific pyridine C3-substitutents were selected to mask the additional HBD and mimic the planar azaindole motif. Although less potent compared to the 7-azaindoles, 2-amino-3-methoxypyridine <b>6</b> (<i>K</i><sub>i</sub> = 0.142 μM, MDR1 BA/AB = 2.2) and 2-amino-3-(trifluoromethyl)pyridine <b>7</b> (<i>K</i><sub>i</sub> = 0.154 μM, MDR1 BA/AB = 1.6) showed better efflux ratios and in vitro metabolic stability.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Interestingly, 3-methyl-2-aminopyridine <b>8</b> (<i>K</i><sub>i</sub> > 1.6 μM, MDR1 BA/AB = 8.2) and 3-chloro-2-aminopyridine <b>9</b> (<i>K</i><sub>i</sub> = 1 μM, MDR1 BA/AB = 3.6) were efflux substrates and highlighted the importance of C3-substitutents to effectively mask the 2-amino group.</div><div class="NLM_p">With the new pyridine hinge binder, pyrazole N1 substitution (binding under the P-loop) afforded flat SAR (data not shown); thus, we targeted the <i>N</i>-oxetanylpiperidine fragment for modification. Initially, we looked to reduce lipophilicity without increasing tPSA by bridging the piperidine ring to an <i>exo</i>-3-azabicyclo[3.1.0]hexane to assess if productive interactions could be achieved in the region of the solvent-exposed opening. Gratifyingly, this subtle change provided significant improvements in binding affinity and lipophilic efficiencies while preserving tPSA (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The matched pairs 2-amino-3-trifluoromethylpyridines <b>7</b> (<i>K</i><sub>i</sub> = 0.154 μM, LipE = 3.5, p<i>K</i><sub>a</sub> = 6.55)/<b>10</b> (<i>K</i><sub>i</sub> = 0.007 μM, LipE = 5.6, p<i>K</i><sub>a</sub> = 5.9) and 2-amino-3-methoxypyridines <b>6</b> (<i>K</i><sub>i</sub> = 0.142 μM, LipE = 4.6)/<b>12</b> (<i>K</i><sub>i</sub> = 0.007 μM, LipE = 6.5) showed approximately 20-fold improvement in binding affinity through minimal alteration of the scaffold.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 2. <a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0012.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">pJNK IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">MDR1-MDCK BA/AB (AB)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">LM CL<sub>hep</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a> (mL min<sup>–1</sup> kg<sup>–1</sup>) H/R/M<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">ClogP</th><th class="colsep0 rowsep0" align="center" char=".">tPSA</th><th class="colsep0 rowsep0" align="center" char=".">LipE<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.97 (16)</td><td class="colsep0 rowsep0" align="char" char=".">5/13/41</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">CF<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.035</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">1.9 (2.2)</td><td class="colsep0 rowsep0" align="char" char=".">2/10/23</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">0.873</td><td class="colsep0 rowsep0" align="char" char=".">2.1 (6.8)</td><td class="colsep0 rowsep0" align="char" char=".">4/12/18</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">OCF<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td><td class="colsep0 rowsep0" align="char" char=".">0.328</td><td class="colsep0 rowsep0" align="char" char=".">6.6 (5.4)</td><td class="colsep0 rowsep0" align="char" char=".">1/10/32</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.195</td><td class="colsep0 rowsep0" align="char" char=".">1.3 (10.1)</td><td class="colsep0 rowsep0" align="char" char=".">4/14/30</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">All assay results represent the geometric mean of a minimum of two determinations, and these assays generally produced results within 3-fold of the reported mean.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">MDCK-MDR1 human P-gp transfected cell line. (BA/AB) = Basolateral-to-apical/apical-to-basolateral ratio. AB = Apical-to-basolateral flux, Units = ×10<sup>–6</sup> cm s<sup>–1</sup>.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Liver microsome-predicted hepatic clearance.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">H/R/M = human/rat/mouse.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">LipE = −log <i>K</i><sub>i</sub> – ClogP.</p></div></div></div><div class="NLM_p">Crystal structures of piperidine <b>7</b> and 3-azabicyclo[3.1.0]hexane <b>10</b> bound to the DLK kinase domain were determined at 2.96 and 2.45 Å resolutions, respectively. We observed a consistent disposition for the core scaffold (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a) to form hydrogen bonds to the kinase hinge element and engaged with the flexible glycine-rich P-loop, suggesting that the potency difference is not due to fundamental changes in the protein conformation or coarse adjustments of the core of the small molecule. However, the azabicyclo[3.1.0]hexane portion did show a shifted position relative to the piperidine moiety it replaced, assuming a more orthogonal orientation relative to the core ring systems and a slight shift toward the hinge side of the protein cavity en route to the more solvent exposed region. This approach to backbone carbonyl groups of Ala194 and Gln195 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b) and the conformational rigidity of the 3-azabicyclo[3.1.0]hexane may account for some of the improved potency of compound <b>10</b>. Finally, the terminal oxetane also differs significantly in position between the two structures. In brief, a combination of subtle effects is believed to contribute to the notable improvement in DLK binding affinity.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlay of two crystallographic structures of piperidine <b>7</b> (protein/ligand/waters in dark green/bright green/pale green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5VO2">5VO2</a>) and azabicyclo[3.1.0]hexane <b>10</b> (ivory/brown/ivory, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5VO1">5VO1</a>) bound to the DLK kinase domain. (a) Viewed down into the ATP-binding pocket with the glycine-rich P loop removed from the foreground. The kinase “hinge” is at the upper left, providing a canonical kinase binding motif of hydrogen bonds with the small molecule ligand. The core 5-(pyrazol-3-yl)pyridin-2-amines maintain a consistent position, while the solvent-oriented oxetane differs between piperidine (<b>7</b>) or the azabicyclo[3.1.0]hexane (<b>10</b>). (b) A rotated view of the overlay with the hinge at the rear, highlighting the proximity of the azabicyclo[3.1.0]hexane moiety to carbonyl groups of DLK residues 194 and 195 and showing the slight shift of the isopropyl moiety of the ligand at the center of the image.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A variety of 3-substituents on the 2-aminopyridine hinge binder maintained favorable interactions with the Met-190 gatekeeper side chain. The trifluoromethylpyridine <b>10</b> (MDR1 BA/AB = 0.97, AB = 16 × 10<sup>–6</sup> cm/s) and difluoromethylpyridine <b>11</b> (MDR1 BA/AB = 1.9, AB = 2.2 × 10<sup>–6</sup> cm/s) retained desirable permeability properties and metabolic stability in liver microsomes (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). In addition to fluoroalkyls, C3 alkoxy analogs, such as methoxy analog <b>12</b> (<i>K</i><sub>i</sub> = 0.007 μM, p-JNK IC<sub>50</sub> = 0.873 μM, MDR1 BA/AB = 2.1), difluoromethoxy analog <b>13</b> (<i>K</i><sub>i</sub> = 0.008 μM, p-JNK IC<sub>50</sub> = 0.328 μM, MDR1 BA/AB = 6.6), and trifluoromethoxy analog <b>14</b> (<i>K</i><sub>i</sub> = 0.003 μM, p-JNK IC<sub>50</sub> = 0.195 μM, MDR1 BA/AB = 1.3) have comparable biochemical potencies. The difluoromethoxy analog <b>13</b> in particular suffered from an efflux liability, presumably due to the polar nature of this group.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">We then investigated 3-substituents of the 3-azabicyclo[3.1.0]hexane toward solvent as shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. Substitution toward the solvent exposed region was more tolerant of changes with minimal effect on binding affinity as the oxetanylmethyl <b>15</b>, difluoroethyl <b>17</b>, 2-methoxyethyl <b>18</b>, and 2-hydroxypropyl <b>19</b> had similar potency, permeability, and microsomal stability as oxetane <b>10</b>. The <i>N</i>-acetyl <b>16</b> (MDR1 BA/AB = 3.8, AB = 5.7 × 10<sup>–6</sup> cm s<sup>–1</sup>) maintained potency at the expense of an efflux liability. From this analysis, the oxetane group provided the best balance of potency and properties and became the preferred substitution toward solvent.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 3. <a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0013.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0014.gif" alt="" id="GRAPHIC-d59e996-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Compound <b>19</b> was tested as racemate. All assay results represent the geometric mean of a minimum of two determinations, and these assays generally produced results within 3-fold of the reported mean.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last"><sup><i>b</i></sup>MDCK-MDR1 human P-gp transfected cell line. (BA/AB) = Basolateral-to-apical/apical-to-basolateral ratio. AB = Apical-to-basolateral flux, Units = ×10<sup>–6</sup> cm s<sup>–1</sup>.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Liver microsome-predicted hepatic clearance.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">H/R/M = human/rat/mouse.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">LipE = −log <i>K</i><sub>i</sub> – ClogP.</p></div></div><div></div></div><div class="NLM_p">The P-loop region of DLK was explored via the pyrazole N1 substitution with the 2-amino-3-trifluoromethylpyridine and 2-amino-3-trifluoromethoxypyridine hinge binders. Increasing lipophilicity in this area improved cellular potency and afforded good permeability (methyl <b>20</b> and <b>21</b> < ethyl <b>22</b> < trifluoroethyl <b>23</b> ∼ cyclopropylmethyl <b>24</b> and <b>25</b> < isobutyl <b>26</b>) (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Polar atoms were less tolerated at this position (2-methylbutan-2-ol <b>27</b><i>K</i><sub>i</sub> = 0.023 μM, p-JNK IC<sub>50</sub> = 0.829 μM) while cycloalkyls such as cyclobutyl <b>28</b> and cyclopentyl <b>29</b> deteriorated lipophilic efficiency.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 4. <a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0015.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0016.gif" alt="" id="GRAPHIC-d59e1093-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">All assay results represent the geometric mean of a minimum of two determinations, and these assays generally produced results within 3-fold of the reported mean.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">MDCK-MDR1 human P-gp transfected cell line. (BA/AB) = Basolateral-to-apical/apical-to-basolateral ratio. AB = Apical-to-basolateral flux, Units = ×10<sup>–6</sup> cm s<sup>–1</sup>.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Liver microsome-predicted hepatic clearance.</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">H/R/M = human/rat/mouse.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">LipE = −log <i>K</i><sub>i</sub> – ClogP.</p></div></div><div></div></div><div class="NLM_p">The in vitro data from a number of compounds displayed an encouraging combination of properties and were suitable for further evaluation. Based on their optimal combination of properties including cellular potency, microsomal stability, and lipophilicity, compounds <b>14</b> and <b>24</b> were progressed to a range of in vitro screens to examine potential safety liabilities (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Kinase selectivity was assessed using a panel of 220 kinases (Life Technologies) that included cytoplasmic and receptor tyrosine kinases, serine/threonine kinases, and lipid kinases. Single point testing at 1 μM revealed few kinases with ≥50% inhibition (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a> Compound <b>14</b>, Flt3, PAK4, STK33, TrkA; Compound <b>24</b>, Axl, CSF1R, DMPK, EphA7, Flt3, TrkA). No kinases were inhibited to a degree of >70% by either compound, constituting a significant improvement compared to previous DLK inhibitors.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Binding affinity (<i>K</i><sub>d</sub>) of compounds <b>14</b> and <b>24</b> were tested for the homologous mixed lineage kinase LZK as no kinase activities assays are available and were determined to be 0.460 μM (42 × DLK <i>K</i><sub>d</sub>) and 0.120 μM (24 × DLK <i>K</i><sub>d</sub>), respectively (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). The specific rearrangement of the hinge binder along with an <i>exo</i>-3-azabicyclo[3.1.0]hexane group is believed to favorably position these inhibitors in DLK with specific interactions to hinge residue Phe192 and gatekeeper residue Met190, which are typically different in kinases inhibited by Compound <b>1</b> and 2-((6-(3,3-difluoropyrrolidin-1-yl)-4-(1-(oxetan-3-yl)-piperidin-4-yl)pyridin-2-yl)amino)isonicotinonitrile (<b>GNE-3511</b>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Inhibitors <b>14</b> and <b>24</b> were also evaluated in a broad panel of biochemical radioligand-binding and enzyme assays, including 42 targets of major classes of biogenic amine receptors, neuropeptide receptors, ion channels, and neurotransmitter transporters. The results of these assays did not reveal any significant off-target binding for either compound. hERG ion channel inhibition from a patch clamp assay was minimal for <b>14</b> (14% at 10 μM) and moderate for <b>24</b> (42% at 10 μM). Taken together, these results demonstrated that <b>14</b> and <b>24</b> were highly selective and had selectivity profiles suitable for chronic dosing.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Kinase selectivity of compounds <b>14</b> and <b>24</b> @ 1 μM (333 × and 250 × DLK <i>K</i><sub>i</sub>, respectively). Values are reported as percent inhibition and determined in a 220 kinase panel at Life Technologies. EGFR* = EGFR(T790M, L858R), RAF1* = RAF1(Y340D, Y341D), MYLK* = MYLK(smMLCK), MYLK3* = MYLK3(caMLCK), and p38_alpha* = p38_alpha(direct). Kinases with ≥50% inhibition for compound <b>14</b> are Flt3 (IC<sub>50</sub> = 0.709 μM), PAK4 (IC<sub>50</sub> = 0.673 μM), STK16 (IC<sub>50</sub> = 1.52 μM), and TrkA (IC<sub>50</sub> = 1.55 μM). Kinases with ≥50% inhibition for compound <b>24</b> are Axl (IC<sub>50</sub> = 0.448 μM), CSF1R (IC<sub>50</sub> = 1.22 μM), DMPK (IC<sub>50</sub> = 1.38 μM), EphA7 (IC<sub>50</sub> = 0.665 μM), Flt3 (IC<sub>50</sub> = 0.238 μM), and TrkA (IC<sub>50</sub> = 0.383 μM). Biochemical IC<sub>50</sub> values were determined at Life Technologies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Screening Assays</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>24</b></th><th class="colsep0 rowsep0" align="center"><b>14</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG ion channel<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (inhibition @ 1, 10 μM)</td><td class="colsep0 rowsep0" align="left">11%, 42%</td><td class="colsep0 rowsep0" align="left">6%, 14%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">receptor panel<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (binding hits >50% of control @ 10 uM)</td><td class="colsep0 rowsep0" align="left">none</td><td class="colsep0 rowsep0" align="left">none</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="6" align="left">JNK pathway and related kinases IC<sub>50</sub><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">JNK1 > 10 μM</td><td class="colsep0 rowsep0" align="left">JNK1 > 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JNK2 > 10 μM</td><td class="colsep0 rowsep0" align="left">JNK2 > 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JNK3 > 10 μM</td><td class="colsep0 rowsep0" align="left">JNK3 > 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MLK1 = 3.5 μM</td><td class="colsep0 rowsep0" align="left">MLK1 = 5.92 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MLK2 = 5.15 μM</td><td class="colsep0 rowsep0" align="left">MLK2 = 7.88 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MLK3 > 10 μM</td><td class="colsep0 rowsep0" align="left">MLK3 > 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">LZK and DLK binding affinity<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">LZK <i>K</i><sub>d</sub> = 0.120 μM</td><td class="colsep0 rowsep0" align="left">LZK <i>K</i><sub>d</sub> = 0.460 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DLK <i>K</i><sub>d</sub> = 0.0051 μM</td><td class="colsep0 rowsep0" align="left">DLK <i>K</i><sub>d</sub> = 0.011 μM</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">ChanTest FASTPatch hERG Assay.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00843/suppl_file/jm7b00843_si_001.pdf" class="ext-link">Supporting Information</a>; CEREP: A<sub>1</sub>, A<sub>2A</sub>, α1, α2, β1, β2, BZD, D<sub>1</sub>, D<sub>2S</sub>, ET<sub>A</sub>, GABA<sub>A1</sub> (α1,β2,γ2), GABA<sub>B(1b)</sub>, Kainate, H<sub>1</sub>, H<sub>2</sub>, M<sub>1</sub>, M<sub>2</sub>, M<sub>3</sub>, NK<sub>1</sub>, N neuronal α4β2, N muscle-type, Opiod, PPARα, PPARδ, Rolipram, 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, 5-HT<sub>3</sub>, 5-HT<sub>4e</sub>, Ca<sup>2+</sup> channel (L, dihydropyridine site), Ca<sup>2+</sup> channel (L, verapamil site) (phenylalkylamine), K<sub>ATP</sub> channel, hERG (membrane preparation), K<sub>V</sub> channel, Na<sup>+</sup> channel (site 2), Cl<sup>–</sup> channel (GABA-gated), Norepinephrine transporter, Dopamine transporter, 5-HT transporter, Acetylcholinesterase.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Biochemical IC<sub>50</sub> values were determined at Life Technologies.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last"><i>K</i><sub>d</sub> values were determined at DiscoverX.</p></div></div></div><div class="NLM_p">To confirm that the selective DLK inhibition elicited by <b>14</b> and <b>24</b> was sufficient to result in neuroprotection, we examined these azabicyclo[3.1.0]hexane pyrazoles in a high-content in vitro axon degeneration assay.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> A dose dependent protection of axons was observed with both <b>14</b> and <b>24</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. Compound <b>14</b> EC<sub>50</sub> = 0.574 μM, Compound <b>24</b> EC<sub>50</sub> = 0.457 μM), which correlated well with the IC<sub>50</sub> in the p-JNK assay, though the neuroprotection EC<sub>50</sub> was shifted as near complete DLK/JNK inhibition is required to elicit protection in this acute setup.<a onclick="showRef(event, 'ref13 ref14 ref22'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref22">(13, 14, 22)</a> In addition, these compounds were significantly (∼5 fold) more potent in this functional assay as compared to the potency we previously reported for Compound <b>1</b> (EC<sub>50</sub> = 2.05 μM).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> For all compounds, the maximum protection of axons achieved was roughly 80% of a positive control in which degeneration was not induced. These results demonstrate that selective inhibition of DLK is sufficient to elicit potent neuroprotection, though LZK or other pathways may also contribute to axonal degeneration in this setup as been observed in other experimental paradigms.<a onclick="showRef(event, 'ref13 ref23'); return false;" href="javascript:void(0);" class="ref ref13 ref23">(13, 23)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Evaluation of compounds using an in vitro axon degeneration assay. Representative curves for compound <b>14</b> (red) and compound <b>24</b> (blue) show EC<sub>50</sub> values of 0.574 μM and 0.457 μM, respectively. Max activity reflects the extent of axonal protection relative to a positive control where degeneration was not induced as measured by high content imaging of axons followed by automated quantification. Each data point represents averages from three independent assays ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> In Vivo Compound Characterization</h3><div class="NLM_p">Based on these promising in vitro results, <b>14</b> and <b>24</b> were progressed to in vivo studies. Pharmacokinetic (PK) data from these compounds in various preclinical species are shown in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>. In Sprague–Dawley rats, <i>N</i>-isopropyl pyrazole <b>14</b> showed low plasma clearance (total and unbound), long half-life, good bioavailability, and high <i>K</i><sub>puu</sub> (brain). The slightly more lipophilic and more potent <i>N</i>-cyclopropylmethyl analog <b>24</b> also maintained good bioavailability and brain penetration but with moderate CL<sub>p</sub> and half-life in rat. Both compounds also displayed good unbound clearance in C57BL/6 mice, with <b>24</b> exhibiting a longer half-life. However, based on the superior rat exposure profile and better stability in higher species liver microsomes/hepatocytes, <b>14</b> was determined to be the best compound to advance to further studies. Compound <b>14</b> was then dosed in cynomolgus monkeys and displayed low plasma clearance (total and unbound), moderate volume of distribution, long half-life, good bioavailability, and <i>K</i><sub>puu</sub> (CSF/unbound plasma).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Properties of DLK inhibitors <b>24</b> and <b>14</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>24</b></th><th class="colsep0 rowsep0" align="center"><b>14</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center"><b>Sprague–Dawley Rat PK</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>p</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">8.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>u</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">342</td><td class="colsep0 rowsep0" align="left">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>d</sub> (L kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">5.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">8.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i></td><td class="colsep0 rowsep0" align="left">63% (1 mg kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">57% (5 mg kg<sup>–1</sup>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">56% (25 mg kg<sup>–1</sup>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">49% (75 mg kg<sup>–1</sup>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">55% (150 mg kg<sup>–1</sup>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>puu</sub> (AUC)</td><td class="colsep0 rowsep0" align="left">0.908</td><td class="colsep0 rowsep0" align="left">0.78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center"><b>C57BL/6 Mouse PK</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>p</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">9.3</td><td class="colsep0 rowsep0" align="left">24.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>u</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">113</td><td class="colsep0 rowsep0" align="left">186</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>d</sub> (L kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">3.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">2.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i></td><td class="colsep0 rowsep0" align="left">93% (15 mg kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">60% (50 mg kg<sup>–1</sup>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">99% (30 mg kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">73% (100 mg kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>puu</sub> (6 h)</td><td class="colsep0 rowsep0" align="left">0.81 (PO 5 mg kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">0.540 (PO 50 mg kg<sup>–1</sup>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center"><b>Cyno PK</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>p</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>u</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>d</sub> (L kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">7.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">103% (1 mg kg<sup>–1</sup>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CSF <i>K</i><sub>puu</sub> (AUC)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.710</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Oral doses were formulated as aqueous suspensions in 1% methylcellulose; intravenous doses were formulated in 10% DMSO, 10% Cremophor EL in saline.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Rat PPB: inhibitor <b>24</b> = 90.9%; inhibitor <b>14</b> = 82.3%.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Mouse PPB: inhibitor <b>24</b> = 91.8%; inhibitor <b>14</b> = 86.8%.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">Cyno PPB: inhibitor <b>14</b> = 80.9%.</p></div></div></div><div class="NLM_p">The cell-based potency, protein binding, and in vivo exposure observed for <b>14</b> suggested that sustained DLK inhibition in brain could be achieved at reasonable dose levels. To test this directly, 9–10 month old PS2APP mice<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> were dosed orally with either 15 mg kg<sup>–1</sup> or 50 mg kg<sup>–1</sup> of compound <b>14</b>. This mouse model of Alzheimer’s Disease displays amyloid plaque pathology as well as aberrant DLK/JNK pathway activity in neurons that reflects what is observed in Alzheimer’s patients and thus represents an excellent model for testing of DLK inhibitors in the context of chronic neurodegeneration.<a onclick="showRef(event, 'ref7 ref24'); return false;" href="javascript:void(0);" class="ref ref7 ref24">(7, 24)</a> A single dose of <b>14</b> resulted in significantly decreased phosphorylation of the downstream transcription factor c-Jun at 6 h that correlated well with levels of compound in brain (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A,B), with the 50 mg kg<sup>–1</sup> dose resulting in a near complete inhibition of p-c-Jun. Although phosphorylation of c-Jun is multiple steps downstream of DLK, p-c-Jun was selected as the primary marker for in vivo DLK inhibition as c-Jun phosphorylation in the adult brain is highly specific to stressed neurons while the upstream signaling components MKK4/7 and JNK display high levels of basal phosphorylation unrelated to the PS2APP phenotype, which could confound calculations of in vivo potency.<a onclick="showRef(event, 'ref3 ref6 ref25'); return false;" href="javascript:void(0);" class="ref ref3 ref6 ref25">(3, 6, 25)</a> Consistent with this, a smaller reduction in p-MKK4 and a trend toward reduced p-JNK was also observed following dosing of <b>14</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C,D). P-c-Jun was reduced by 42% at the 15 mg/kg dose where levels of <b>14</b> were 2.09 μM in plasma and 2.79 μM in brain (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B,E). When corrected for protein binding (plasma = 86.8% and brain = 93.2%), free concentration of <b>14</b> was found to be 0.277 μM in plasma and 0.190 μM in brain. Furthermore, when the relationship between free brain concentrations of <b>14</b> was based on data from individual animals rather than dose groups (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D), a strong PK/PD relationship could be observed with an approximate IC<sub>50</sub> of 0.190 μM. These results are consistent with the observations of PK/PD studies with two other DLK inhibitors developed at Genentech when tested in a nerve injury model.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> In all of these studies, the free drug levels required for 50% inhibition of p-c-Jun were consistent with the cell-based p-JNK IC<sub>50</sub> assay when corrected for serum binding.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Single dose of compound <b>14</b> reduces p-c-Jun in the PS2APP model of Alzheimer’s disease. (A) Representative Western blot images of p-MKK4, p-JNK, p-c-Jun, and a GAPDH control from cortical lysates of PS2APP mice treated with vehicle (MCT) or compound <b>14</b> at 15 or 50 mg/kg PO (<i>n</i> = 7–8 animals per group). (B–D) Quantification of p-MKK4, p-JNK, and p-c-Jun following compound <b>14</b> dosing. A significant treatment effect was observed for p-c-Jun at both dose levels while p-MKK4 levels were significantly reduced only at the 50 mg/kg dose as compared to vehicle (****<i>p</i> < 0.0001, **<i>p</i> < 0.01 versus vehicle by Dunnett’s post hoc test, #<i>p</i> < 0.05 by Student’s <i>t</i> test) (C) Total concentration of <b>14</b> in brain 6 h postdose. (D) In vivo PK/PD relationship for brain exposure versus p-c-Jun reduction in individual animals from both dose groups determined an IC<sub>50</sub> = 0.190 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The safety profile of <b>14</b> was then evaluated in a 7-day repeat-dose study in Sprague–Dawley rats, and the compound was shown to be tolerated at doses up to 75 mg kg<sup>–1</sup> (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). Females had higher exposure (∼2-fold by AUC<sub>24h</sub> and <i>C</i><sub>max</sub>) than males. DLK inhibitor <b>14</b> maintained good brain penetration based on the unbound brain/unbound plasma and CSF/unbound plasma ratios (<i>K</i><sub>puu</sub>) assessed 24 h after the last dose. Findings related to dosing with inhibitor <b>14</b> included dose-dependent effects on body weight (reduced gain at 25 mg kg<sup>–1</sup> or loss at 75 mg kg<sup>–1</sup>). Hematology findings associated with <b>14</b> comprised of a dose-dependent decrease in reticulocyte count and immature reticulocyte fraction with no effect on mature red cell mass. At 75 mg kg<sup>–1</sup> in males only, decreases in monocyte and eosinophil counts were also observed. The hematological effects correlated with hypocellularity of the bone marrow that was observed at 75 mg kg<sup>–1</sup>. Other findings included lymphocyte hypocellularity/apoptosis in the spleen, thymus, and lymph nodes, and increases in liver transaminases and total bilirubin with no corresponding histopathology. Based on the tight correlation between IC<sub>50</sub> for DLK inhibition in vitro and in vivo as well as the observation that a ∼ 50% reduction in DLK is sufficient to elicit neuroprotection (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> exposure multiples for this study were calculated based on the p-JNK cell IC<sub>50</sub> for inhibitor <b>14</b> corrected for protein binding in the cell media (IC<sub>50</sub> = 0.195 μM, 0.129 μM when corrected for bovine serum binding).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> This equated to free AUC<sub>24h</sub> levels of 3.096 μM·h. On day 7, inhibitor <b>14</b> achieved exposure multiples of 11 × AUC and 15 × <i>C</i><sub>max</sub> in males, and 22 × AUC and 25 × <i>C</i><sub>max</sub> in females. In summary, DLK inhibitor <b>14</b> was tolerated in rats at concentrations well exceeding those required for DLK inhibition.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Inhibitor <b>14</b> Rat in Vivo Toxicity Study</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg kg<sup>–1</sup> d<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center">sex</th><th class="colsep0 rowsep0" align="center">day 7 free plasma AUC<sub>0–24h</sub> (multiple<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a>)</th><th class="colsep0 rowsep0" align="center">day 7 free plasma <i>C</i><sub>max</sub> (multiple<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a>)</th><th class="colsep0 rowsep0" align="center">day 7 <i>K</i><sub>puu</sub> at 24 h</th><th class="colsep0 rowsep0" align="center">treatment-related findings<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">M (3)</td><td class="colsep0 rowsep0" align="left">12.2 μM·h (3.9×)</td><td class="colsep0 rowsep0" align="left">0.81 μM (6.3×)</td><td class="colsep0 rowsep0" align="left">0.75</td><td class="colsep0 rowsep0" align="left">reduced body weight, gain decreased RET, IRF</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">increased GLDH, ALT, T.Bili (females only)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">F (3)</td><td class="colsep0 rowsep0" align="left">28.0 μM·h (9.0×)</td><td class="colsep0 rowsep0" align="left">1.45 μM (11×)</td><td class="colsep0 rowsep0" align="left">0.59</td><td class="colsep0 rowsep0" align="left">no histopathological findings</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">M (3)</td><td class="colsep0 rowsep0" align="left">34.3 μM·h (11×)</td><td class="colsep0 rowsep0" align="left">1.88 μM (15×)</td><td class="colsep0 rowsep0" align="left">0.84</td><td class="colsep0 rowsep0" align="left">body weight loss, decreased RET, IRF, and increased MCHC</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">F (3)</td><td class="colsep0 rowsep0" align="left">67.1 μM·h (22×)</td><td class="colsep0 rowsep0" align="left">3.19 μM (25×)</td><td class="colsep0 rowsep0" align="left">0.72</td><td class="colsep0 rowsep0" align="left">decreased MON and EOS (males only); increased GLDH, ALT, T.Bili (females only)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">bone marrow hypocellularity; spleen, thymus, lymph nodes (lymphoid hypocellularity/apoptosis)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Multiple = Exposure multiple above targeted free AUC<sub>24h</sub> of 3.096 μM·h or free concentration of 0.129 μM</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">ALT, Alanine aminotransferase; EOS, Eosinophil; GLU, Glucose; GLDH, glutamate dehydrogenase; IRF, Immature reticulocyte fraction; MCHC, Mean corpuscular hemoglobin concentration; MON, Monocyte; RET, Reticulocyte; T.Bili, Total bilirubin.</p></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Chemistry</h3><div class="NLM_p">The preparation of compounds <b>2</b>–<b>9</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Sandmeyer reaction of <i>tert</i>-butyl 4-(3-amino-1-isopropyl-1<i>H</i>-pyrazol-5-yl)piperidine-1-carboxylate (<b>30</b>) resulted in iodopyrazole <b>31</b>. Subsequent <i>N-</i>Boc deprotection followed by reductive amination with 3-oxetanone provided oxetane <b>32</b>. Suzuki–Miyaura cross coupling with the requisite azaindole or aminopyridine boronate furnished compounds <b>2</b>–<b>9</b>. The syntheses of <b>10</b>–<b>13</b>, <b>15</b>–<b>21</b>, <b>23</b>, and <b>26</b>–<b>29</b> are outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Addition of deprotonated acetonitrile to 3-(<i>tert</i>-butyl) 6-ethyl <i>exo</i>-3-azabicyclo[3.1.0]hexane-3,6-dicarboxylate (<b>33</b>) produced α-cyanoketone <b>34</b>. Hydrazine addition to nitrile <b>34</b> with in situ cyclodehydration afforded 3-aminopyrazole <b>35</b>, which was converted to the corresponding 3-iodopyrazole <b>36</b> via a Sandmeyer reaction. <i>N</i>1-Pyrazole alkylation with 2-bromopropane afforded <i>N</i>-isopropyl <b>37</b>, which upon deprotection provided amine <b>38</b> for further derivatization. Additional pyrazole N1 groups were obtained by alkylation of iodopyrazole <b>36</b> with iodomethane, trifluoroethyl triflate, isobutyl bromide, 2,2-dimethyloxirane, cyclobutyl bromide, and cyclopentyl bromide to provide <i>N</i>-methyl <b>39</b>, trifluoroethyl <b>40</b>, isobutyl <b>41</b>, 2-methyl-2-hydroxypropyl <b>42</b>, cyclobutyl <b>43</b>, and cyclopentyl <b>44</b>, respectively. Functionalization of the <i>exo</i>-3-azabicycl[3.1.0]hexane <b>38</b> by reductive amination, acylation, and alkylation provided differentially substituted intermediates <b>45</b>–<b>50</b>. Similarly, acid mediated <i>N</i>-Boc deprotection of <b>39</b>–<b>44</b> followed by reductive amination with 3-oxetanone furnished 3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexanes <b>51</b>–<b>56</b>. Suzuki–Miyaura coupling of intermediates <b>45</b>–<b>56</b> with the appropriately substituted 2-aminopyridyl boronates afforded analogs <b>10</b>–<b>13</b>, <b>15</b>–<b>21</b>, <b>23</b>, and <b>26</b>–<b>29</b>.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaI, NaNO<sub>2</sub>, <i>p</i>-toluenesulfonic acid, CH<sub>3</sub>CN, H<sub>2</sub>O, 0 °C, 0.5 h, 60% yield; (b) (i) HCl, 1,4-dioxane, CH<sub>3</sub>OH, 0–23 °C, 2 h; (ii) 3-oxetanone, NaBH<sub>3</sub>CN, CH<sub>3</sub>OH, 50 °C, 3 h, 95% yield; (c) R–(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl), Pd(dppf)Cl<sub>2,</sub> 1,4-dioxane, H<sub>2</sub>O, Cs<sub>2</sub>CO<sub>3</sub>, 110 °C microwave, 0.5 h.</p></p></figure><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>3</sub>CN, <i>t</i>-BuOK, THF, 23 °C, 1 h, 94% crude yield; (b) hydrazine monohydrate, <i>i-</i>PrOH, 80 °C, 16 h, 80% yield (2-steps); (c) NaI, NaNO<sub>2</sub>, <i>p</i>-toluenesulfonic acid monohydrate, CH<sub>3</sub>CN, H<sub>2</sub>O, 23 °C, 1 h, 26% yield; (d) 2-bromopropane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 23 °C, 10–16 h, 23% yield; (e) R-I, R-Br, or R-OSO<sub>2</sub>CF<sub>3</sub>, Cs<sub>2</sub>CO<sub>3</sub> or K<sub>2</sub>CO<sub>3</sub>, DMF or CH<sub>3</sub>CN, 23 °C, 10–16 h; (f) 2,2-dimethyloxirane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 16 h, 47% yield; (g) (TFA, CH<sub>2</sub>Cl<sub>2</sub>) or (HCl, EtOAc) or (HCl, 1,4-dioxane, CH<sub>3</sub>OH), 23 °C, 1–3 h; (h) 3-oxetanone, NaBH<sub>3</sub>CN, CH<sub>3</sub>OH, 23–60 °C, 1–3 h; (i) R-Br or R-OSO<sub>2</sub>Me, (<i>i</i>-Pr)<sub>2</sub>NEt, THF or DMF, 40–50 °C, 16 h; (j) Ac<sub>2</sub>O, (<i>i</i>-Pr)<sub>2</sub>NEt, 25 °C, 1 h, 75% yield; (k) 2-methyloxirane, CH<sub>3</sub>OH, 23 °C, 16 h, 55% yield; (l) R-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl), Pd(dppf)Cl<sub>2,</sub> Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 100–120 °C microwave, 0.5 h.</p></p></figure><div class="NLM_p">An alternative route was also developed and is exemplified by the preparation of compounds <b>14</b>, <b>22</b>, <b>24</b>, and <b>25</b> in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Amide coupling of (<i>exo</i>)-3-(<i>tert</i>-butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid <b>57</b> with <i>N,O</i>-dimethylhydroxylamine hydrochloride afforded Weinreb amide <b>58</b>. Subsequent addition of methylmagnesium bromide obtained methyl ketone <b>59</b>. Acylation of the lithium enolate of ketone <b>59</b> with ethyl oxalate followed by direct treatment of the ethyl 2,3-dioxobutanoate with isopropyl hydrazine, ethyl hydrazine, or methylcyclopropyl hydrazine yielded pyrazolyl esters <b>60</b>–<b>62</b>, regioselectively. The synthesis of aminopyrazoles <b>66</b>–<b>68</b> was accomplished by the following sequence: saponification of esters <b>60</b>–<b>62</b>; Curtius rearrangement of the resulting acids <b>63</b>–<b>65</b>; and <i>N</i>-Cbz removal by hydrogenolysis afforded 3-aminopyrazoles <b>69</b>–<b>71</b>. Sandmeyer reaction of amino pyrazoles <b>69</b>–<b>71</b> provided 3-iodopyrazoles <b>72</b>–<b>74</b>. Acid mediated <i>N</i>-Boc deprotection and reductive amination with 3-oxetanone yielded oxetanes <b>75</b>–<b>77</b>. Final Suzuki–Miyaura cross coupling of iodides <b>75</b>–<b>77</b> with the required amino pyridyl boronate furnished compounds <b>14</b>, <b>22</b>, <b>24</b>, and <b>25.</b></div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N,O</i>-dimethylhydroxylamine hydrochloride, HATU, Et<sub>3</sub>N, DMF, 23 °C, 2 h, 84% yield; (b) MeMgBr, THF, Et<sub>2</sub>O, 23 °C, 2 h, 89% yield; (c) (i) (CO<sub>2</sub>Et)<sub>2</sub>, LiHMDS, 25 °C, 3 h; (ii) isopropylhydrazine or ethylhydrazine or cyclopropylmethylhydrazine, EtOH, 50 °C, 0.3 h; (d) aq. NaOH, EtOH, 23 °C, 2 h; (e) diphenylphosphoryl azide, BnOH, (<i>i</i>-Pr)<sub>2</sub>NEt, toluene, 90 °C, 4 h; (f) H<sub>2</sub> (1 atm), CH<sub>3</sub>OH, 10% Pd/C, 23 °C, 1.5 h; (g) NaI, NaNO<sub>2</sub>, <i>p</i>-toluenesulfonic acid, CH<sub>3</sub>CN, H<sub>2</sub>O, 0–23 °C, 3 h; (h) (i) (TFA, CH<sub>2</sub>Cl<sub>2</sub>) or (HCl, EtOAc), 23 °C, 1 h; (ii) 3-oxetanone, acetic acid, NaBH<sub>3</sub>CN, CH<sub>3</sub>OH, 40–60 °C, 2 h; (i) R-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub> or Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN or 1,4-dioxane, H<sub>2</sub>O, 105 °C microwave or reflux, 0.25–3.5 h.</p></p></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32263" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32263" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Building upon the broad research interest in DLK as a potential new therapeutic target for treatment of neurodegenerative conditions, we have further optimized recently described pyrazole inhibitor <b>1</b> using a property and structural-based approach. Important to this effort were structure guided variation of key polar contacts with the hinge residues of DLK and introduction of an <i>exo</i>-3-azabicyclo[3.1.0]hexane group that improved potency, kinase selectivity, and CNS pharmacokinetic properties. This effort led to the identification of <b>14</b>, which has favorable in vitro safety properties and in vivo tolerability, enabling interrogation of DLK inhibition in models of chronic neurodegeneration. The notable in vivo properties of these azabicyclo[3.1.0]hexane pyrazoles have advanced our knowledge of the mechanisms of DLK inhibition and our efforts to progress DLK inhibitors toward clinical study.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87800" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87800" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Methods</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> ClogP</h4><div class="NLM_p last">Values were calculated using MoKa v2.6.6, available from Molecular Discovery Ltd.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> p<i>K</i><sub>a</sub></h4><div class="NLM_p last">Values were determined by Analiza Inc. using capillary electrophoresis.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> DLK Biochemical Assay</h4><div class="NLM_p last">The biochemical assay was performed as previously described.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> p-JNK Cell Assay</h4><div class="NLM_p last">The p-JNK cell assay for generation of IC<sub>50</sub> values was performed as previously described.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> In Vitro Axon Degeneration Cell Assay</h4><div class="NLM_p last">The assay was conducted as previously described.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> MKK4 and MKK7 Biochemical Assays</h4><div class="NLM_p last">The assay was conducted as previously described.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> In Vitro Transporter Assays</h4><div class="NLM_p last">The in vitro transporter assays were performed as previously described.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Life Technologies Kinase Assays</h4><div class="NLM_p last">Compounds were tested in Life Technologies’ SelectScreen (Madison, WI) against 220 representative kinases at a concentration of 1 μM, which is 333- and 250-fold greater than the <i>K</i><sub>i</sub> for compounds <b>14</b> and <b>24</b>, respectively, against human recombinant DLK in the DLK enzyme assay. The kinase assays were carried out using Z′-LYTE Technology (Life Technologies, Madison WI), which measured labeled peptide phosphorylation via fluorescence resonance energy transfer (FRET) following protocols developed and performed by Life Technologies.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> DiscoverX KINOMEscan Profiling Service</h4><div class="NLM_p last">Binding affinities were determined at DiscoverX (Fremont, CA) for LZK and DLK.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div><div id="sec5_1_9a" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Structure Determination</h4><div class="NLM_p last">Protein crystallography was performed as previously described,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and refinement statistics are included with the PDB deposition.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Animal Models</h4><div class="NLM_p last">All experiments were performed under animal protocols approved by the Animal Care and Use Committee at Genentech and adhere to ACS Ethical Guidelines for animal studies. For all in vivo studies, PS2APP mice,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Sprague–Dawley rats, and cynomolgus monkeys were dosed with compound <b>14</b> orally as a MCT suspension. Homozygous PS2APP mice (9–10 mo) were given a single oral dose of vehicle or 15 mg kg<sup>–1</sup> or 50 mg kg<sup>–1</sup> of compound <b>14</b>, and terminal plasma was collected from deeply anaesthetized animals via cardiac puncture. The animals were then perfused with PBS, and the brains were extracted. The left cortex and cerebellum were collected and frozen at −80 °C until further processing. The cortex was homogenized in 10<i>V</i> of RIPA buffer for Western blots as described previously.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The cerebellum was used for brain PK measurements.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General</h3><div class="NLM_p last">All commercially available reagents and solvents were used as received. Reactions using air or moisture sensitive reagents were performed under an atmosphere of nitrogen using freshly opened EMD DriSolv solvents. Reaction progress was monitored by TLC or LCMS. Flash chromatography was performed with Isco CombiFlash Companion systems using prepacked silica gel columns (40–60 μm particle size RediSep or 20–40 μm spherical silica gel RediSep Gold columns, or similar columns from other vendors). Preparative reverse phase HPLC purifications were performed on a Varian Prostar instrument, using a Phenomenex Gemini-NX C-18 (3 cm × 5 cm; 5 μM) stationary phase, with 0.1% aqueous formic acid/acetonitrile or 0.1% aqueous ammonium hydroxide/acetonitrile gradients as the mobile phase (typically 5–85% acetonitrile over 10 min) with a flow rate of 60 mL/min. NMR spectra were measured on Bruker 300, 400, or 500 MHz spectrometers, and chemical shifts were reported in ppm downfield from TMS using residual nondeuterated solvent as internal standards (CHCl<sub>3</sub>, 7.26 ppm; DMSO, 2.50 ppm; MeOH, 3.31 ppm). The following abbreviations are used: br = broad signal, s = singlet, d = doublet, dd = doublet of doublets, t = triplet, q = quartet, m = multiplet. The purity of final compounds was verified by HPLC to be >95% in all cases using either of the following methods: (1) Agilent 1200 instrument with an Agilent SB C-18 (2.1 mm × 30 mm; 1.8 μm particle size) stationary phase, and a gradient of water/acetonitrile (5–95% over 10 min; 0.05% TFA in both phases) at a flow rate of 0.4 mL/min; quantification of target and impurities was done by UV detection at 254 nm; (2) Shimadzu LC-2010<i>A</i>/2020A instrument with an Ultimate C-18 (3.0 mm × 50 mm; 3 μm particle size) stationary phase, and a gradient of water/acetonitrile (10–80% over 6 min then 80% over 2 min; 0.05% TFA in both phases) at a flow rate of 1.2 mL/min and oven temperature of 40 °C; quantification of target and impurities was done by UV detection at 254 nm.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Experimental Details</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-Fluoro-5-(1-isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1<i>H</i>-pyrazol-3-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>2</b>)</h4><div class="NLM_p last">To a solution of 4-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-1-(oxetan-3-yl)piperidine <b>(32)</b> (80 mg, 0.2 mmol), 3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (104 mg, 0.40 mmol), and cesium carbonate (139 mg, 0.40 mmol) in 10:1 1,4-dioxane/water (2 mL) was added 1,1′-bis(diphenylphosphino)ferrocene-palladium(II) dichloride (15 mg, 0.02 mmol). The mixture was heated at 110 °C using microwave irradiation. After 30 min, the reaction mixture was concentrated under reduced pressure, and the resulting residue was purified by preparative reverse phase HPLC to afford a white solid (30.5 mg, 40% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>27</sub>FN<sub>5</sub>O 384.2, found 384.0; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.45 (s, 1 H), 8.71–8.70 (m, 1 H), 8.25–8.23 (m, 1 H), 7.43–7.42 (m, 1 H), 6.59 (s, 1 H), 4.57–4.51 (m, 2 H), 4.44–4.41 (m, 1 H), 3.41–3.36 (m, 1 H), 3.07–3.04 (m, 1 H), 2.78–2.69 (m, 2 H), 2.52–2.50 (m, 1 H), 2.48–2.36 (m, 2 H), 1.92–1.81 (m, 3 H), 1.78–1.71 (m, 2 H), 1.42 (d, <i>J</i> = 6.4 Hz, 6 H).</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3-Chloro-5-(1-isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1<i>H</i>-pyrazol-3-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>3</b>)</h4><div class="NLM_p last">The title compound (2 mg, 6% yield) was prepared in a manner analogous to <b>2</b> by substituting 3<b>-</b>chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine for 3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>27</sub>ClN<sub>5</sub>O 400.2, found 399.9; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.72 (s, 1 H), 8.32 (s, 1 H), 7.45 (s, 1 H), 6.55 (s, 1 H), 4.76–4.73 (m, 2 H), 4.68–4.61 (m, 3 H), 3.60–3.57 (m, 1 H), 2.97–2.94 (m, 2 H), 2.88–2.82 (m, 1 H), 2.11–1.99 (m, 4 H), 1.913–1.82 (m, 2 H), 1.55 (d, <i>J</i> = 6.4 Hz, 6 H).</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 5-(1-Isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1<i>H</i>-pyrazol-3-yl)-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>4</b>)</h4><div class="NLM_p last">The title compound (21.7 mg, 12% yield) was prepared in a manner analogous to <b>2</b> by substituting 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine for 3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>30</sub>N<sub>5</sub>O 380.2, found 380.0; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.03 (s, 1 H), 8.81 (s, 1 H), 7.50 (s, 1 H), 6.88–6.85 (m, 1 H), 4.97–4.88 (m, 2 H), 4.79–4.76 (m, 1 H), 4.18–4.09 (m, 2 H), 3.90–3.82 (m, 1 H), 3.69–3.56 (m, 3 H), 3.25–3.13 (m, 1 H), 3.14 (s, 1 H), 2.46 (s, 3 H), 2.35–2.18 (m, 4 H), 1.57 (d, <i>J</i> = 6.0 Hz, 6 H).</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 5-(1-Isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>5</b>)</h4><div class="NLM_p last">The title compound (12.8 mg, 6% yield) was prepared in a manner analogous to <b>2</b> by substituting 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine for 3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>27</sub>F<sub>3</sub>N<sub>5</sub>O 434.2, found 433.9; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.78 (s, 1 H), 8.40 (s, 1 H), 7.88 (s, 1 H), 6.55 (s, 1 H), 4.79–4.75 (m, 2 H), 4.69–4.64 (m, 3 H), 3.74–3.71 (m, 1 H), 3.07–3.02 (m, 2 H), 2.93–2.87 (m, 1 H), 2.35–2.15 (m, 2 H), 2.06–2.03 (m, 2 H), 1.89–1.86 (m, 2 H), 1.54 (d, <i>J</i> = 6.4 Hz, 6 H).</div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 5-(1-Isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1<i>H</i>-pyrazol-3-yl)-3-methoxypyridin-2-amine (<b>6</b>)</h4><div class="NLM_p last">The title compound (5.8 mg, 6% yield) was prepared in a manner analogous to <b>2</b> by substituting 3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine for 3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>30</sub>N<sub>5</sub>O<sub>2</sub> 372.2, found 372.3; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.92 (s, 1H), 7.53 (s, 1H), 7.01 (s, 2H), 6.51 (s, 1H), 4.99–4.47 (m, 5H), 3.94 (s, 3H), 3.06 (s, 1H), 2.49–2.36 (m,4H), 2.01 (s, 5H), 1.42 (d, <i>J</i> = 6.5 Hz, 6H).</div></div><div id="sec5_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 5-(1-Isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethyl)-pyridin-2-amine (<b>7</b>)</h4><div class="NLM_p last">The title compound (24.5 mg, 31% yield) was prepared in a manner analogous to <b>2</b> by substituting 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine for 3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>27</sub>F<sub>3</sub>N<sub>5</sub>O 410.2, found 410.0; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.53 (s, 1 H), 8.13 (s, 1 H), 6.42 (s, 1 H), 4.79–4.76 (m, 2 H), 4.72–4.69 (m, 2 H), 4.62–4.55 (m, 1 H), 3.92–3.86 (m, 1 H), 3.18–3.15 (m, 2 H), 2.97–2.87 (m, 1 H), 2.46–2.39 (m, 2 H), 2.06–2.03 (m, 2 H), 1.92–1.82 (m, 2 H), 1.48 (d, <i>J</i> = 6.8 Hz, 6 H).</div></div><div id="sec5_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 5-(1-Isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1<i>H</i>-pyrazol-3-yl)-3-methylpyridin-2-amine (<b>8</b>)</h4><div class="NLM_p last">The title compound (21.5 mg, 24% yield) was prepared in a manner analogous to <b>2</b> by substituting 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine for 3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>30</sub>N<sub>5</sub>O 356.2, found 356.3; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.19 (s, 1H), 7.93 (s, 1H), 6.88 (s, 2H), 6.45 (s, 1H), 4.82–4.39 (m, 3H), 2.53–2.44 (m, 9H), 2.17 (s, 3H), 1.97 (d, J = 13.0 Hz, 2H), 1.41 (d, J = 6.5 Hz, 6H).</div></div><div id="sec5_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3-Chloro-5-(1-isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1<i>H</i>-pyrazol-3-yl)pyridin-2-amine (<b>9</b>)</h4><div class="NLM_p last">The title compound (21.9 mg, 30% yield) was prepared in a manner analogous to <b>2</b> by substituting 3-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine for 3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine. LCMS: <i>m</i>/<i>z</i> [M + H]+ calcd for C<sub>19</sub>H<sub>27</sub>ClN<sub>5</sub>O 376.2, found 376.0; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.33 (s, 1 H), 7.96 (s, 1 H), 6.19 (s, 1 H), 4.84 (s, 2 H), 4.69–4.62 (m, 4 H), 4.42–4.39 (m, 1 H), 3.52–3.49 (m, 1 H), 2.88–2.85 (m, 2 H), 2.64–2.58 (m, 1 H), 1.98–1.90 (m, 4 H), 1.83–1.79 (m, 2 H), 1.51 (d, <i>J</i> = 6.8 Hz, 6 H).</div></div><div id="sec5_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 5-(1-Isopropyl-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (<b>10</b>)</h4><div class="NLM_p last">To a solution of (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane (<b>45</b>) (0.50 g, 1.34 mmol), 5-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine (463 mg, 1.61 mmol), and cesium carbonate (655 mg, 2.01 mmol) in 10:1 1,4-dioxane/water (5 mL) was added 1,1′-bis(diphenylphosphino)ferrocene-palladium(II)dichloride (196 mg, 0.27 mmol) under nitrogen. The mixture was heated at 100 °C under microwave irradiation. After 30 min, the reaction mixture was concentrated under reduced pressure, and the resulting residue was purified by flash column chromatography (6% ethyl acetate in hexanes) to afford a white solid (297 mg, 54% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>25</sub>F<sub>3</sub>N<sub>5</sub>O 408.2, found 408.0; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.54 (d, <i>J</i> = 2.1 <i>Hz</i>, 1 H), 7.98 (d, <i>J</i> = 2.1 <i>Hz</i>, 1 H), 6.50 (br s, 2 H), 6.39 (s, 1 H), 4.67 (m, 1 H), 4.56 (t, <i>J</i> = 6.6 <i>Hz</i>, 2 H), 4.48 (t, <i>J</i> = 6.0 <i>Hz</i>, 2 H), 3.75 (m, 1 H), 3.12 (d, <i>J</i> = 8.7 <i>Hz</i>, 2 H), 2.42 (m, 2 H), 2.15 (m, 1 H), 1.81 (m, 2 H), 1.42 (d, <i>J</i> = 6.5 <i>Hz</i>, 6 H).</div></div><div id="sec5_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 3-(Difluoromethyl)-5-(1-isopropyl-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)pyridin-2-amine formate (<b>11</b>)</h4><div class="NLM_p last">To a solution of (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane (<b>45</b>) (80 mg, 0.2 mmol), 3-(difluoromethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine (85 mg, 0.3 mmol), and cesium carbonate (163 mg,0.50 mmol) in 5:1 1,4-dioxane/water (4 mL) was added 1,1′-bis(diphenylphosphino)ferrocene-palladium(II)dichloride (15 mg, 0.020 mmol), and the mixture was purged with nitrogen. The mixture was heated at 110 °C under microwave irradiation for 30 min. The reaction mixture was partitioned between ethyl acetate (20 mL) and saturated aqueous sodium chloride solution (15 mL). The organic layer was concentrated. Purification by preparative reverse phase HPLC afforded a white solid (8 mg, 10% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>26</sub>F<sub>2</sub>N<sub>5</sub>O 390.2, found 390.2; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.40 (s, 1H), 8.16 (s, 1H), 8.04–8.02 (m, 1H), 6.83 (t, <i>J</i> = 55.2 Hz, 1 H), 6.21 (s, 1H), 4.76–4.72 (m, 2H), 4.67–4.65 (m, 2H), 3.94–3.90 (m, 1H), 3.40–3.20 (m, 2H), 2.69–2.66 (m, 2H), 2.32–2.30 (s, 1H), 1.94–1.93 (m, 2H), 1.53–1.51(m, 6H).</div></div><div id="sec5_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 5-(1-Isopropyl-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)-3-methoxypyridin-2-amine (<b>12</b>)</h4><div class="NLM_p last">The title compound (19 mg, 19% yield) was prepared in a manner analogous to <b>11</b> by substituting 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(methoxy)pyridin-2-amine for 3-(difluoromethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>28</sub>N<sub>5</sub>O<sub>2</sub> 370.2, found 370.2; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.87 (s, 1H), 7.32 (s, 1H), 6.29 (s, 1H), 5.89 (s, 2H), 4.72–4.46 (m, 5H), 3.84 (s, 3H), 3.18 (s, 2H), 2.48–2.42 (m, 3H), 2.18 (s, 1H), 1.84 (s, 2H), 1.43 (d, <i>J</i> = 6.6 Hz, 6H).</div></div><div id="sec5_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-(Difluoromethoxy)-5-(1-isopropyl-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)pyridin-2-amine (<b>13</b>)</h4><div class="NLM_p last">The title compound (13.6 mg, 26% yield) was prepared in a manner analogous to <b>11</b> by substituting 3-(difluoromethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine for 3-(difluoromethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>26</sub>F<sub>2</sub>N<sub>5</sub>O<sub>2</sub> 406.2, found 406.0; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.16 (s, 1 H), 7.74 (s, 1 H), 6.88 (t, <i>J</i> = 73.2 Hz, 1 H), 6.19 (s, 1 H), 4.80–4.72 (m, 3 H), 4.66–4.63 (m, 2 H), 3.85–3.80 (m, 1 H), 3.23 (d, <i>J</i> = 9.2 Hz, 2 H), 2.54–2.52 (m, 2 H), 2.32–2.30 (m, 1 H), 1.88–1.87 (m, 2 H), 1.54 (d, <i>J</i> = 6.4 Hz, 6 H).</div></div><div id="sec5_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 5-(1-Isopropyl-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethoxy)pyridin-2-amine (<b>14</b>)</h4><div class="NLM_p last">To a suspension of (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane (<b>75</b>) (45 g, 120 mmol), 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethoxy)pyridin-2-amine (44 g, 144 mmol), and cesium carbonate (59 g, 180 mmol) in 10:1 1,4-dioxane/water (990 mL) was added Pd(dppf)Cl<sub>2</sub> (8.82 g, 12 mmol). The mixture was purged with nitrogen for 30 min and heated to reflux for 3.5 h. The reaction was cooled to room temperature and filtered. The filtrate was concentrated in vacuo, and the resulting residue was purified by flash column chromatography (1% methanol in dichloromethane) to afford product (20 g, 39% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.25 (s, 1 H), 7.83 (s, 1 H), 6.19 (s, 1 H), 4.80–4.70 (m, 3 H), 4.64–4.61 (m, 2 H), 3.83–3.76 (m, 1 H), 3.21 (d, <i>J</i> = 8.8 Hz, 2 H), 2.50 (d, <i>J</i> = 8.8 Hz, 2 H), 2.30–2.28 (m, 1 H), 1.87–1.85 (m, 2 H), 1.52 (d, <i>J</i> = 6.4 Hz, 6 H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d6</i>) δ 151.93, 145.33, 143.50, 143.21, 130.10, 125.11, 121.62, 119.57, 119.12, 99.08, 74.58, 55.99, 50.44, 49.29, 24.38, 22.51, 13.98. HRMS (ESI) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>20</sub>H<sub>25</sub>N<sub>5</sub>O<sub>2</sub>F<sub>3</sub> 424.1955; found 424.1944. Anal. Calcd for C<sub>20</sub>H<sub>24</sub>N<sub>5</sub>O<sub>2</sub>F<sub>3</sub>: C, 56.73; H, 5.71; N, 16.54. Found C, 56.58; H, 5.60; N, 16.50; Melting point 198.4–199.1 °C.</div></div><div id="sec5_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 5-(1-Isopropyl-5-((exo)-3-(oxetan-3-ylmethyl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (<b>15</b>)</h4><div class="NLM_p last">The title compound (26 mg, 24% yield) was prepared in a manner analogous to <b>11</b> by substituting (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-ylmethyl)-3-azabicyclo[3.1.0]hexane for (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine for 3-(difluoromethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>26</sub>F<sub>3</sub>N<sub>5</sub>O 422.2, found 422.2; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.54 (s, 1H), 7.97 (s, 1H), 6.50 (s, 2H), 6.37 (s, 1H), 4.74–4.51 (m, 3H), 4.33–4.16 (m, 2H), 3.16–2.95 (m, 3H), 2.74 (d, <i>J</i> = 7.4 Hz, 2H), 2.43–2.30 (m, 2H), 2.15–1.93 (m, 1H), 1.76 (d, <i>J</i> = 2.8 Hz, 2H), 1.41 (d, <i>J</i> = 6.6 Hz, 6H).</div></div><div id="sec5_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 1-((Exo)-6-(3-(6-amino-5-(trifluoromethyl)pyridin-3-yl)-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexan-3-yl)ethanone (<b>16</b>)</h4><div class="NLM_p last">To a solution of 1-((exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexan-3-yl)ethanone (<b>47</b>) (90.0 mg, 0.25 mmol), 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine (134 mg, 0.330 mmol), and cesium carbonate (163 mg, 0.5 mmol) in 6:1 1,4-dioxane/water (3 mL) was added 1,1′-bis(diphenylphosphino)ferrocene-palladium(II)dichloride (18 mg, 0.025 mmol). The mixture was heated at 120 °C under microwave irradiation for 30 min. The reaction mixture was concentrated under reduced pressure and purified by preparative reverse phase HPLC to afford a white solid (65 mg, 66% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>F<sub>3</sub>N<sub>5</sub>O 394.2, found 394.1; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.51 (s, 1 H), 8.12 (s, 1 H), 6.28 (s, 1 H), 4.80–4.74 (m, 1 H), 3.93–3.87 (m, 2 H), 3.79–3.75 (m, 1 H), 3.54–3.50 (m, 1 H), 2.10–2.07 (m, 4 H), 2.04–2.00 (m, 1 H), 1.76–1.74 (m, 1 H), 1.51 (d, <i>J</i> = 6.8 Hz, 6 H).</div></div><div id="sec5_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 5-(5-((Exo)-3-(2,2-difluoroethyl)-3-azabicyclo[3.1.0]hexan-6-yl)-1-isopropyl-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (<b>17</b>)</h4><div class="NLM_p last">To a solution of (exo)-3-(2,2-difluoroethyl)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane (<b>48</b>) (73 mg, 0.19 mmol), 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine (102 mg, 0.38 mmol), and cesium carbonate (125 mg, 0.380 mmol) in 6:1 1,4-dioxane/water (2 mL) was added 1,1′-bis(diphenylphosphino)ferrocene-palladium(II)dichloride (14 mg, 0.019 mmol). The mixture was heated at 120 °C under microwave irradiation for 30 min. The reaction mixture was concentrated under reduced pressure. Purification by preparative reverse phase HPLC afforded an off-white solid (38 mg, 48% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>F<sub>5</sub>N<sub>5</sub> 416.2, found 416.1; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.50 (s, 1 H), 8.11 (s, 1 H), 6.22 (s, 1 H), 6.06–5.76 (m, 1 H), 4.78–4.71 (m, 1 H), 3.28 (d, <i>J</i> = 8.8 Hz, 2 H), 2.93–2.84 (m, 2 H), 2.65–2.63 (m, 2 H), 2.22–2.21 (m, 1 H), 1.84–1.82 (m, 2 H), 1.51 (d, <i>J</i> = 6.8 Hz, 6 H).</div></div><div id="sec5_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 5-(1-Isopropyl-5-((exo)-3-(2-methoxyethyl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (<b>18</b>)</h4><div class="NLM_p last">The title compound (54 mg, yield 20%).) was prepared in a manner analogous to <b>11</b> by using (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(2-methoxyethyl)-3-azabicyclo[3.1.0]hexane for (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine for 3-(difluoromethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>27</sub>F<sub>3</sub>N<sub>5</sub>O 410.2, found 410.0; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.50 (s, 1 H), 8.10 (s, 1 H), 6.24 (s, 1 H), 4.78–4.75 (m, 1 H), 3.60–3.56 (m, 2 H), 3.49–3.46 (m, 2 H), 3.39 (s, 3 H), 3.01–2.94 (m, 2 H), 2.72–2.68 (m, 2 H), 2.36–1.34 (m, 1 H), 2.02–1.98 (m, 2 H), 1.52 (d, <i>J</i> = 6.4 Hz, 6 H).</div></div><div id="sec5_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-((Exo)-6-(3-(6-amino-5-(trifluoromethyl)pyridin-3-yl)-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexan-3-yl)propan-2-ol (<b>19</b>)</h4><div class="NLM_p last">To a solution of 1-((exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexan-3-yl)propan-2-ol (<b>50</b>) (70 mg, 0.2 mmol), 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine (75 mg, 0.26 mmol), and cesium carbonate (130 mg, 0.4 mmol) in 6:1 1,4-dioxane/water (2 mL) was added 1,1′-bis(diphenylphosphino)ferrocene-palladium(II)dichloride (14.6 mg, 0.02 mmol). The mixture was heat at 110 °C under microwave irradiation for 30 min. The reaction mixture was concentrated under reduced pressure. Purification by preparative reverse phase HPLC afforded a white solid (23 mg, 27% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>27</sub>F<sub>3</sub>N<sub>5</sub>O 410.2, found 410.1; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.48 (s, 1H), 8.10 (s, 1H), 6.18 (s, 1H), 4.81–4.76 (m, 1H), 3.86–3.82 (m, 1H), 3.23 (d, <i>J</i> = 9.2 Hz, 2H), 2.57–2.47 (m, 2H), 2.42–2.40 (m, 2H), 2.34–2.32 (m, 1H), 1.79 (s, 2H), 1.50 (d, <i>J</i> = 6.4 Hz, 6H), 1.13 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec5_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 5-(1-Methyl-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (<b>20</b>)</h4><div class="NLM_p last">The title compound (34 mg, 30% yield) was prepared in a manner analogous to <b>11</b> by using (exo)-6-(3-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane for (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine for 3-(difluoromethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.49 (s, 1 H), 8.09 (s, 1 H), 6.26 (s, 1 H), 4.73–4.70 (m, 2 H), 4.63–4.60 (m, 2 H), 3.89 (s, 3 H), 3.79–3.75 (m, 1 H), 3.23 (d, <i>J</i> = 8.8 Hz, 2 H), 2.50 (d, <i>J</i> = 8.8 Hz, 2 H), 2.29 (s, 1 H), 1.86 (s, 2 H).</div></div><div id="sec5_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 5-(1-Methyl-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethoxy)pyridin-2-amine (<b>21</b>)</h4><div class="NLM_p last">The title compound (17.4 mg, 15% yield) was prepared in a manner analogous to <b>11</b> by using (exo)-6-(3-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane for (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethoxy)pyridin-2-amine for 3-(difluoromethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.24 (s, 1 H), 7.85 (s, 1 H), 6.23 (s, 1 H), 4.73–4.60 (m, 4 H), 3.88 (s, 3 H), 3.79 (s, 1 H), 3.23 (d, <i>J</i> = 8.8 Hz, 2 H), 2.50 (d, <i>J</i> = 8.8 Hz, 2 H), 2.29 (s, 1 H), 1.86 (s, 2 H).</div></div><div id="sec5_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 5-(1-Ethyl-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (<b>22</b>)</h4><div class="NLM_p last">A solution of (exo)-6-(1-ethyl-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane (<b>76</b>) (25 mg, 0.07 mmol), 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine (25 mg, 0.088 mmol), and 1,1′-bis(diphenylphosphino)ferrocene-palladium(II)dichloride (10 mg, 0.013 mmol) in acetonitrile (2 mL) and 1 M aqueous potassium carbonate (1 mL) was heated at 105 °C under microwave irradiation for 15 min. The reaction mixture was concentrated, and the resulting residue was purified by preparative-HPLC to afford a white solid (9.5 mg, 35% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>F<sub>3</sub>N<sub>5</sub>O 394.2, found 394.1; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.50 (s, 1H), 8.10 (s, 1H), 6.24 (s, 1H), 4.74–4.70 (m, 2H), 4.65–4.61 (m, 2H), 4.29–4.22 (m, 2H), 3.85–3.81 (m, 1H), 3.31–3.23 (m, 2H), 2.57–2.54 (m, 2H), 2.30 (s, 1H), 1.89 (s, 2H), 1.47–1.43 (m, 3H).</div></div><div id="sec5_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 5-(5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1-(2,2,2-trifluoroethyl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (<b>23</b>)</h4><div class="NLM_p last">The title compound (7.6 mg, 8% yield) was prepared in a manner analogous to <b>11</b> by using (exo)-6-(3-iodo-1-(2,2,2-trifluoroethyl)-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane for (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine for 3-(difluoromethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>F<sub>6</sub>N<sub>5</sub>O 448.2, found 448.1; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.56 (dd, J = 2.2, 0.8 Hz, 1H), 8.09 (dd, J = 2.2, 0.7 Hz, 1H), 6.10 (d, J = 0.7 Hz, 1H), 5.03 (s, 2H), 4.78 (q, J = 8.3 Hz, 2H), 4.70 (t, J = 6.7 Hz, 2H), 4.64–4.53 (m, 2H), 3.81 (tt, J = 6.8, 5.8 Hz, 1H), 3.16 (d, J = 8.8 Hz, 2H), 2.50 (d, J = 8.8, 2.0, 0.8 Hz, 2H), 2.25 (t, J = 3.3 Hz, 1H), 1.85–1.76 (m, 2H).</div></div><div id="sec5_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 5-(1-(Cyclopropylmethyl)-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (<b>24</b>)</h4><div class="NLM_p last">To a suspension of (exo)-6-(1-(cyclopropylmethyl)-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane <b>(77)</b> (40 g, 0.1 mol), 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine (36 g, 0.12 mol), and cesium carbonate (51 g, 0.15 mol) in 10:1 dioxane/water (880 mL) was added 1,1′-bis(diphenylphosphino)ferrocene palladium dichloride (7.3 g, 8.9 mmol). The mixture was purged with nitrogen for 15 min and heated to reflux for 3.5 h. The reaction was cooled to room temperature and filtered. The filtrate was concentrated in vacuo, and the resulting residue was purified by flash column chromatography (1% methanol in dichloromethane) to afford product (23 g, 53%). <sup>1</sup>H NMR (CDCl<sub>3</sub> 400 MHz), δ 8.56 (s, 1H), 8.10 (s, 1H), 6.04 (s, 1H), 5.02 (m, 2H), 4.71 (m, 2H), 4.63 (m, 2H), 4.08 (d, <i>J</i> = 6.8 Hz, 2H), 3.81 (m, 1H), 3.16 (d, <i>J</i> = 8.8 Hz, 2H), 2.50 (m, 2H), 2.27 (t, <i>J</i> = 3.2 Hz, 1H), 1.79 (m, 2H), 1.35 (m, 1H), 0.61 (m, 2H), 0.44 (m, 2H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d6</i>) δ 154.52, 148.83, 145.32, 144.25, 131.05 (q, J = 4.30 Hz), 125.21 (q, z = 270.47 Hz), 117.85, 105.54 (q, J = 31.0 Hz), 98.57, 74.40, 55.80, 52.71, 50.30, 24.97, 14.19, 11.40, 3.50. HRMS (ESI) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>21</sub>H<sub>25</sub>N<sub>5</sub>OF<sub>3</sub> 420.2006; found: 420.2001. Anal. Calcd for C<sub>21</sub>H<sub>24</sub>N<sub>5</sub>OF<sub>3</sub>·0.5H<sub>2</sub>O: C, 58.87; H, 5.88; N, 16.35. Found C, 58.85; H, 5.65; N, 16.33; Melting Point 198.6–200 °C.</div></div><div id="sec5_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 5-(1-(Cyclopropylmethyl)-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethoxy)pyridin-2-amine (<b>25</b>)</h4><div class="NLM_p last">The title compound (29.4 mg, 96% yield) was prepared in a manner analogous to <b>22</b> by substituting (exo)-6-(1-(cyclopropylmethyl)-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane for (exo)-6-(1-ethyl-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethoxy)pyridin-2-amine for 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>25</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub> 436.2, found 436.1; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.26 (s, 1 H), 7.83–7.82 (m, 1 H), 6.21 (s, 1 H), 4.72 (t, <i>J</i> = 6.8 Hz, 2 H), 4.62 (t, <i>J</i> = 6.0 Hz, 2 H), 4.09 (d, <i>J</i> = 7.2 Hz, 2 H), 3.83–3.77 (m, 1 H), 3.20 (d, <i>J</i> = 9.2 Hz, 2 H), 2.51 (d, <i>J</i> = 8.0 Hz, 2 H), 2.33–2.31 (m, 1 H), 1.88 (s, 2 H), 1.37–1.31 (m, 1 H), 0.62–0.58 (m, 2 H), 0.47–0.45 (m, 2 H).</div></div><div id="sec5_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 5-(1-Isobutyl-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (<b>26</b>)</h4><div class="NLM_p last">The title compound (11.9 mg, 11% yield) was prepared in a manner analogous to <b>11</b> by using (exo)-6-(3-iodo-1-isobutyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane for (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine for 3-(difluoromethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.56 (s, 1 H), 8.10 (s, 1 H), 6.02 (s, 1 H), 4.96 (s, 2 H), 4.73–4.63 (m, 4 H), 3.98 (d, <i>J</i> = 7.2 Hz, 2 H), 3.84–3.82 (m, 1 H), 3.17 (d, <i>J</i> = 8.8 Hz, 2 H), 2.51–2.24 (m, 4 H), 1.78 (s, 2 H), 0.98 (d, <i>J</i> = 6.8 Hz, 6 H).</div></div><div id="sec5_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-(3-(6-Amino-5-(trifluoromethyl)pyridin-3-yl)-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-1-yl)-2-methylpropan-2-ol (<b>27</b>)</h4><div class="NLM_p last">The title compound (7.3 mg, 8% yield) was prepared in a manner analogous to <b>11</b> by using 1-(3-iodo-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-1-yl)-2-methylpropan-2-ol for (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine for 3-(difluoromethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>27</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub> 438.2, found 438.1; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.52 (s, 1 H), 8.12 (s, 1 H), 6.26 (s, 1 H), 4.74–4.67 (m, 2 H), 4.63–4.60 (m, 2 H), 4.18 (s, 2 H), 3.82–3.76 (m, 1 H), 3.20 (d, <i>J</i> = 9.2 Hz, 2 H), 2.50 (d, <i>J</i> = 8.4 Hz, 2 H), 2.41–2.40 (m, 1 H), 1.88 (s, 2 H), 1.27 (s, 6 H).</div></div><div id="sec5_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 5-(1-Cyclobutyl-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (<b>28</b>)</h4><div class="NLM_p last">The title compound (5.4 mg, 13% yield) was prepared in a manner analogous to <b>11</b> by using (exo)-6-(1-cyclobutyl-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane for (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine for 3-(difluoromethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>25</sub>F<sub>3</sub>N<sub>5</sub>O 420.2, found 420.2; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.53 (s, 1 H), 8.14 (s, 1 H), 6.25 (s, 1 H), 5.03–4.99 (m, 1 H), 4.76–4.73 (m, 2 H), 4.66–4.63 (m, 2 H), 3.91–3.87 (m, 1 H), 3.32–3.30 (m, 2 H), 2.78–2.62 (m, 4 H), 2.50–2.43 (m, 2 H), 2.28–2.26 (m, 1 H), 1.95–1.90 (m, 4 H).</div></div><div id="sec5_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 5-(1-Cyclopentyl-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (<b>29</b>)</h4><div class="NLM_p last">The title compound (52 mg, 44% yield) was prepared in a manner analogous to <b>11</b> by using (exo)-6-(1-cyclopentyl-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane for (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine for 3-(difluoromethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>27</sub>F<sub>3</sub>N<sub>5</sub>O 434.2, found 433.9; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.52 (s, 1 H), 8.12 (s, 1 H), 6.24 (s, 1 H), 4.94–4.90 (m, 1 H), 4.76–4.73 (m, 2 H), 4.67–4.64 (m, 2 H), 3.88–3.82 (m, 1 H), 3.26 (d, <i>J</i> = 9.2 <i>Hz</i>, 2 H), 2.59–2.56 (m, 2 H), 2.34–2.32 (m, 1 H), 2.18–2.09 (m, 4 H), 2.04–1.98 (m, 2 H), 1.90 (s, 2 H), 1.89–1.74 (m, 2 H).</div></div><div id="sec5_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>tert</i>-Butyl 4-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)piperidine-1-carboxylate (<b>31</b>)</h4><div class="NLM_p last">To an ice-cooled solution of <i>tert</i>-butyl 4-(3-amino-1-isopropyl-1<i>H</i>-pyrazol-5-yl)piperidine-1-carboxylate (<b>30</b>) (0.60 g, 2.0 mmol) in 8:1 acetonitrile/water (15 mL) were added <i>p</i>-toluenesulfonic acid (1.14 g, 6.00 mmol) and sodium nitrite (0.28 g, 4.0 mmol). After 30 min, sodium iodide (0.60 mg, 4.0 mmol) was slowly added, and the reaction was warmed to 23 °C for 3 h. The reaction mixture was poured into water (50 mL), and the resulting solution was extracted with ethyl acetate (3 × 50 mL). The collected organic phase was washed with saturated aqueous sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. Purification of the resulting residue by flash column chromatography (15% ethyl acetate in petroleum ether) afforded a yellow solid (0.5 g, 60% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>27</sub>IN<sub>3</sub>O<sub>2</sub> 420.1, found 420.1.</div></div><div id="sec5_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 4-(3-Iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-1-(oxetan-3-yl)piperidine (<b>32</b>)</h4><div class="NLM_p last">To an ice-cooled solution of <i>tert</i>-butyl 4-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)piperidine-1-carboxylate (<b>31</b>) (1.5 g, 3.6 mmol) in methanol (20 mL) was added 4 M HCl/1,4-dioxane solution (2.5 mL) in methanol (2.5 mL). The reaction was warmed to 23 °C. After 2 h, the mixture was concentrated, and the resulting residue (1.20 g) was dissolved in methanol (30 mL). Oxetan-3-one (1.35 g, 18.8 mmol) was then added, and the mixture was maintained at 23 °C. After 2 h, sodium cyanoborohydride (0.730 g, 11.3 mmol) was added to the reaction, and the mixture was heated at 50 °C. After 3 h, the reaction mixture was diluted with water (100 mL), and the resulting mixture was extracted with ethyl acetate (3 × 100 mL). The collected organic was dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. Purification by flash column chromatography (5:1 → 2:1 petroleum ether/ethyl acetate) afforded a white solid (1.34 g, 95% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>23</sub>IN<sub>3</sub>O 376.3, found 376.1; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.13 (s, 1 H), 4.68–4.60 (m, 4 H), 4.39–4.33 (m, 1 H), 3.52–3.49 (m, 1 H), 2.83 (d, <i>J</i> = 11.6 Hz, 2 H), 2.61–2.53 (m, 1 H), 1.95–1.83 (m, 4 H), 1.78–1.65 (m, 2 H), 1.46 (d, <i>J</i> = 6.8 Hz, 6 H).</div></div><div id="sec5_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>tert</i>-Butyl (exo)-6-(2-cyanoacetyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>34</b>)</h4><div class="NLM_p last">To an ice-cooled solution of (exo)-3-<i>tert</i>-butyl 6-ethyl 3-azabicyclo[3.1.0]hexane-3,6-dicarboxylate (<b>33</b>) (27.0 g, 0.106 mol) in tetrahydrofuran (500 mL) and acetonitrile (21.7 g, 0.529 mol) was added potassium <i>tert</i>-butoxide (21.1 g, 0.188 mmol) over 30 min. The resulting mixture was warmed to 23 °C. After 1 h, the reaction mixture was partitioned between 0.5 M aqueous HCl (200 mL) and ethyl acetate (400 mL). The organic phase was separated, and the aqueous layer was extracted with ethyl acetate (2 × 400 mL). The combined organic phase was washed with saturated aqueous sodium chloride solution (150 mL), dried over anhydrous sodium sulfate, and concentrated to afford crude product (25 g, 94% crude yield) which was used without further purification.</div></div><div id="sec5_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>tert</i>-Butyl (exo)-6-(3-amino-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>35</b>)</h4><div class="NLM_p last">A solution of crude (exo)-<i>tert</i>-butyl 6-(2-cyanoacetyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>34</b>) (25 g, ∼0.1 mol) and hydrazine monohydrate (20 mL) in isopropanol (500 mL) was heated at 80 °C. After 16 h, the reaction was cooled to room temperature and concentrated under reduced pressure. The residue was dissolved in dichloromethane (300 mL) and washed sequentially with water (300 mL) and brine (300 mL). The organic phase was dried over sodium sulfate, filtered, and concentrated. Purification by flash column chromatography (ethyl acetate) afforded a white solid (21 g, 80% 2-steps). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub> 265.2, found 265.1.</div></div><div id="sec5_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>tert</i>-Butyl (exo)-6-(3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>36</b>)</h4><div class="NLM_p last">To an ice-cooled solution of (exo)-<i>tert</i>-butyl 6-(3-amino-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>35</b>) (10.5 g, 39.77 mmol) and <i>p</i>-toluenesulfonic acid hydrate (20.3 g, 119 mmol) in 5:1 acetonitrile/water (120 mL) was added dropwise a solution of sodium nitrite (8.20 g, 119 mmol) and sodium iodide (17.9 g, 119 mmol) in water (10 mL). The mixture was warmed to 23 °C. After 1 h, the reaction mixture was partitioned between water (50 mL) and ethyl acetate (30 mL). The organic was separated and the aqueous was extracted with ethyl acetate (2 × 30 mL). The combined organic was washed with saturated aqueous sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, filtered, and concentrated. Purification by flash column chromatography (ethyl acetate) afforded a yellow solid (3.8 g, 26% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.05 (s, 1 H), 3.80–3.66 (m, 2 H), 3.49–3.41 (m, 2 H), 1.96–1.94 (m, 1 H), 1.82–1.80 (m, 1 H), 1.78–1.70 (m, 1 H), 1.46–1.44 (m, 9 H).</div></div><div id="sec5_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>tert</i>-Butyl (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>37</b>)</h4><div class="NLM_p last">To a solution of (exo)-<i>tert</i>-butyl 6-(3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>36</b>) (7.00 g, 18.7 mmol) and cesium carbonate (12.2 g, 37.3 mmol) in <i>N,N</i>-dimethylformamide (80 mL) was added 2-bromopropane (4.60 g, 37.3 mmol) at 23 °C. After 10 h, the reaction mixture was diluted with ethyl acetate (60 mL). The solids were filtered, and the filtrate was concentrated under reduced pressure. Purification by flash column chromatography (10% ethyl acetate in petroleum ether) afforded a tan solid (1.8 g, 23% yield). <i>R</i><sub><i>f</i></sub> = 0.4 in 20% ethyl acetate in petroleum ether; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.95 (s, 1 H), 4.60–4.53 (m, 1 H), 3.77–3.74 (m, 1 H), 3.67–3.64 (m, 1 H), 3.47–3.44 (m, 2 H), 1.80–1.75 (m, 2 H), 1.59–1.55 (m, 1 H), 1.48–1.46 (m, 15 H).</div></div><div id="sec5_3_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (Exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane (<b>38</b>)</h4><div class="NLM_p last">To an ice-cooled solution of (exo)-<i>tert</i>-butyl 6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>37</b>) (1.0 g, 2.4 mmol) in dichloromethane (20 mL) was added trifluoroacetic acid (3 mL). The resulting mixture was stirred warmed to 23 °C. After 3 h, the mixture was concentrated under reduced pressure. The residue was redissolved in dichloromethane and concentrated under reduced pressure to afford a yellow oil (0.63 g, 81% crude yield), which was used further without purification.</div></div><div id="sec5_3_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>tert</i>-Butyl (exo)-6-(3-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>39</b>)</h4><div class="NLM_p last">To a suspension of (exo)-<i>tert</i>-butyl 6-(3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>36</b>) (1.13 g, 3.00 mmol) and potassium carbonate (459 mg, 3.33 mmol) in acetonitrile (20 mL) was added iodomethane (3.00 g, 21.1 mmol) at 23 °C. After 16 h, the reaction mixture was filtered, and the filtrate was concentrated under reduced pressure. Purification by flash column chromatography (10% ethyl acetate in petroleum ether) afforded a white solid (200 mg, 39% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>21</sub>IN<sub>3</sub>O<sub>2</sub> 390.1, found 390.1.</div></div><div id="sec5_3_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>tert</i>-Butyl (exo)-6-(3-iodo-1-(2,2,2-trifluoroethyl)-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>40</b>)</h4><div class="NLM_p last">A suspension of <i>tert</i>-butyl (exo)-6-(3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>36</b>) (0.600 g, 1.60 mmol), 2,2,2-trifluoroethyl trifluoromethanesulfonate (742 mg, 3.20 mmol), and cesium carbonate (1.04 g, 3.20 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (6 mL) was heated at 60 °C for 2 h. The reaction mixture was diluted with ethyl acetate (60 mL), and the resulting mixture was sequentially washed with saturated aqueous sodium bicarbonate solution (40 mL), water (20 mL), and saturated aqueous sodium chloride solution (20 mL). The organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. Purification by flash column chromatography (0 → 15% ethyl acetate in heptane) afforded the a yellow solid (684 mg, 94% yield).</div></div><div id="sec5_3_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>tert</i>-Butyl (exo)-6-(3-iodo-1-isobutyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>41</b>)</h4><div class="NLM_p last">The title compound (400 mg, 31%) was prepared in a manner analogous to <b>37</b> by substituting 1-bromo-2-methylpropane for 2-bromopropane. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>27</sub>IN<sub>3</sub>O<sub>2</sub> 432.1, found 432.2.</div></div><div id="sec5_3_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>tert</i>-Butyl (exo)-6-(1-(2-hydroxy-2-methylpropyl)-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>42</b>)</h4><div class="NLM_p last">A suspension of <i>tert</i>-butyl (exo)-6-(3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>36</b>) (200 mg, 0.533 mmol), 2,2-dimethyloxirane (154 mg, 2.14 mmol), and cesium carbonate (347 mg, 1.07 mmol) in <i>N,N-</i>dimethylformamide (5 mL) was heated 90 °C for 16 h. The mixture was filtered, and the filtrate was concentrated under reduced pressure. Purification by flash column chromatography (40% ethyl acetate in petroleum ether) afforded a white solid (111 mg, 47% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>27</sub>IN<sub>3</sub>O<sub>3</sub> 448.1, found 447.9.</div></div><div id="sec5_3_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>tert</i>-Butyl (exo)-6-(1-cyclobutyl-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>43</b>)</h4><div class="NLM_p last">The title compound (350 mg, 16% yield) was prepared in a manner analogous to <b>37</b> by substituting bromocyclobutane for 2-bromopropane. <i>R</i><sub><i>f</i></sub> = 0.3 in 12:1 petroleum ether/ethyl acetate; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.97 (s, 1 H), 4.81–4.76 (m, 1 H), 3.79–3.65 (m, 2 H), 3.47–3.44(m, 2 H), 2.74–2.70 (m, 2 H), 2.42–2.34 (m, 2 H), 1.90–1.54 (m, 5 H), 1.47 (s, 9 H).</div></div><div id="sec5_3_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>tert</i>-Butyl (exo)-6-(1-cyclopentyl-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>44</b>)</h4><div class="NLM_p last">The title compound (810 mg, 30% yield) was prepared in a manner analogous to <b>37</b> by substituting bromocyclopentane for 2-bromopropane. <i>R</i><sub><i>f</i></sub> = 0.4 in 6:1 petroleum ether/ethyl acetate; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.95 (s, 1 H), 4.60–4.53 (m, 1 H), 3.77–3.74 (m, 1 H), 3.67–3.64 (m, 1 H), 3.47–3.44 (m, 2 H), 1.80–1.75 (m, 2 H), 1.59–1.55 (m, 1 H), 1.48–1.46 (m, 15 H).</div></div><div id="sec5_3_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (Exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane (<b>45</b>)</h4><div class="NLM_p last">To a solution of crude (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane (<b>38</b>) (0.78 g, ∼2.46 mmol) and triethylamine (0.2 mL) in methanol (10 mL) was added oxetan-3-one (0.880 g, 12.3 mmol) at 23 °C for 1 h before the addition of sodium cyanoborohydride (774 mg, 12.3 mmol). After 3 h, the mixture was partitioned between water (15 mL) and ethyl acetate (20 mL). The aqueous layer was separated and extracted with ethyl acetate (2 × 20 mL). The combined organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated. Purification by flash column chromatography (10% ethyl acetate in petroleum ether) afforded a white solid (0.62 g, 68% 2-steps). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>21</sub>IN<sub>3</sub>O 374.1, found 373.8.</div></div><div id="sec5_3_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (Exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-ylmethyl)-3-azabicyclo[3.1.0]hexane (<b>46</b>)</h4><div class="NLM_p last">A solution of (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane (<b>38</b>) (0.500 g, 1.58 mmol), 3-(bromomethyl)oxetane (476 mg, 3.15 mmol), and <i>N,N</i>-diisopropylethylamine (2.75 mL, 15.8 mmol) in <i>N,N-</i>dimethylformamide (5 mL) was heated at 50 °C for 16 h. The reaction mixture was concentrated under reduced pressure to afford a yellow oil (611 mg, 99% crude yield), which was used without further purification. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>23</sub>IN<sub>3</sub>O 388.1, found 388.3.</div></div><div id="sec5_3_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 1-((Exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexan-3-yl)ethanone (<b>47</b>)</h4><div class="NLM_p last">To a solution of (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane (<b>38</b>) (106 mg, 0.33 mmol) and <i>N,N</i>-diisopropylethylamine (0.12 mL, 0.67 mmol) in dichloromethane (2 mL) was added acetic anhydride (68 mg, 0.67 mmol) at 23 °C. After 1 h, the mixture was concentrated, and the resulting residue was purified by preparative TLC (70% ethyl acetate in petroleum ether) to afford an off-white solid <b>(</b>90 mg, 75% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>19</sub>IN<sub>3</sub>O 360.1, found 360.1.</div></div><div id="sec5_3_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (Exo)-3-(2,2-difluoroethyl)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane (<b>48</b>)</h4><div class="NLM_p last">A solution of (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane (<b>38</b>) (83 mg, 0.26 mmol), 2,2-difluoroethyl trifluoromethanesulfonate (280 mg, 1.31 mmol), and <i>N,N</i>-diisopropylethylamine (0.10 mL, 0.52 mmol) in tetrahydrofuran (5 mL) was heated at 40 °C. After 14 h, the reaction mixture was concentrated under reduced pressure, and the resulting residue was purified by preparative TLC (30% ethyl acetate in petroleum ether) to afford a white solid (73 mg, 73% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>19</sub>F<sub>2</sub>IN<sub>3</sub> 382.1, found 381.9.</div></div><div id="sec5_3_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (Exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(2-methoxyethyl)-3-azabicyclo[3.1.0]hexane (<b>49</b>)</h4><div class="NLM_p last">The title compound (145 mg, 89% crude yield) was prepared in a manner analogous to (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-ylmethyl)-3-azabicyclo[3.1.0]hexane (<b>46</b>) by substituting 1-bromo-2-methoxyethane for 3-(bromomethyl)oxetane. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>23</sub>IN<sub>3</sub>O 376.1, found 376.1.</div></div><div id="sec5_3_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 1-((Exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexan-3-yl)propan-2-ol (<b>50</b>)</h4><div class="NLM_p last">To a solution of (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane (<b>38</b>) (342 mg, 1.08 mmol) in methanol (5 mL) was added 2-methyloxirane (189 mg, 3.24 mmol) at 23 °C. After 16 h, the reaction mixture was concentrated under reduced pressure, and the resulting residue was purified by flash column chromatography (30% ethyl acetate in petroleum ether) to afford a white solid (220 mg, 55% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>23</sub>IN<sub>3</sub>O 376.1, found 375.8.</div></div><div id="sec5_3_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (Exo)-6-(3-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane (<b>51</b>)</h4><div class="NLM_p last">To an ice-cooled solution of <i>tert</i>-butyl (exo)-6-(3-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>39</b>) (550 mg, 1.41 mmol) in ethyl acetate (10 mL) was added 4 M hydrogen chloride in ethyl acetate (5 mL) at 23 °C. After 1 h, the reaction mixture was concentrated to afford crude amine (408 mg), which was used without further purification. LCMS (ESI): <i>m</i>/<i>z</i> = 290.1 [M + H]<sup>+</sup>. To a solution of crude (exo)-6-(3-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane hydrochloride (408 mg) in methanol (20 mL) were added triethylamine (0.5 mL), oxetan-3-one (508 mg, 7.06 mmol), and acetic acid (0.5 mL). The reaction was heated at 50 °C for 1 h. After cooling to 23 °C, sodium cyanoborohydride (133 mg, 2.10 mmol) was added, and the mixture was heated at 60 °C for 1 h. The reaction mixture was concentrated, and the resulting residue was dissolved in ethyl acetate (30 mL). The organic solution was washed with saturated aqueous sodium chloride solution (15 mL) and concentrated. Purification by preparative reverse phase HPLC afforded an off-white solid (320 mg, 66% yield). LCMS: <i>m</i>/<i>z</i> 346.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (Exo)-6-(3-iodo-1-(2,2,2-trifluoroethyl)-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane (<b>52</b>)</h4><div class="NLM_p last">The title compound (88 mg, 44% yield) was prepared in a manner analogous to <b>51</b> by substituting <i>tert</i>-butyl (exo)-6-(3-iodo-1-(2,2,2-trifluoroethyl)-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate for <i>tert</i>-butyl (exo)-6-(3-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>16</sub>F<sub>3</sub>IN<sub>3</sub>O 414.0, found 414.2.</div></div><div id="sec5_3_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (Exo)-6-(3-iodo-1-isobutyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane (<b>53</b>)</h4><div class="NLM_p last">The title compound (330 mg, 28% yield) was prepared in a manner analogous to <b>51</b> by substituting <i>tert</i>-butyl (exo)-6-(3-iodo-1-isobutyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate for <i>tert</i>-butyl (exo)-6-(3-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>23</sub>IN<sub>3</sub>O 388.1, found 388.2.</div></div><div id="sec5_3_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 1-(3-iodo-5-((exo)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1<i>H</i>-pyrazol-1-yl)-2-methylpropan-2-ol (<b>54</b>)</h4><div class="NLM_p last">To a round-bottomed flask charged with <i>tert</i>-butyl (exo)-6-(1-(2-hydroxy-2-methylpropyl)-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>42</b>) (111 mg, 0.248 mmol) was added 4 M hydrogen chloride in 1,4-dioxane (4 mL) at 23 °C. After 1 h, the reaction mixture was concentrated to afford an off-white solid (86 mg), which was used without further purification. LCMS: <i>m</i>/<i>z</i> = 347.8 [M + H]<sup>+</sup>. To a solution of 1-(5-((exo)-3-azabicyclo[3.1.0]hexan-6-yl)-3-iodo-1<i>H</i>-pyrazol-1-yl)-2-methylpropan-2-ol hydrochloride (86 mg) in methanol (5 mL) were added oxetan-3-one (54 mg, 0.74 mmol) and acetic acid (0.1 mL). The mixture was heated at 60 °C for 30 min. After cooling to 23 °C, sodium cyanoborohydride (47 mg, 0.74 mmol) was added, and the mixture was heated at 60 °C for 1.5 h. The reaction mixture was concentrated, and the resulting residue was purified by preparative-TLC (70% ethyl acetate in petroleum ether) to afford a white solid (88 mg, 89% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>23</sub>IN<sub>3</sub>O<sub>2</sub> 404.1, found 403.8.</div></div><div id="sec5_3_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (Exo)-6-(1-cyclobutyl-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane (<b>55</b>)</h4><div class="NLM_p last">The title compound (250 mg, 80% yield) was prepared in a manner analogous to <b>51</b> by substituting <i>tert</i>-butyl (exo)-6-(1-cyclobutyl-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate for <i>tert</i>-butyl (exo)-6-(3-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>21</sub>IN<sub>3</sub>O 386.1, found 385.9.</div></div><div id="sec5_3_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (Exo)-6-(1-cyclopentyl-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane (<b>56</b>)</h4><div class="NLM_p last">The title compound (138 mg, 97% yield) was prepared in a manner analogous to <b>51</b> by substituting <i>tert</i>-butyl (exo)-6-(1-cyclopentyl-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate for <i>tert</i>-butyl (exo)-6-(3-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>23</sub>IN<sub>3</sub>O 400.1, found 400.0.</div></div><div id="sec5_3_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> <i>tert</i>-Butyl (exo)-6-(methoxy(methyl)carbamoyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>58</b>)</h4><div class="NLM_p last">To a solution of 3-(<i>tert</i>-butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid (<b>57</b>) (27 g, 0.12 mol), <i>N,O</i>-dimethylhydroxylamine hydrochloride (11.7 g, 0.12 mol), and 1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate (45 g, 0.12 mol) in <i>N,N</i>-dimethylformamide (300 mL) was added triethylamine (36 g, 0.36 mol) at 23 °C. After 2 h, the reaction mixture was evaporated under reduced pressure, and the resulting residue was diluted with ethyl acetate (300 mL). The organic phase was sequentially washed with aqueous 1 N sodium hydroxide solution (2 × 100 mL), water, and saturated aqueous sodium chloride solution. The collected organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated. Purification by flash column chromatography (20% ethyl acetate in petroleum ether) afforded a white solid (27 g, 84% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 3.74 (s, 3H), 3.68–3.65 (m, 1H), 3.58–3.55 (m, 1H), 3.48–3.44 (m, 2H), 3.20 (s, 3H), 2.09–2.04 (m, 2H), 1.97 (s, 1H), 1.45 (s, 9H).</div></div><div id="sec5_3_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> <i>tert</i>-Butyl (exo)-6-acetyl-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>59</b>)</h4><div class="NLM_p last">To an ice-cooled solution of <i>tert</i>-butyl (exo)-6-(methoxy(methyl)carbamoyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>58</b>) (27 g, 0.1 mol) in tetrahydrofuran (500 mL) was added dropwise a solution of 3 M methylmagnesium bromide in diethyl ether (167 mL, 0.5 mol). The mixture was warmed to 23 °C. After 2 h, the reaction mixture was diluted with saturated aqueous ammonium chloride solution (250 mL), and the resulting mixture was extracted with ethyl acetate (2 × 300 mL). The combined organic phase was washed with saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated. Purification by flash column chromatography (10% ethyl acetate in petroleum ether) afforded an off-white solid (20 g, 89% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 3.68–3.66 (m, 1H), 3.60–3.56 (m, 1H), 3.43–3.40 (m, 2H), 2.26 (s, 3H), 2.09–2.07 (m, 2H), 1.83–1.81 (m, 1H), 1.45 (s, 9H).</div></div><div id="sec5_3_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> <i>tert</i>-Butyl (exo)-6-(3-(ethoxycarbonyl)-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>60</b>)</h4><div class="NLM_p last">To an ice-cooled solution of <i>tert</i>-butyl (exo)-6-acetyl-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>59</b>) (137 g, 610 mmol) and diethyl oxalate (134 g, 916 mmol) in tetrahydrofuran (1.26 L) was added dropwise lithium bis(trimethylsilyl)amide (1.2 L, 1.2 mol, 1.0 M in tetrahydrofuran). The mixture was warmed to 23 °C. After 1 h, the reaction mixture was poured into 0.5 M hydrochloric acid (20 L). The resulting mixture was extracted with ethyl acetate (3 × 2 L). The combined organic was washed with saturated aqueous sodium chloride solution (2 L), dried over anhydrous sodium sulfate, filtered, and concentrated. To a solution of the resulting residue (250 g) in ethanol (3.05 L) was added isopropylhydrazine hydrochloride (216 g, 1.95 mol) at 23 °C. After 13 h, the reaction was concentrated in vacuo. This sequence was repeated four additional times on the same scale. The combined material was purified by flash column chromatography (6 → 12% ethyl acetate in petroleum ether) to afford a yellow solid (770 g, 69% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.35 (s, 1H), 4.71–4.61 (m, 1H), 4.34 (q, <i>J</i> = 7.2 Hz, 2H), 3.78–3.63 (m, 2H), 3.45 (br. d., <i>J</i> = 11.2 Hz, 2H), 1.88–1.74 (m, 3H), 1.59 (t, <i>J</i> = 3.2 Hz, 1H), 1.51 (d, <i>J</i> = 6.8 Hz, 7H), 1.44 (s, 10H), 1.34 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec5_3_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> <i>tert</i>-Butyl (exo)-6-(3-(ethoxycarbonyl)-1-ethyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>61</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl (exo)-6-acetyl-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>59</b>) (2.5 g, 11 mmol) and diethyl oxalate (2.4 g, 0.020 mol) in tetrahydrofuran (50 mL) was added lithium bis(trimethylsilyl)amide (22 mL, 66.6 mmol, 3.0 M in tetrahydrofuran) at −70 °C. The mixture was warmed to 23 °C. After 3 h, the reaction mixture was poured into 0.5 M hydrochloric acid (100 mL), and the resulting mixture was extracted with ethyl acetate (2 × 50 mL). The combined organic phase was washed with saturated aqueous sodium chloride solution (20 mL), dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. A solution of the resulting residue and ethylhydrazine (1.5 g, 25 mmol) in ethanol (40 mL) was heated at 50 °C. After 20 min, the reaction was concentrated in vacuo. Purification by flash column chromatography (20% ethyl acetate in petroleum ether) afforded a yellow solid (2.6 g, 69% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.39 (s, 1H), 4.40–4.25 (m, 4H), 3.78–3.68 (m, 2H), 3.51–3.47 (m, 2H), 1.85–1.60 (m, 2H), 1.49–1.47 (m, 1H), 1.46–1.36 (m, 15H).</div></div><div id="sec5_3_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> <i>tert</i>-Butyl (exo)-6-(1-(cyclopropylmethyl)-3-(ethoxycarbonyl)-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>62</b>)</h4><div class="NLM_p last">The title compound (260 g, 52% yield) was prepared in a manner analogous to <b>61</b> by substituting (cyclopropylmethyl)hydrazine for ethylhydrazine. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.40 (s, 1H), 4.36–4.41 (m, 2H), 4.11–4.12 (m, 2H), 3.66–3.77 (m, 2H), 3.47–3.51 (m, 2H), 1.83–1.88 (m, 2H), 1.63–1.65 (m, 1H), 1.48 (m, 9H), 1.34–1.40 (m, 3H), 1.32 (m, 1H), 0.58–0.63 (m, 2H), 0.41–0.43 (m, 2H).</div></div><div id="sec5_3_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 5-((Exo)-3-(<i>tert</i>-butoxycarbonyl)-3-azabicyclo[3.1.0]hexan-6-yl)-1-isopropyl-1<i>H</i>-pyrazole-3-carboxylic acid (<b>63</b>)</h4><div class="NLM_p last">To a solution <i>tert</i>-butyl (exo)-6-(3-(ethoxycarbonyl)-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>60</b>) (385 g, 1.06 mol) in ethanol (2.54 L) was added 6 M aqueous sodium hydroxide solution (794 mL) at room temperature. After 30 min, ethanol was removed from the reaction in vacuo, and the remaining solution was diluted with water (4 L). The aqueous solution was acidified to pH = 2 with 2 M hydrochloric acid. The resulting solids were filtered, rinsed with water (2 L), and dried. This reaction was performed twice to afford crude product (710 g, 99% yield), which was used without further purification. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub> 336.2, found 336.2.</div></div><div id="sec5_3_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 5-((Exo)-3-(<i>tert</i>-butoxycarbonyl)-3-azabicyclo[3.1.0]hexan-6-yl)-1-ethyl-1<i>H</i>-pyrazole-3-carboxylic acid (<b>64</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl (exo)-6-(3-(ethoxycarbonyl)-1-ethyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>61</b>) (2.64 g, 7.5 mmol) in ethanol (30 mL) was added 7.6 M aqueous sodium hydroxide (5 mL) at 23 °C. After 2 h, the organic was removed under reduced pressure, and the remaining aqueous solution was diluted with water (10 mL). The aqueous solution was acidified to pH = 2 with 2 M hydrochloric acid. The mixture was extracted with ethyl acetate (2 × 30 mL). The combined organic was washed with brine, dried over sodium sulfate, filtered, and concentrated to afford a brown solid (1.5 g, 63% crude yield), which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d6</i>): δ 12.5 (br, 1H), 6.38 (s, 1H), 4.2–4.19 (m, 2H), 3.61–3.56 (m, 2H), 3.43–3.38 (m, 2H), 1.93–1.90 (m, 2H), 1.74–1.71 (m, 1H), 1.40 (s, 9H), 1.36–1.32 (m, 3H).</div></div><div id="sec5_3_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 5-((Exo)-3-(<i>tert</i>-butoxycarbonyl)-3-azabicyclo[3.1.0]hexan-6-yl)-1-(cyclopropylmethyl)-1<i>H</i>-pyrazole-3-carboxylic acid (<b>65</b>)</h4><div class="NLM_p last">The title compound (420 g, 87% yield) was prepared in a manner analogous to <b>64</b> using (exo)-<i>tert</i>-butyl 6-(1-(cyclopropylmethyl)-3-(ethoxycarbonyl)-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate for (exo)-<i>tert</i>-butyl 6-(3-(ethoxycarbonyl)-1-ethyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.37 (s, 1H), 4.07–4.09 (m, 2H), 3.57 (m, 2H), 3.43 (m, 2H), 1.93 (m, 2H), 1.74 (m, 1H), 1.39 (s, 9H), 1.24 (m, 1H), 0.50–0.52 (m, 2H), 0.35–0.36 (m, 2H).</div></div><div id="sec5_3_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> <i>tert</i>-Butyl (exo)-6-(3-(((benzyloxy)carbonyl)amino)-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>66</b>)</h4><div class="NLM_p last">To a solution of 5-((exo)-3-(<i>tert</i>-butoxycarbonyl)-3-azabicyclo[3.1.0]hexan-6-yl)-1-isopropyl-1<i>H</i>-pyrazole-3-carboxylic acid (<b>63</b>) (355 g, 1.06 mol), <i>N,N</i>-diisopropylethylamine (277 mL, 1.59 mmol), and benzyl alcohol (343 g, 3.18 mol) in toluene (3 L) at 100 °C was added dropwise diphenyl phosphorylazide (437 g, 1.59 mmol) in toluene (500 mL). The resulting reaction mixture was stirred at 100 °C. After 3 h, the reaction was concentrated in vacuo. The residues from two reactions performed on the same scale were combined and purified by flash column chromatography (9 → 25% ethyl acetate in petroleum ether) to afford a yellow solid (770 g, 82% yield). LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>33</sub>N<sub>4</sub>O<sub>4</sub> 441.3, found 441.1.</div></div><div id="sec5_3_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>tert</i>-Butyl (exo)-6-(3-(((benzyloxy)carbonyl)amino)-1-ethyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>67</b>)</h4><div class="NLM_p last">To a solution of (exo)-5-(3-(<i>tert</i>-butoxycarbonyl)-3-azabicyclo[3.1.0]hexan-6-yl) −1-ethyl-1<i>H</i>-pyrazole-3-carboxylic acid (<b>64</b>) (1.5 g, 4.8 mmol), <i>N,N</i>-diisopropylethylamine (1.1 mL, 6.3 mmol), and benzyl alcohol (2.6 g, 24 mmol) in toluene (30 mL) at 90 °C was added dropwise a solution of diphenylphosphorazidate (1.98 g, 7.2 mmol) in toluene (5 mL). Upon complete addition of DPPA, the reaction mixture was maintained at 90 °C for 4 h. The reaction mixture was concentrated in vacuo, and the resulting residue was purified by flash column chromatography (20% ethyl acetate in petroleum ether) to afford a white solid (1.4 g, 70% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.52 (s, 1H), 7.39–7.34 (m, 5H), 6.11 (s, 1H), 5.18 (s, 2H), 4.06–4.00 (m, 2H), 3.78–3.64 (m, 2H), 3.49–3.45 (m, 2H), 1.88–1.79 (m, 2H), 1.59–1.56 (m, 1H), 1.48 (s, 9H), 1.34–1.32 (m, 6H).</div></div><div id="sec5_3_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>tert</i>-Butyl (exo)-6-(3-(benzyloxycarbonylamino)-1-(cyclopropylmethyl)-<i>1H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>68</b>)</h4><div class="NLM_p last">The title compound (50 g, 99% crude yield) was prepared in a manner analogous to <b>67</b> substituting 5-((exo)-3-(<i>tert</i>-butoxycarbonyl)-3-azabicyclo[3.1.0]hexan-6-yl)-1-(cyclopropylmethyl)-1<i>H</i>-pyrazole-3-carboxylic acid for (exo)-5-(3-(<i>tert</i>-butoxycarbonyl)-3-azabicyclo[3.1.0]hexan-6-yl)-1-ethyl-1<i>H</i>-pyrazole-3-carboxylic acid. The material was used without purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.76 (s, 1H), 7.32–7.37 (m, 5H), 6.12 (s, 1H), 5.18 (m, 2H), 3.85–3.86 (m, 2H), 3.63–3.75 (m, 2H), 3.45–3.48 (m, 2H), 1.80–1.88 (m, 2H), 1.53 (m, 1H), 1.47 (s, 9H), 1.13–1.19 (m, 1H), 0.51–0.55 (m, 2H), 0.28–0.30 (m, 2H).</div></div><div id="sec5_3_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>tert</i>-Butyl (exo)-6-(3-amino-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>69</b>)</h4><div class="NLM_p last">A solution of <i>tert</i>-butyl (exo)-6-(3-(((benzyloxy)carbonyl)amino)-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>66</b>) (77 g, 1.7 mol) and 10% palladium on carbon (10 g) in methanol (1.2 L) was stirred under hydrogen (50 psi) at room temperature. After 1 h, the reaction was filtered, and the filtrate was concentrated in vacuo. This reaction was performed 10× to provide crude product as a colorless oil (510 g), which was without further purification. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub> 307.2, found 307.2.</div></div><div id="sec5_3_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> <i>tert</i>-Butyl (exo)-6-(3-amino-1-ethyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>70</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl (exo)-6-(3-(((benzyloxy)carbonyl)amino)-1-ethyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>67</b>) (1.3 g, 3.0 mmol) in methanol (15 mL) was added Pd/C (200 mg, 10% on carbon). The mixture was stirred under hydrogen (1 atm) at 23 °C for 1.5 h. The reaction mixture was filtered, and the filtrate was concentrated in vacuo to afford a colorless oil (850 mg, 80% crude yield), which was used without further purification. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>25</sub>N<sub>4</sub>O<sub>2</sub> 293.2, found 293.2.</div></div><div id="sec5_3_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> <i>tert</i>-Butyl (exo)-6-(3-amino-1-(cyclopropylmethyl)-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>71</b>)</h4><div class="NLM_p last">The title compound (50 g, 87% yield) was prepared in a manner analogous to <b>70</b> and substituting <i>tert</i>-butyl (exo)-6-(3-(benzyloxycarbonylamino)-1-(cyclopropylmethyl)-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate for <i>tert</i>-butyl (exo)-6-(3-(((benzyloxy)carbonyl)amino)-1-ethyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub><b>)</b> δ 5.05–5.07 (s, 1H), 4.37 (m, 2H), 3.72–3.74 (m, 2H), 3.52–3.54 (m, 2H), 3.36–3.39 (m, 2H), 1.75 (m, 2H), 1.51–1.53 (m, 1H), 1.39 (s, 9H), 1.11–1.16 (m, 1H), 0.42–0.47 (m, 2H), 0.25–0.28 (m, 2H).</div></div><div id="sec5_3_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> <i>tert</i>-Butyl (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>72</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl (exo)-6-(3-amino-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>69</b>) (125 g, 408 mmol) and <i>p</i>-toluenesulfonic acid mono hydrate (233 g, 1.22 mol) in acetonitrile (2.36 L) and water (602 mL) at 10 °C was added dropwise a solution of sodium nitrite (70.4. 1.02 mmol) and sodium iodide (153 g, 1.02 mol) in water (602 mL). Upon complete addition of reagents, the reaction was warmed to 23 °C. After 1 h, the reaction was cooled to 0 °C and diluted with sodium sulfite aqueous solution (500 mL). The resulting mixture was extracted with ethyl acetate (3 × 2 L). The combined organic was washed with saturated aqueous sodium chloride solution (1 L), dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. Purification by flash column chromatography (6 → 9% ethyl acetate in petroleum ether) afforded a yellow oil (400 g, 58% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.94 (s, 1H), 4.55 (m, 1H), 3.73 (br. d., <i>J</i> = 11.2 Hz, 1H), 3.64 (br. d., <i>J</i> = 11.2 Hz, 1H), 3.44 (br. d., <i>J</i> = 11.2 Hz, 2H), 1.76 (br. d., <i>J</i> = 19.2 Hz, 2H), 1.54 (t, <i>J</i> = 3.2 Hz, 1H), 1.47–1.40 (m, 15H).</div></div><div id="sec5_3_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> <i>tert</i>-Butyl (exo)-6-(1-ethyl-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>73</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl 6-(3-amino-1-ethyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>70</b>) (0.600 g, 2.05 mmol) and <i>p</i>-toluenesulfonic acid (1.16 g, 6.10 mmol) in acetonitrile (20 mL) and water (2 mL) at 23 °C was added dropwise a solution of sodium nitrite (350 mg. 5.1 mmol) and sodium iodide (770 mg, 5.1 mmol) in water (5 mL). After 3 h, the reaction was diluted with ethyl acetate (50 mL). The aqueous layer was separated and extracted with ethyl acetate (2 × 20 mL). The combined organic phase was washed with saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. Purification by flash column chromatography (10% ethyl acetate in petroleum ether) afforded a brown oil (0.50 g, 75% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.97 (s, 1H), 4.22–4.16 (m, 2H), 3.79–3.66 (m, 2H), 3.51–3.45 (m, 2H), 1.82–1.78 (m, 2H), 1.52–1.42 (m, 13H).</div></div><div id="sec5_3_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> <i>tert</i>-Butyl (exo)-6-(1-(cyclopropylmethyl)-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>74</b>)</h4><div class="NLM_p last">The title compound (70 g, 41% yield) was prepared in a manner analogous to <b>73</b> substituting <i>tert</i>-butyl (exo)-6-(3-amino-1-(cyclopropylmethyl)-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate for <i>tert</i>-butyl (exo)-6-(3-amino-1-ethyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate. Purification by flash chromatography (6 → 9% ethyl acetate in petroleum ether) provided product. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.96 (s, 1H), 3.99–4.06 (m, 2H), 3.64–3.76 (m, 2H), 3.45–3.51 (m, 2H), 1.78–1.81 (m, 2H), 1.56–1.58 (m, 1H), 1.45 (s, 9H), 1.23–1.26 (m, 1H), 0.55–0.58 (m, 2H), 0.34–0.37 (m, 2H).</div></div><div id="sec5_3_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> (Exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane (<b>75</b>)</h4><div class="NLM_p last">To an ice-cooled solution of (<i>tert</i>-butyl (exo)-6-(3-iodo-1-isopropyl-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>72</b>) (0.20 kg, 480 mmol) in ethyl acetate (1 L) was added hydrogen chloride in ethyl acetate (0.50 L, 1.2 mol). The mixture was warmed to room temperature. After 2 h, the reaction was concentrated. To a solution of the crude material in methanol (2.1 L) were added triethylamine (334 mL, 2.41 mol) and oxetan-3-one (94.7 g, 1.31 mol) at 10 °C. After 30 min, sodium cyanoborohydride (82.6 g, 1.31 mol) was added portionwise, and the resulting mixture was warmed to room temperature for 3 h. The reaction mixture was diluted with water (700 mL) and extracted with ethyl acetate (3 × 2 L). The collected organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. Purification by flash column chromatography (9 → 20% ethyl acetate in petroleum ether) afforded a white solid (55 g, 31% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.87 (s, 1H), 4.79–4.73 (m, 1H), 4.68–4.50 (m, 7H), 3.71 (m, 1H), 3.06 (d, <i>J</i> = 8.8 Hz, 2H), 2.39 (m, 2H), 2.14 (t, <i>J</i> = 3.2 Hz, 1H), 1.42 (d, <i>J</i> = 6.8 Hz, 5H), 1.46–1.38 (m, 1H).</div></div><div id="sec5_3_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> (Exo)-6-(1-Ethyl-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane (<b>76</b>)</h4><div class="NLM_p last">The title compound (0.20 g, 64% yield) was prepared in a manner analogous to <b>77</b> substituting <i>tert</i>-butyl (exo)-6-(1-ethyl-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate for <i>tert</i>-butyl (exo)-6-(1-(cyclopropylmethyl)-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate. LCMS: <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>19</sub>IN<sub>3</sub>O 361.1, found 361.7.</div></div><div id="sec5_3_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> (Exo)-6-(1-(cyclopropylmethyl)-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexane (<b>77</b>)</h4><div class="NLM_p last">To an ice-cooled solution of <i>tert</i>-butyl (exo)-6-(1-(cyclopropylmethyl)-3-iodo-1<i>H</i>-pyrazol-5-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (110 g, 0.26 mmol) in dichloromethane (1.3 L) was added trifluoroacetic acid (260 mL). The reaction mixture was warmed to 40 °C for 2 h and concentrated in vacuo. The resulting residue was dissolved in methanol (1.3 L), and the solution was cooled to 0 °C. Triethylamine (142 g, 1.41 mol) and oxetan-3-one (55.4 g, 0.768 mol) were added, and the mixture was warmed to room temperature for 20 min and cooled to 10 °C. Sodium cyanoborohydride (48.4 g, 0.768 mol) was added, and the resulting suspension was warmed to 40 °C. After 3 h, the reaction was diluted with water (400 mL), and the resulting mixture was extracted with ethyl acetate (3 × 1.5 L). The combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated. Purification by flash column chromatography (9 → 20% ethyl acetate in petroleum ether) provided product (81 g, 82% yield). <sup>1</sup>H NMR: (CDCl<sub>3</sub> 400 MHz), δ 5.94 (s, 1H), 4.68 (m, 2H), 4.60 (m, 2H), 4.03 (d, <i>J</i> = 7.2 Hz, 2H), 3.78 (m, 1H), 3.12 (d, <i>J</i> = 8.8 Hz, 2H), 2.46 (m, 2H), 2.21 (t, <i>J</i> = 3.2 Hz, 1H), 1.71 (m, 2H), 1.27 (m, 1H), 0.57 (m, 2H), 0.39 (m, 2H).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d59e6366-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00843">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38346" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38346" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00843" class="ext-link">10.1021/acs.jmedchem.7b00843</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">CEREP Receptor panel data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00843/suppl_file/jm7b00843_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00843/suppl_file/jm7b00843_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00843/suppl_file/jm7b00843_si_001.pdf">jm7b00843_si_001.pdf (96.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00843/suppl_file/jm7b00843_si_002.csv">jm7b00843_si_002.csv (2.55 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors for DLK kinase domain complexes are available in the PDB with accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5VO1">5VO1</a> (<b>7</b>) and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5VO2">5VO2</a> (<b>10</b>).</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b00843" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph W. Lewcock</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7a161f0d191519113a1e14161354191517"><span class="__cf_email__" data-cfemail="264a43514549454d6642484a4f0845494b">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Siu</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2822-6584" title="Orcid link">http://orcid.org/0000-0002-2822-6584</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bbc8d2ce95d6d2d8d3daded7fbdcded5de95d8d4d6"><span class="__cf_email__" data-cfemail="bccfd5c992d1d5dfd4ddd9d0fcdbd9d2d992dfd3d1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Snahel Patel</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William J. Meilandt</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rebecca I. Erickson</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinhua Chen</span> - <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gauri Deshmukh</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony A. Estrada</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reina N. Fuji</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Gibbons</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy Gustafson</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seth F. Harris</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jose Imperio</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wendy Liu</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xingrong Liu</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yichin Liu</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph P. Lyssikatos</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Changyou Ma</span> - <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianping Yin</span> - <span class="hlFld-Affiliation affiliation">†Department
of Discovery Chemistry, ∥Department of Safety Assessment, §Department of Structural Biology, ‡Department of Neurosciences, ⊥Department of Drug
Metabolism and Pharmacokinetics, and ∇Department of Biochemical and Cellular
Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of
Chemistry, WuXi AppTec Co., Ltd., 288 Fute Zhonglu, Wai Gao Qiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d59e6363-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i103">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78260" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78260" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the following individuals for their contributions: Chris Hamman, Mengling Wong, and Michael Hayes for compound purification; Genentech Biomolecular Resources group for construct generation; Emile Plise and Jonathan Cheong for MDR1-MDCK data; Xiaolin Zhang, Allan Jaochico, and Xiao Ding for bioanalytical data; Amy Sambrone for formulations work; Tim Earr for tissue collection; York Rudhard and the Evotec team for biochemical and cell-based potency data; Wuxi for support with analog synthesis; and Genentech compound management for sample handling. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02- 05CH11231. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393) and the National Center for Research Resources (P41RR001209). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS, NCRR or NIH.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i104" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i104"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i105" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i105"> Abbreviations Used</h2><tr><td class="NLM_term">ClogP</td><td class="NLM_def"><p class="first last">calculated logarithm of partition coefficient</p></td></tr><tr><td class="NLM_term">CNS MPO</td><td class="NLM_def"><p class="first last">central nervous system multiparameter optimization</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle medium</p></td></tr><tr><td class="NLM_term">DLK</td><td class="NLM_def"><p class="first last">dual leucine zipper kinase</p></td></tr><tr><td class="NLM_term">DRG</td><td class="NLM_def"><p class="first last">dorsal root ganglion</p></td></tr><tr><td class="NLM_term">DAST</td><td class="NLM_def"><p class="first last">diethylaminosulfur trifluoride</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">HBD</td><td class="NLM_def"><p class="first last">hydrogen bond donor</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>puu</sub></td><td class="NLM_def"><p class="first last">unbound partition coefficient</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">MAP3K12</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase kinase kinase 12</p></td></tr><tr><td class="NLM_term">MCT</td><td class="NLM_def"><p class="first last">methylcellulose Tween 80</p></td></tr><tr><td class="NLM_term">MKK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase kinase</p></td></tr><tr><td class="NLM_term">MLK</td><td class="NLM_def"><p class="first last">mixed-lineage kinase</p></td></tr><tr><td class="NLM_term">MDR1</td><td class="NLM_def"><p class="first last">multidrug resistance protein 1</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin-Darby canine kidney</p></td></tr><tr><td class="NLM_term">MSD</td><td class="NLM_def"><p class="first last">Meso Scale Discovery detection</p></td></tr><tr><td class="NLM_term">NGF</td><td class="NLM_def"><p class="first last">nerve growth factor</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i106">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Watkins, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntwork-Rodriguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastham-Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modrusan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminker, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessier-Lavigne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">4039</span><span class="NLM_x">–</span> <span class="NLM_lpage">4044</span><span class="refDoi"> DOI: 10.1073/pnas.1211074110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1073%2Fpnas.1211074110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=4039-4044&author=T.+A.+Watkinsauthor=B.+Wangauthor=S.+Huntwork-Rodriguezauthor=J.+Yangauthor=Z.+Jiangauthor=J.+Eastham-Andersonauthor=Z.+Modrusanauthor=J.+S.+Kaminkerauthor=M.+Tessier-Lavigneauthor=J.+W.+Lewcock&title=DLK+initiates+a+transcriptional+program+that+couples+apoptotic+and+regenerative+responses+to+axonal+injury&doi=10.1073%2Fpnas.1211074110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1211074110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1211074110%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DT.%2BA.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHuntwork-Rodriguez%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DEastham-Anderson%26aufirst%3DJ.%26aulast%3DModrusan%26aufirst%3DZ.%26aulast%3DKaminker%26aufirst%3DJ.%2BS.%26aulast%3DTessier-Lavigne%26aufirst%3DM.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DDLK%2520initiates%2520a%2520transcriptional%2520program%2520that%2520couples%2520apoptotic%2520and%2520regenerative%2520responses%2520to%2520axonal%2520injury%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D4039%26epage%3D4044%26doi%3D10.1073%2Fpnas.1211074110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Shin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beirowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milbrandt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiAntonio, A.</span><span> </span><span class="NLM_article-title">Dual leucine zipper kinase is required for retrograde injury signaling and axonal regeneration</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span><span class="refDoi"> DOI: 10.1016/j.neuron.2012.04.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1016%2Fj.neuron.2012.04.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2012&pages=1015-1022&author=J.+E.+Shinauthor=Y.+Choauthor=B.+Beirowskiauthor=J.+Milbrandtauthor=V.+Cavalliauthor=A.+DiAntonio&title=Dual+leucine+zipper+kinase+is+required+for+retrograde+injury+signaling+and+axonal+regeneration&doi=10.1016%2Fj.neuron.2012.04.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2012.04.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2012.04.028%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DJ.%2BE.%26aulast%3DCho%26aufirst%3DY.%26aulast%3DBeirowski%26aufirst%3DB.%26aulast%3DMilbrandt%26aufirst%3DJ.%26aulast%3DCavalli%26aufirst%3DV.%26aulast%3DDiAntonio%26aufirst%3DA.%26atitle%3DDual%2520leucine%2520zipper%2520kinase%2520is%2520required%2520for%2520retrograde%2520injury%2520signaling%2520and%2520axonal%2520regeneration%26jtitle%3DNeuron%26date%3D2012%26volume%3D74%26spage%3D1015%26epage%3D1022%26doi%3D10.1016%2Fj.neuron.2012.04.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Sengupta Ghosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozniak, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">DLK induces developmental neuronal degeneration via selective regulation of proapoptotic JNK activity</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">194</span><span class="NLM_x">, </span> <span class="NLM_fpage">751</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span><span class="refDoi"> DOI: 10.1083/jcb.201103153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1083%2Fjcb.201103153" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2011&pages=751-764&author=A.+Sengupta+Ghoshauthor=B.+Wangauthor=C.+D.+Pozniakauthor=M.+Chenauthor=R.+J.+Wattsauthor=J.+W.+Lewcock&title=DLK+induces+developmental+neuronal+degeneration+via+selective+regulation+of+proapoptotic+JNK+activity&doi=10.1083%2Fjcb.201103153"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201103153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201103153%26sid%3Dliteratum%253Aachs%26aulast%3DSengupta%2BGhosh%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DPozniak%26aufirst%3DC.%2BD.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DDLK%2520induces%2520developmental%2520neuronal%2520degeneration%2520via%2520selective%2520regulation%2520of%2520proapoptotic%2520JNK%2520activity%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2011%26volume%3D194%26spage%3D751%26epage%3D764%26doi%3D10.1083%2Fjcb.201103153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Larhammar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntwork-Rodriguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanoy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta Ghosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminker, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastham-Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modrusan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farley, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessier-Lavigne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, T. A.</span><span> </span><span class="NLM_article-title">Dual leucine zipper kinase-dependent PERK activation contributes to neuronal degeneration following insult</span> <span class="citation_source-journal">eLife</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e20725</span><span class="refDoi"> DOI: 10.7554/eLife.20725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.7554%2FeLife.20725" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=e20725&author=M.+Larhammarauthor=S.+Huntwork-Rodriguezauthor=Z.+Jiangauthor=H.+Solanoyauthor=A.+Sengupta+Ghoshauthor=B.+Wangauthor=J.+S.+Kaminkerauthor=K.+Huangauthor=J.+Eastham-Andersonauthor=M.+Siuauthor=Z.+Modrusanauthor=M.+M.+Farleyauthor=M.+Tessier-Lavigneauthor=J.+W.+Lewcockauthor=T.+A.+Watkins&title=Dual+leucine+zipper+kinase-dependent+PERK+activation+contributes+to+neuronal+degeneration+following+insult&doi=10.7554%2FeLife.20725"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.7554%2FeLife.20725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.20725%26sid%3Dliteratum%253Aachs%26aulast%3DLarhammar%26aufirst%3DM.%26aulast%3DHuntwork-Rodriguez%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DSolanoy%26aufirst%3DH.%26aulast%3DSengupta%2BGhosh%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DKaminker%26aufirst%3DJ.%2BS.%26aulast%3DHuang%26aufirst%3DK.%26aulast%3DEastham-Anderson%26aufirst%3DJ.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DModrusan%26aufirst%3DZ.%26aulast%3DFarley%26aufirst%3DM.%2BM.%26aulast%3DTessier-Lavigne%26aufirst%3DM.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26aulast%3DWatkins%26aufirst%3DT.%2BA.%26atitle%3DDual%2520leucine%2520zipper%2520kinase-dependent%2520PERK%2520activation%2520contributes%2520to%2520neuronal%2520degeneration%2520following%2520insult%26jtitle%3DeLife%26date%3D2017%26volume%3D6%26spage%3De20725%26doi%3D10.7554%2FeLife.20725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Tedeschi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradke, F.</span><span> </span><span class="NLM_article-title">The DLK signalling pathway--a double-edged sword in neural development and regeneration</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span><span class="refDoi"> DOI: 10.1038/embor.2013.64</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1038%2Fembor.2013.64" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=605-614&author=A.+Tedeschiauthor=F.+Bradke&title=The+DLK+signalling+pathway%2D%2Da+double-edged+sword+in+neural+development+and+regeneration&doi=10.1038%2Fembor.2013.64"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fembor.2013.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fembor.2013.64%26sid%3Dliteratum%253Aachs%26aulast%3DTedeschi%26aufirst%3DA.%26aulast%3DBradke%26aufirst%3DF.%26atitle%3DThe%2520DLK%2520signalling%2520pathway--a%2520double-edged%2520sword%2520in%2520neural%2520development%2520and%2520regeneration%26jtitle%3DEMBO%2520Rep.%26date%3D2013%26volume%3D14%26spage%3D605%26epage%3D614%26doi%3D10.1038%2Fembor.2013.64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pozniak, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta Ghosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogineni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanoy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bustos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jubb, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayalon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weimer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degeneration</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">2553</span><span class="NLM_x">–</span> <span class="NLM_lpage">2567</span><span class="refDoi"> DOI: 10.1084/jem.20122832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1084%2Fjem.20122832" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=2553-2567&author=C.+D.+Pozniakauthor=A.+Sengupta+Ghoshauthor=A.+Gogineniauthor=J.+E.+Hansonauthor=S.+H.+Leeauthor=J.+L.+Larsonauthor=H.+Solanoyauthor=D.+Bustosauthor=H.+Liauthor=H.+Nguauthor=A.+M.+Jubbauthor=G.+Ayalonauthor=J.+Wuauthor=K.+Scearce-Levieauthor=Q.+Zhouauthor=R.+M.+Weimerauthor=D.+S.+Kirkpatrickauthor=J.+W.+Lewcock&title=Dual+leucine+zipper+kinase+is+required+for+excitotoxicity-induced+neuronal+degeneration&doi=10.1084%2Fjem.20122832"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1084%2Fjem.20122832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20122832%26sid%3Dliteratum%253Aachs%26aulast%3DPozniak%26aufirst%3DC.%2BD.%26aulast%3DSengupta%2BGhosh%26aufirst%3DA.%26aulast%3DGogineni%26aufirst%3DA.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLarson%26aufirst%3DJ.%2BL.%26aulast%3DSolanoy%26aufirst%3DH.%26aulast%3DBustos%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DNgu%26aufirst%3DH.%26aulast%3DJubb%26aufirst%3DA.%2BM.%26aulast%3DAyalon%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DWeimer%26aufirst%3DR.%2BM.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DDual%2520leucine%2520zipper%2520kinase%2520is%2520required%2520for%2520excitotoxicity-induced%2520neuronal%2520degeneration%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D2553%26epage%3D2567%26doi%3D10.1084%2Fjem.20122832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Miller, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Press, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milbrandt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiAntonio, A.</span><span> </span><span class="NLM_article-title">A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1038/nn.2290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1038%2Fnn.2290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=19287387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtFCisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=387-389&author=B.+R.+Millerauthor=C.+Pressauthor=R.+W.+Danielsauthor=Y.+Sasakiauthor=J.+Milbrandtauthor=A.+DiAntonio&title=A+dual+leucine+kinase-dependent+axon+self-destruction+program+promotes+Wallerian+degeneration&doi=10.1038%2Fnn.2290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration</span></div><div class="casAuthors">Miller, Bradley R.; Press, Craig; Daniels, Richard W.; Sasaki, Yo; Milbrandt, Jeffrey; DiAntonio, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-389</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Axon degeneration underlies many common neurol. disorders, but the signaling pathways that orchestrate axon degeneration are unknown.  We found that dual leucine kinase promoted degeneration of severed axons in Drosophila and mice, and that its target, c-Jun N-terminal kinase, promoted degeneration locally in axons as they committed to degenerate.  This pathway also promoted degeneration after chemotherapy exposure and may be a component of a general axon self-destruction program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWn57Z1aoqF7Vg90H21EOLACvtfcHk0ljypVr35tp3Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtFCisrs%253D&md5=8565d1f74e199f63e29c411454003ec4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnn.2290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2290%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DB.%2BR.%26aulast%3DPress%26aufirst%3DC.%26aulast%3DDaniels%26aufirst%3DR.%2BW.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DMilbrandt%26aufirst%3DJ.%26aulast%3DDiAntonio%26aufirst%3DA.%26atitle%3DA%2520dual%2520leucine%2520kinase-dependent%2520axon%2520self-destruction%2520program%2520promotes%2520Wallerian%2520degeneration%26jtitle%3DNat.%2520Neurosci.%26date%3D2009%26volume%3D12%26spage%3D387%26epage%3D389%26doi%3D10.1038%2Fnn.2290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Welsbie, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlinicke, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackler, L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auld, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simard-Bisson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blouin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enke, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boye, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merbs, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh-Armstrong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauswirth, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiAntonio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickells, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yau, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quigley, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, D. J.</span><span> </span><span class="NLM_article-title">Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">4045</span><span class="NLM_x">–</span> <span class="NLM_lpage">4050</span><span class="refDoi"> DOI: 10.1073/pnas.1211284110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1073%2Fpnas.1211284110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=4045-4050&author=D.+S.+Welsbieauthor=Z.+Yangauthor=Y.+Geauthor=K.+L.+Mitchellauthor=X.+Zhouauthor=S.+E.+Martinauthor=C.+A.+Berlinickeauthor=L.+Hacklerauthor=J.+Fullerauthor=J.+Fuauthor=L.+H.+Caoauthor=B.+Hanauthor=D.+Auldauthor=T.+Xueauthor=S.+Hiraiauthor=L.+Germainauthor=C.+Simard-Bissonauthor=R.+Blouinauthor=J.+V.+Nguyenauthor=C.+H.+Davisauthor=R.+A.+Enkeauthor=S.+L.+Boyeauthor=S.+L.+Merbsauthor=N.+Marsh-Armstrongauthor=W.+W.+Hauswirthauthor=A.+DiAntonioauthor=R.+W.+Nickellsauthor=J.+Ingleseauthor=J.+Hanesauthor=K.+W.+Yauauthor=H.+A.+Quigleyauthor=D.+J.+Zack&title=Functional+genomic+screening+identifies+dual+leucine+zipper+kinase+as+a+key+mediator+of+retinal+ganglion+cell+death&doi=10.1073%2Fpnas.1211284110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1211284110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1211284110%26sid%3Dliteratum%253Aachs%26aulast%3DWelsbie%26aufirst%3DD.%2BS.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DMitchell%26aufirst%3DK.%2BL.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DMartin%26aufirst%3DS.%2BE.%26aulast%3DBerlinicke%26aufirst%3DC.%2BA.%26aulast%3DHackler%26aufirst%3DL.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DL.%2BH.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DAuld%26aufirst%3DD.%26aulast%3DXue%26aufirst%3DT.%26aulast%3DHirai%26aufirst%3DS.%26aulast%3DGermain%26aufirst%3DL.%26aulast%3DSimard-Bisson%26aufirst%3DC.%26aulast%3DBlouin%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DJ.%2BV.%26aulast%3DDavis%26aufirst%3DC.%2BH.%26aulast%3DEnke%26aufirst%3DR.%2BA.%26aulast%3DBoye%26aufirst%3DS.%2BL.%26aulast%3DMerbs%26aufirst%3DS.%2BL.%26aulast%3DMarsh-Armstrong%26aufirst%3DN.%26aulast%3DHauswirth%26aufirst%3DW.%2BW.%26aulast%3DDiAntonio%26aufirst%3DA.%26aulast%3DNickells%26aufirst%3DR.%2BW.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DHanes%26aufirst%3DJ.%26aulast%3DYau%26aufirst%3DK.%2BW.%26aulast%3DQuigley%26aufirst%3DH.%2BA.%26aulast%3DZack%26aufirst%3DD.%2BJ.%26atitle%3DFunctional%2520genomic%2520screening%2520identifies%2520dual%2520leucine%2520zipper%2520kinase%2520as%2520a%2520key%2520mediator%2520of%2520retinal%2520ganglion%2520cell%2520death%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D4045%26epage%3D4050%26doi%3D10.1073%2Fpnas.1211284110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Valakh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babetto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiAntonio, A.</span><span> </span><span class="NLM_article-title">Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/j.nbd.2015.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1016%2Fj.nbd.2015.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=25726747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1yitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2015&pages=13-25&author=V.+Valakhauthor=E.+Freyauthor=E.+Babettoauthor=L.+J.+Walkerauthor=A.+DiAntonio&title=Cytoskeletal+disruption+activates+the+DLK%2FJNK+pathway%2C+which+promotes+axonal+regeneration+and+mimics+a+preconditioning+injury&doi=10.1016%2Fj.nbd.2015.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury</span></div><div class="casAuthors">Valakh, Vera; Frey, Erin; Babetto, Elisabetta; Walker, Lauren J.; DiAntonio, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-25</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Nerve injury can lead to axonal regeneration, axonal degeneration, and/or neuronal cell death.  Remarkably, the MAP3K dual leucine zipper kinase, DLK, promotes each of these responses, suggesting that DLK is a sensor of axon injury.  In Drosophila, mutations in proteins that stabilize the actin and microtubule cytoskeletons activate the DLK pathway, suggesting that DLK may be activated by cytoskeletal disruption.  Here we test this model in mammalian sensory neurons.  We find that pharmacol. agents designed to disrupt either the actin or microtubule cytoskeleton activate the DLK pathway, and that activation is independent of calcium influx or induction of the axon degeneration program.  Moreover, activation of the DLK pathway by targeting the cytoskeleton induces a pro-regenerative state, enhancing axon regeneration in response to a subsequent injury in a process akin to preconditioning.  This highlights the potential utility of activating the DLK pathway as a method to improve axon regeneration.  Moreover, DLK is required for these responses to cytoskeletal perturbations, suggesting that DLK functions as a key neuronal sensor of cytoskeletal damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop9lR4GkX5prVg90H21EOLACvtfcHk0lj8Ig0fY1fR_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1yitb4%253D&md5=1d76b9e4aa3bbdc42d5b43f04e48aef7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2015.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2015.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DValakh%26aufirst%3DV.%26aulast%3DFrey%26aufirst%3DE.%26aulast%3DBabetto%26aufirst%3DE.%26aulast%3DWalker%26aufirst%3DL.%2BJ.%26aulast%3DDiAntonio%26aufirst%3DA.%26atitle%3DCytoskeletal%2520disruption%2520activates%2520the%2520DLK%252FJNK%2520pathway%252C%2520which%2520promotes%2520axonal%2520regeneration%2520and%2520mimics%2520a%2520preconditioning%2520injury%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2015%26volume%3D77%26spage%3D13%26epage%3D25%26doi%3D10.1016%2Fj.nbd.2015.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meilandt, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanoy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogineni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta Ghosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandham, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozniak, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modrusan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudhard, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carano, R. A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weimer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">Loss of dual leucine zipper kinase signaling is protective in multiple neurodegenerative disease models</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">eaag0394</span><span class="refDoi"> DOI: 10.1126/scitranslmed.aag0394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1126%2Fscitranslmed.aag0394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=28814543" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=eaag0394&author=C.+E.+Le+Pichonauthor=W.+J.+Meilandtauthor=S.+Dominguezauthor=H.+Solanoyauthor=H.+Linauthor=H.+Nguauthor=A.+Gogineniauthor=A.+Sengupta+Ghoshauthor=Z.+Jiangauthor=S.-H.+Leeauthor=J.+Maloneyauthor=V.+D.+Gandhamauthor=C.+D.+Pozniakauthor=B.+Wangauthor=S.+Leeauthor=M.+Siuauthor=S.+Patelauthor=Z.+Modrusanauthor=X.+Liuauthor=Y.+Rudhardauthor=M.+Bacaauthor=A.+Gustafsonauthor=J.+Kaminkerauthor=R.+A.+D.+Caranoauthor=E.+J.+Huangauthor=O.+Foremanauthor=R.+Weimerauthor=K.+Scearce-Levieauthor=J.+W.+Lewcock&title=Loss+of+dual+leucine+zipper+kinase+signaling+is+protective+in+multiple+neurodegenerative+disease+models&doi=10.1126%2Fscitranslmed.aag0394"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aag0394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aag0394%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DMeilandt%26aufirst%3DW.%2BJ.%26aulast%3DDominguez%26aufirst%3DS.%26aulast%3DSolanoy%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DNgu%26aufirst%3DH.%26aulast%3DGogineni%26aufirst%3DA.%26aulast%3DSengupta%2BGhosh%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DS.-H.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DGandham%26aufirst%3DV.%2BD.%26aulast%3DPozniak%26aufirst%3DC.%2BD.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DModrusan%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DRudhard%26aufirst%3DY.%26aulast%3DBaca%26aufirst%3DM.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DKaminker%26aufirst%3DJ.%26aulast%3DCarano%26aufirst%3DR.%2BA.%2BD.%26aulast%3DHuang%26aufirst%3DE.%2BJ.%26aulast%3DForeman%26aufirst%3DO.%26aulast%3DWeimer%26aufirst%3DR.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DLoss%2520of%2520dual%2520leucine%2520zipper%2520kinase%2520signaling%2520is%2520protective%2520in%2520multiple%2520neurodegenerative%2520disease%2520models%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26spage%3Deaag0394%26doi%3D10.1126%2Fscitranslmed.aag0394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ferraris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsbie, D.</span><span> </span><span class="NLM_article-title">Dual leucine zipper kinase as a therapeutic target for neurodegenerative conditions</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1923</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span><span class="refDoi"> DOI: 10.4155/fmc.13.150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.4155%2Ffmc.13.150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=24175744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislyntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1923-1934&author=D.+Ferrarisauthor=Z.+Yangauthor=D.+Welsbie&title=Dual+leucine+zipper+kinase+as+a+therapeutic+target+for+neurodegenerative+conditions&doi=10.4155%2Ffmc.13.150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Dual leucine zipper kinase as a therapeutic target for neurodegenerative conditions</span></div><div class="casAuthors">Ferraris, Dana; Yang, Zhiyong; Welsbie, Derek</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1923-1934</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Dual leucine zipper kinase (DLK) is a serine/threonine protein kinase that is a member of the mixed lineage kinase subfamily.  Mixed lineage kinases are upstream MAP3Ks that activate the JNK pathway.  DLK is primarily responsible for activating JNK and mediating the apoptotic stress response in various cell types, specifically neurons.  Inhibition and knockdown of DLK has been demonstrated to have neuroprotective effects in cellular and animal models of Alzheimer's disease, glaucoma, Parkinson's disease and other neurodegenerative conditions.  Several series of ATP-binding site inhibitors have been identified through profiling efforts providing launch points for future medicinal chem. programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp30bZGinlt2bVg90H21EOLACvtfcHk0lj8Ig0fY1fR_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislyntg%253D%253D&md5=b233930ced57264fedae91bafacb6585</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.150%26sid%3Dliteratum%253Aachs%26aulast%3DFerraris%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWelsbie%26aufirst%3DD.%26atitle%3DDual%2520leucine%2520zipper%2520kinase%2520as%2520a%2520therapeutic%2520target%2520for%2520neurodegenerative%2520conditions%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D1923%26epage%3D1934%26doi%3D10.4155%2Ffmc.13.150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Oetjen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemcke, T.</span><span> </span><span class="NLM_article-title">Dual leucine zipper kinase (MAP3K12) modulators: a patent review (2010–2015)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span><span class="refDoi"> DOI: 10.1517/13543776.2016.1170810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1517%2F13543776.2016.1170810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=27043251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Gis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=607-616&author=E.+Oetjenauthor=T.+Lemcke&title=Dual+leucine+zipper+kinase+%28MAP3K12%29+modulators%3A+a+patent+review+%282010%E2%80%932015%29&doi=10.1517%2F13543776.2016.1170810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Dual leucine zipper kinase (MAP3K12) modulators: a patent review (2010-2015)</span></div><div class="casAuthors">Oetjen, Elke; Lemcke, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">607-616</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: The dual leucine zipper kinase (DLK, MAP3K12) is essential for neuronal development and has been shown to mediate axon regeneration.  On the other hand, DLK is involved in the pathogenesis of neurodegenerative disease and diabetes mellitus.  Several patents have been published claiming to modulate or inhibit DLK by various approaches including ATP competitive inhibitors.  In addn., two publications describe SAR of highly selective DLK inhibitors with efficacy in distinct mouse models of neurodegeneration.: This review summarized patents claiming to modulate DLK activity published between 2010 and 2015.  Peer-reviewed publications related to the patents and addnl. peer-reviewed publications are included.  This article describes 18 patents from three pharmaceutical companies and three academic research groups.: Several methods are proposed to modulate DLK activity, some of them very exptl. and not suitable for easy application in patients.  ATP competitive kinase inhibitors exert high affinity, but for the majority, no information about their selectivity is available.  To date, two inhibitors have been tested in mice.  Given the controversial findings that DLK is required for neurodegeneration and for axon regeneration, more research is needed to further elucidate the regulation and the function of this kinase in diverse organs/tissues and under physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW_r7JJP42xrVg90H21EOLACvtfcHk0liM1oOZVM_BHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Gis7w%253D&md5=6457f83dc7ff008a774eee2a934f3f64</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1517%2F13543776.2016.1170810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2016.1170810%26sid%3Dliteratum%253Aachs%26aulast%3DOetjen%26aufirst%3DE.%26aulast%3DLemcke%26aufirst%3DT.%26atitle%3DDual%2520leucine%2520zipper%2520kinase%2520%2528MAP3K12%2529%2520modulators%253A%2520a%2520patent%2520review%2520%25282010%25E2%2580%25932015%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D607%26epage%3D616%26doi%3D10.1517%2F13543776.2016.1170810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De La Torre, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huestis, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanoy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span> </span><span class="NLM_article-title">Discovery of dual leucine zipper kinase (DLK, MAP3K12) inhibitors with activity in neurodegeneration models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span><span class="refDoi"> DOI: 10.1021/jm5013984</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5013984" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSjsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=401-418&author=S.+Patelauthor=F.+Cohenauthor=B.+J.+Deanauthor=K.+De+La+Torreauthor=G.+Deshmukhauthor=A.+A.+Estradaauthor=A.+S.+Ghoshauthor=P.+Gibbonsauthor=A.+Gustafsonauthor=M.+P.+Huestisauthor=C.+E.+Le+Pichonauthor=H.+Linauthor=W.+Liuauthor=X.+Liuauthor=Y.+Liuauthor=C.+Q.+Lyauthor=J.+P.+Lyssikatosauthor=C.+Maauthor=K.+Scearce-Levieauthor=Y.+G.+Shinauthor=H.+Solanoyauthor=K.+L.+Starkauthor=J.+Wangauthor=B.+Wangauthor=X.+Zhaoauthor=J.+W.+Lewcockauthor=M.+Siu&title=Discovery+of+dual+leucine+zipper+kinase+%28DLK%2C+MAP3K12%29+inhibitors+with+activity+in+neurodegeneration+models&doi=10.1021%2Fjm5013984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Dual Leucine Zipper Kinase (DLK, MAP3K12) Inhibitors with Activity in Neurodegeneration Models</span></div><div class="casAuthors">Patel, Snahel; Cohen, Frederick; Dean, Brian J.; De La Torre, Kelly; Deshmukh, Gauri; Estrada, Anthony A.; Ghosh, Arundhati Sengupta; Gibbons, Paul; Gustafson, Amy; Huestis, Malcolm P.; Le Pichon, Claire E.; Lin, Han; Liu, Wendy; Liu, Xingrong; Liu, Yichin; Ly, Cuong Q.; Lyssikatos, Joseph P.; Ma, Changyou; Scearce-Levie, Kimberly; Shin, Young G.; Solanoy, Hilda; Stark, Kimberly L.; Wang, Jian; Wang, Bei; Zhao, Xianrui; Lewcock, Joseph W.; Siu, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">401-418</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dual leucine zipper kinase (DLK, MAP3K12) was recently identified as an essential regulator of neuronal degeneration in multiple contexts.  Here the authors describe the generation of potent and selective DLK inhibitors starting from a high-throughput screening hit.  Using proposed hinge-binding interactions to infer a binding mode and specific design parameters to optimize for CNS druglike mols., the authors came to focus on the di(pyridin-2-yl)amines because of their combination of desirable potency and good brain penetration following oral dosing.  The lead inhibitor GNE-3511 I displayed concn.-dependent protection of neurons from degeneration in vitro and demonstrated dose-dependent activity in two different animal models of disease.  These results suggest that specific pharmacol. inhibition of DLK may have therapeutic potential in multiple indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBLUV7fJcY-rVg90H21EOLACvtfcHk0liM1oOZVM_BHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSjsr3P&md5=8f4ebdbfb0d324a4253bcd832e690a18</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm5013984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5013984%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DDean%26aufirst%3DB.%2BJ.%26aulast%3DDe%2BLa%2BTorre%26aufirst%3DK.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DGhosh%26aufirst%3DA.%2BS.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DHuestis%26aufirst%3DM.%2BP.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DShin%26aufirst%3DY.%2BG.%26aulast%3DSolanoy%26aufirst%3DH.%26aulast%3DStark%26aufirst%3DK.%2BL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26aulast%3DSiu%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520dual%2520leucine%2520zipper%2520kinase%2520%2528DLK%252C%2520MAP3K12%2529%2520inhibitors%2520with%2520activity%2520in%2520neurodegeneration%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D401%26epage%3D418%26doi%3D10.1021%2Fjm5013984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanoy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">Scaffold-hopping and structure-based discovery of potent, selective, and brain penetrant N-(1H-pyrazol-3-yl)pyridin-2-amine inhibitors of dual leucine zipper kinase (DLK, MAP3K12)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8182</span><span class="NLM_x">–</span> <span class="NLM_lpage">8199</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01072</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Kit7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8182-8199&author=S.+Patelauthor=S.+F.+Harrisauthor=P.+Gibbonsauthor=G.+Deshmukhauthor=A.+Gustafsonauthor=T.+Kellarauthor=H.+Linauthor=X.+Liuauthor=Y.+Liuauthor=Y.+Liuauthor=C.+Maauthor=K.+Scearce-Levieauthor=A.+S.+Ghoshauthor=Y.+G.+Shinauthor=H.+Solanoyauthor=J.+Wangauthor=B.+Wangauthor=J.+Yinauthor=M.+Siuauthor=J.+W.+Lewcock&title=Scaffold-hopping+and+structure-based+discovery+of+potent%2C+selective%2C+and+brain+penetrant+N-%281H-pyrazol-3-yl%29pyridin-2-amine+inhibitors+of+dual+leucine+zipper+kinase+%28DLK%2C+MAP3K12%29&doi=10.1021%2Facs.jmedchem.5b01072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold-Hopping and Structure-Based Discovery of Potent, Selective, And Brain Penetrant N-(1H-Pyrazol-3-yl)pyridin-2-amine Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12)</span></div><div class="casAuthors">Patel, Snahel; Harris, Seth F.; Gibbons, Paul; Deshmukh, Gauri; Gustafson, Amy; Kellar, Terry; Lin, Han; Liu, Xingrong; Liu, Yanzhou; Liu, Yichin; Ma, Changyou; Scearce-Levie, Kimberly; Ghosh, Arundhati Sengupta; Shin, Young G.; Solanoy, Hilda; Wang, Jian; Wang, Bei; Yin, Jianping; Siu, Michael; Lewcock, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8182-8199</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent data suggest that inhibition of dual leucine zipper kinase (DLK, MAP3K12) has therapeutic potential for treatment of a no. of indications ranging from acute neuronal injury to chronic neurodegenerative disease.  Thus, high demand exists for selective small mol. DLK inhibitors with favorable drug-like properties and good CNS penetration.  Herein the authors describe a shape-based scaffold hopping approach to convert pyrimidine 1 to a pyrazole core with improved physicochem. properties.  The authors also present the first crystal structures of DLK.  By utilizing a combination of property and structure-based design, the authors identified inhibitor I, a potent, selective, and brain-penetrant inhibitor of DLK with activity in an in vivo nerve injury model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJzgZkA0g77bVg90H21EOLACvtfcHk0lj0103pCalYuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Kit7fN&md5=e7b850d7c7d2eac3317b573ace2c6fab</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01072%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DKellar%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DGhosh%26aufirst%3DA.%2BS.%26aulast%3DShin%26aufirst%3DY.%2BG.%26aulast%3DSolanoy%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DScaffold-hopping%2520and%2520structure-based%2520discovery%2520of%2520potent%252C%2520selective%252C%2520and%2520brain%2520penetrant%2520N-%25281H-pyrazol-3-yl%2529pyridin-2-amine%2520inhibitors%2520of%2520dual%2520leucine%2520zipper%2520kinase%2520%2528DLK%252C%2520MAP3K12%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8182%26epage%3D8199%26doi%3D10.1021%2Facs.jmedchem.5b01072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Heffron, T. P.</span><span> </span><span class="NLM_article-title">Small molecule kinase inhibitors for the treatment of brain cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">10030</span><span class="NLM_x">–</span> <span class="NLM_lpage">10066</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00618</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00618" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOjt77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10030-10066&author=T.+P.+Heffron&title=Small+molecule+kinase+inhibitors+for+the+treatment+of+brain+cancer&doi=10.1021%2Facs.jmedchem.6b00618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer</span></div><div class="casAuthors">Heffron, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10030-10066</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In addn. to each of the factors that govern the identification of a successful oncol. drug candidate, drug discovery aimed at treating neurol. cancer must also consider the presence of the blood-brain barrier (BBB).  The high level of expression of efflux transporters (e.g., P-glycoprotein (P-gp) and breast cancer resistance protein (Bcrp)) at the BBB limits many small mols. from freely reaching the brain, where neurooncol. malignancies reside.  Furthermore, many of the targets identified for the potential treatment of central nervous system (CNS) malignancies suggest that kinase inhibitors, capable of penetrating the BBB to reach their target, would be desirable.  This Perspective discusses the unmet need for neurooncol. treatments, the appeal of kinase targets in this space, and a summary of what is known about free brain penetration of clin. inhibitors of kinases that are of interest for the treatment of brain cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqij86WIpk16LVg90H21EOLACvtfcHk0lj0103pCalYuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOjt77E&md5=7e184f17a60658174cb44a9fbadc8dfd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26atitle%3DSmall%2520molecule%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520brain%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10030%26epage%3D10066%26doi%3D10.1021%2Facs.jmedchem.6b00618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0ljLEBNOsEnAxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB%282%29+agonists+using+parallel+synthesis+protocols%3A+A+Lipophilic+Efficiency+%28LipE%29+analysis&doi=10.1016%2Fj.bmcl.2009.05.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0ljLEBNOsEnAxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB%25282%2529%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520A%2520Lipophilic%2520Efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409%26doi%3D10.1016%2Fj.bmcl.2009.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Merour, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buron, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ple, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span> </span><span class="NLM_article-title">The azaindole framework in the design of kinase inhibitors</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">19935</span><span class="NLM_x">–</span> <span class="NLM_lpage">19979</span><span class="refDoi"> DOI: 10.3390/molecules191219935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.3390%2Fmolecules191219935" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=19935-19979&author=J.+Y.+Merourauthor=F.+Buronauthor=K.+Pleauthor=P.+Bonnetauthor=S.+Routier&title=The+azaindole+framework+in+the+design+of+kinase+inhibitors&doi=10.3390%2Fmolecules191219935"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3390%2Fmolecules191219935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules191219935%26sid%3Dliteratum%253Aachs%26aulast%3DMerour%26aufirst%3DJ.%2BY.%26aulast%3DBuron%26aufirst%3DF.%26aulast%3DPle%26aufirst%3DK.%26aulast%3DBonnet%26aufirst%3DP.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DThe%2520azaindole%2520framework%2520in%2520the%2520design%2520of%2520kinase%2520inhibitors%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D19935%26epage%3D19979%26doi%3D10.3390%2Fmolecules191219935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.07.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+Decrescenzoauthor=R.+V.+Devrajauthor=E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes&doi=10.1016%2Fj.bmcl.2008.07.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0ljLEBNOsEnAxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDecrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875%26doi%3D10.1016%2Fj.bmcl.2008.07.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker-Glenn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9416</span><span class="NLM_x">–</span> <span class="NLM_lpage">9433</span><span class="refDoi"> DOI: 10.1021/jm301020q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301020q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9416-9433&author=A.+A.+Estradaauthor=X.+Liuauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=B.+K.+Chanauthor=H.+Chenauthor=X.+Dingauthor=A.+G.+DiPasqualeauthor=S.+L.+Dominguezauthor=J.+Dotsonauthor=J.+Drummondauthor=M.+Flagellaauthor=S.+Flynnauthor=R.+Fujiauthor=A.+Gillauthor=J.+Gunzner-Tosteauthor=S.+F.+Harrisauthor=T.+P.+Heffronauthor=T.+Kleinheinzauthor=D.+W.+Leeauthor=C.+E.+Le+Pichonauthor=J.+P.+Lyssikatosauthor=A.+D.+Medhurstauthor=J.+G.+Moffatauthor=S.+Mukundauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=T.+Tranauthor=N.+Trivediauthor=S.+Wangauthor=S.+Zhangauthor=X.+Zhangauthor=G.+Zhaoauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+highly+potent%2C+selective%2C+and+brain-penetrable+leucine-rich+repeat+kinase+2+%28LRRK2%29+small+molecule+inhibitors&doi=10.1021%2Fjm301020q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors</span></div><div class="casAuthors">Estrada, Anthony A.; Liu, Xingrong; Baker-Glenn, Charles; Beresford, Alan; Burdick, Daniel J.; Chambers, Mark; Chan, Bryan K.; Chen, Huifen; Ding, Xiao; DiPasquale, Antonio G.; Dominguez, Sara L.; Dotson, Jennafer; Drummond, Jason; Flagella, Michael; Flynn, Sean; Fuji, Reina; Gill, Andrew; Gunzner-Toste, Janet; Harris, Seth F.; Heffron, Timothy P.; Kleinheinz, Tracy; Lee, Donna W.; Le Pichon, Claire E.; Lyssikatos, Joseph P.; Medhurst, Andrew D.; Moffat, John G.; Mukund, Susmith; Nash, Kevin; Scearce-Levie, Kimberly; Sheng, Zejuan; Shore, Daniel G.; Tran, Thuy; Trivedi, Naimisha; Wang, Shumei; Zhang, Shuo; Zhang, Xiaolin; Zhao, Guiling; Zhu, Haitao; Sweeney, Zachary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9416-9433</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a high demand for potent, selective, and brain-penetrant small mol. inhibitors of leucine-rich repeat kinase 2 (LRRK2) to test whether inhibition of LRRK2 kinase activity is a potentially viable treatment option for Parkinson's disease patients.  Herein we disclose the use of property and structure-based drug design for the optimization of highly ligand efficient aminopyrimidine lead compds.  High throughput in vivo rodent cassette pharmacokinetic studies enabled rapid validation of in vitro-in vivo correlations.  Guided by this data, optimal design parameters were established.  Effective incorporation of these guidelines into our mol. design process resulted in the discovery of small mol. inhibitors such as GNE-7915 (18, I) and 19, which possess an ideal balance of LRRK2 cellular potency, broad kinase selectivity, metabolic stability, and brain penetration across multiple species.  Advancement of GNE-7915 into rodent and higher species toxicity studies enabled risk assessment for early development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptu1BnxYNJQrVg90H21EOLACvtfcHk0lh1eqO1U6EkEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktbfO&md5=9fc7ccca9c973a960e7393c79c1255fa</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm301020q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301020q%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DMukund%26aufirst%3DS.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DTrivedi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520highly%2520potent%252C%2520selective%252C%2520and%2520brain-penetrable%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520small%2520molecule%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9416%26epage%3D9433%26doi%3D10.1021%2Fjm301020q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Muller, K.</span><span> </span><span class="NLM_article-title">Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span><span class="refDoi"> DOI: 10.2533/chimia.2014.356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.2533%2Fchimia.2014.356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=25198745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1emsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2014&pages=356-362&author=K.+Muller&title=Simple+vector+considerations+to+assess+the+polarity+of+partially+fluorinated+alkyl+and+alkoxy+groups&doi=10.2533%2Fchimia.2014.356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups</span></div><div class="casAuthors">Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Chimia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">356-362</span>CODEN:
                <span class="NLM_cas:coden">CHIMAD</span>;
        ISSN:<span class="NLM_cas:issn">0009-4293</span>.
    
            (<span class="NLM_cas:orgname">Swiss Chemical Society</span>)
        </div><div class="casAbstract">A review.  While H/F exchange at aryl groups or introduction of CF3 units have dominated medicinal chem. for decades, the use of partially fluorinated alkyl and alkoxy groups has come into focus more recently.  A simple bond vector anal. scheme, based on the assumption of context-independent bond polarities as well as idealized configurational and conformational geometries, is applied to small alkyl and alkoxy groups with prototypic fluorination patterns for qual. assessments of relative polarities as well as polarity modulation by conformational change.  Combined with a const. vol. increase for each hydrogen/fluorine exchange these polarity ests. can be translated into expected lipophilicity shifts (ΔlogP), using a simple parameterization scheme derived from exptl. logP values.  While terminal monofluoro- and gem-difluoromethyl groups in small aliph. units are correctly predicted to show lower lipophilicity compared to their tri- or non-fluorinated congeners, vicinal difluoro and bis-vicinal trifluoro patterns are identified to exhibit significantly lower lipophilicities than their resp. geminal di- and trifluoro substituted counterparts.  The trifluoromethoxy group is diagnosed as an intrinsically lipophilic unit compared to the parent methoxy group.  The difluoromethoxy group is of particular interest as it can easily interconvert between a highly lipophilic and a polar conformation, thus enabling this unit to adjust to polarity changes of the mol. environment.  For di- and trifluoroalkoxy groups, again the vic-difluoro and bis-vic-trifluoro substitution patterns stand out as most promising to keep lipophilicity low.  The 1,3-difluoro pattern next to an ether moiety shows an interesting conformational dependence of polarity, similar to the difluoromethoxy group.  While very qual. in nature, the simple bond vector anal. promises to be a useful tool for the identification of lipophilicity-lowering fluorinated alkyl or alkoxy groups and particularly those groups that display marked conformation-dependent lipophilicity and thus potentially serve as 'environmental adaptors'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6yZ2IogEjkrVg90H21EOLACvtfcHk0lh1eqO1U6EkEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1emsLrI&md5=073bd4a2d1d9dcc5f1540296263dda62</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2533%2Fchimia.2014.356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2533%252Fchimia.2014.356%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DSimple%2520vector%2520considerations%2520to%2520assess%2520the%2520polarity%2520of%2520partially%2520fluorinated%2520alkyl%2520and%2520alkoxy%2520groups%26jtitle%3DChimia%26date%3D2014%26volume%3D68%26spage%3D356%26epage%3D362%26doi%3D10.2533%2Fchimia.2014.356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Rudhard, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta Ghosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedaran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">Identification of 12/15-lipoxygenase as a regulator of axon degeneration through high-content screening</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2927</span><span class="NLM_x">–</span> <span class="NLM_lpage">2941</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2936-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1523%2FJNEUROSCI.2936-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=25698732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSjs77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=2927-2941&author=Y.+Rudhardauthor=A.+Sengupta+Ghoshauthor=B.+Lippertauthor=A.+Bockerauthor=M.+Pedaranauthor=J.+Kramerauthor=H.+Nguauthor=O.+Foremanauthor=Y.+Liuauthor=J.+W.+Lewcock&title=Identification+of+12%2F15-lipoxygenase+as+a+regulator+of+axon+degeneration+through+high-content+screening&doi=10.1523%2FJNEUROSCI.2936-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 12/15-lipoxygenase as a regulator of axon degeneration through high-content screening</span></div><div class="casAuthors">Rudhard, York; Ghosh, Arundhati Sengupta; Lippert, Beatrix; Boecker, Alexander; Pedaran, Mehdi; Kraemer, Joachim; Ngu, Hai; Foreman, Oded; Liu, Yichin; Lewcock, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2927-2941</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Axon degeneration is a programed process that takes place during development, in response to neuronal injury, and as a component of neurodegenerative disease pathol., yet the mol. mechanisms that drive this process remain poorly defined.  In this study, we have developed a semi-automated, 384-well format axon degeneration assay in rat dorsal root ganglion (DRG) neurons using a trophic factor withdrawal paradigm.  Using this setup, we have screened a library of known drugs and bioactives to identify several previously unappreciated regulators of axon degeneration, including lipoxygenases.  Multiple structurally distinct lipoxygenase inhibitors as well as mouse DRG neurons lacking expression of 12/15-lipoxygenase display protection of axons in this context.  Retinal ganglion cell axons from 12/15-lipoxygenase-null mice were similarly protected from degeneration following nerve crush injury.  Through addnl. mechanistic studies, we demonstrate that lipoxygenases act cell autonomously within neurons to regulate degeneration, and are required for mitochondrial permeabilization and caspase activation in the axon.  These findings suggest that these enzymes may represent an attractive target for treatment of neuropathies and provide a potential mechanism for the neuroprotection obsd. in various settings following lipoxygenase inhibitor treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4GvHK9fLzwLVg90H21EOLACvtfcHk0lh1eqO1U6EkEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSjs77I&md5=0bce092fa10b6fbc1861328e67d82f1c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2936-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2936-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DRudhard%26aufirst%3DY.%26aulast%3DSengupta%2BGhosh%26aufirst%3DA.%26aulast%3DLippert%26aufirst%3DB.%26aulast%3DBocker%26aufirst%3DA.%26aulast%3DPedaran%26aufirst%3DM.%26aulast%3DKramer%26aufirst%3DJ.%26aulast%3DNgu%26aufirst%3DH.%26aulast%3DForeman%26aufirst%3DO.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DIdentification%2520of%252012%252F15-lipoxygenase%2520as%2520a%2520regulator%2520of%2520axon%2520degeneration%2520through%2520high-content%2520screening%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D2927%26epage%3D2941%26doi%3D10.1523%2FJNEUROSCI.2936-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Welsbie, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaskula-Ranga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluch, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buehler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamed, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamling, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, I. D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronai, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlinicke, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, D. J.</span><span> </span><span class="NLM_article-title">Enhanced functional genomic screening identifies novel mediators of dual leucine zipper kinase-dependent injury signaling in neurons</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1154</span><span class="refDoi"> DOI: 10.1016/j.neuron.2017.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1016%2Fj.neuron.2017.06.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2017&pages=1142-1154&author=D.+S.+Welsbieauthor=K.+L.+Mitchellauthor=V.+Jaskula-Rangaauthor=V.+M.+Sluchauthor=Z.+Yangauthor=J.+Kimauthor=E.+Buehlerauthor=A.+Patelauthor=S.+E.+Martinauthor=P.+W.+Zhangauthor=Y.+Geauthor=Y.+Duanauthor=J.+Fullerauthor=B.+J.+Kimauthor=E.+Hamedauthor=X.+Chamlingauthor=L.+Leiauthor=I.+D.+C.+Fraserauthor=Z.+A.+Ronaiauthor=C.+A.+Berlinickeauthor=D.+J.+Zack&title=Enhanced+functional+genomic+screening+identifies+novel+mediators+of+dual+leucine+zipper+kinase-dependent+injury+signaling+in+neurons&doi=10.1016%2Fj.neuron.2017.06.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2017.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2017.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DWelsbie%26aufirst%3DD.%2BS.%26aulast%3DMitchell%26aufirst%3DK.%2BL.%26aulast%3DJaskula-Ranga%26aufirst%3DV.%26aulast%3DSluch%26aufirst%3DV.%2BM.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DBuehler%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DS.%2BE.%26aulast%3DZhang%26aufirst%3DP.%2BW.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DB.%2BJ.%26aulast%3DHamed%26aufirst%3DE.%26aulast%3DChamling%26aufirst%3DX.%26aulast%3DLei%26aufirst%3DL.%26aulast%3DFraser%26aufirst%3DI.%2BD.%2BC.%26aulast%3DRonai%26aufirst%3DZ.%2BA.%26aulast%3DBerlinicke%26aufirst%3DC.%2BA.%26aulast%3DZack%26aufirst%3DD.%2BJ.%26atitle%3DEnhanced%2520functional%2520genomic%2520screening%2520identifies%2520novel%2520mediators%2520of%2520dual%2520leucine%2520zipper%2520kinase-dependent%2520injury%2520signaling%2520in%2520neurons%26jtitle%3DNeuron%26date%3D2017%26volume%3D94%26spage%3D1142%26epage%3D1154%26doi%3D10.1016%2Fj.neuron.2017.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Richards, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouagazzal, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kew, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohrmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockhaus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loetscher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czech, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bluethmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J. A.</span><span> </span><span class="NLM_article-title">PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">8989</span><span class="NLM_x">–</span> <span class="NLM_lpage">9003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=14523101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFOnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=8989-9003&author=J.+G.+Richardsauthor=G.+A.+Higginsauthor=A.+M.+Ouagazzalauthor=L.+Ozmenauthor=J.+N.+Kewauthor=B.+Bohrmannauthor=P.+Malherbeauthor=M.+Brockhausauthor=H.+Loetscherauthor=C.+Czechauthor=G.+Huberauthor=H.+Bluethmannauthor=H.+Jacobsenauthor=J.+A.+Kemp&title=PS2APP+transgenic+mice%2C+coexpressing+hPS2mut+and+hAPPswe%2C+show+age-related+cognitive+deficits+associated+with+discrete+brain+amyloid+deposition+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation</span></div><div class="casAuthors">Richards, J. Grayson; Higgins, Guy A.; Ouagazzal, Abdel-Mouttalib; Ozmen, Laurence; Kew, James N. C.; Bohrmann, Bernd; Malherbe, Pari; Brockhaus, Manfred; Loetscher, Hansruedi; Czech, Christian; Huber, Gerda; Bluethmann, Horst; Jacobsen, Helmut; Kemp, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">8989-9003</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Transgenic mice, expressing mutant β-amyloid precursor proteins (βAPPs), have lead to a better understanding of the pathophysiol. processes in Alzheimer's disease (AD).  In many of these models, however, the temporal development of cognitive decline and the relationship to Aβ deposition and inflammation are unclear.  We now report a novel transgenic mouse line, PS2APP (PS2N141I × APPswe), which develops a severe cerebral amyloidosis in discrete brain regions, and present a cross-sectional anal. of these mice at 4, 8, 12, and 16 mo of age.  Each age cohort was investigated for changes in behavior, electrophysiol. of synapse efficacy, ELISA-detd. Aβ load, histopathol., and in immunoelectron microscopy.  Cognitive deficits were first obsd. at 8 mo when Aβ deposits and inflammation were restricted to discrete brain regions, namely the subiculum and frontolateral (motor and orbital) cortex.  As early as 5 mo, electron microscopy revealed the presence, in these regions, of pre-plaque, immunogold-labeled extracellular fibrillar Aβ.  At the same age, increased levels of insol. Aβ were detected by ELISA, with Aβ1-40 levels exceeding those of Aβ1-42.  Further cognitive decline occurred in an age-related manner, and this was accompanied by the spread of amyloidosis to ultimately affect not only neo- and limbic cortices, but also thalamic and pontine nuclei.  Dentate gyrus post-tetanic potentiation was significantly attenuated at 17 mo, and there were also significant differences in paired-pulse parameters.  This systematic cross-sectional study of the behavioral and pathol. changes in the PS2APP mouse indicates that it develops age-related cognitive decline assocd. with severe amyloidosis and inflammation in discrete brain regions and therefore is suitable for testing a range of potential symptomatic and disease-modifying therapies for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDKdVZTi_SV7Vg90H21EOLACvtfcHk0lgtWzauL3nMog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFOnu78%253D&md5=0cd756fe7367e67cf38e6c64a34a6e14</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DJ.%2BG.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DOuagazzal%26aufirst%3DA.%2BM.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DKew%26aufirst%3DJ.%2BN.%26aulast%3DBohrmann%26aufirst%3DB.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DBrockhaus%26aufirst%3DM.%26aulast%3DLoetscher%26aufirst%3DH.%26aulast%3DCzech%26aufirst%3DC.%26aulast%3DHuber%26aufirst%3DG.%26aulast%3DBluethmann%26aufirst%3DH.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DKemp%26aufirst%3DJ.%2BA.%26atitle%3DPS2APP%2520transgenic%2520mice%252C%2520coexpressing%2520hPS2mut%2520and%2520hAPPswe%252C%2520show%2520age-related%2520cognitive%2520deficits%2520associated%2520with%2520discrete%2520brain%2520amyloid%2520deposition%2520and%2520inflammation%26jtitle%3DJ.%2520Neurosci.%26date%3D2003%26volume%3D23%26spage%3D8989%26epage%3D9003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Coffey, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiciene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hongisto, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brecht, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdegen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, M. J.</span><span> </span><span class="NLM_article-title">c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4335</span><span class="NLM_x">–</span> <span class="NLM_lpage">4345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=12040039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFWgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=4335-4345&author=E.+T.+Coffeyauthor=G.+Smicieneauthor=V.+Hongistoauthor=J.+Caoauthor=S.+Brechtauthor=T.+Herdegenauthor=M.+J.+Courtney&title=c-Jun+N-terminal+protein+kinase+%28JNK%29+2%2F3+is+specifically+activated+by+stress%2C+mediating+c-Jun+activation%2C+in+the+presence+of+constitutive+JNK1+activity+in+cerebellar+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons</span></div><div class="casAuthors">Coffey, Eleanor T.; Smiciene, Giedre; Hongisto, Vesa; Cao, Jiong; Brecht, Stephan; Herdegen, Thomas; Courtney, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4335-4345</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">C-Jun is considered a major regulator of both neuronal death and regeneration.  Stress in primary cultured CNS neurons induces phosphorylation of c-Jun serines 63 and 73 and increased c-Jun protein level.  However, total c-Jun N-terminal protein kinase (JNK) activity does not increase, and no satisfactory explanation for this paradox has been available.  Here we demonstrate that neuronal stress induces strong activation of JNK2/3 in the presence of constitutively and highly active JNK1.  Correspondingly, neurons from JNK1-/- mice show lower constitutive activity and considerably higher responsiveness to stress.  P38 activity can be completely inhibited without effect on c-Jun phosphorylation, whereas 10 μM SB203580 strongly inhibits neuronal JNK2/3, stress-induced c-Jun phosphorylation, induced c-Jun activity, and neuronal death in response to trophic withdrawal stress.  Neither constitutive JNK1 activity nor total neuronal JNK activity were significantly affected by this concn. of drug.  Thus, neuronal stress selectively activates JNK2/3 in the presence of mechanisms maintaining constitutive JNK1 activity, and this JNK2/3 activity selectively targets c-Jun, which is isolated from constitutive JNK1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUUBvsE-JyObVg90H21EOLACvtfcHk0lgtWzauL3nMog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksFWgtb4%253D&md5=2472f44b2c6a531cfc2601999c2fbcde</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoffey%26aufirst%3DE.%2BT.%26aulast%3DSmiciene%26aufirst%3DG.%26aulast%3DHongisto%26aufirst%3DV.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DBrecht%26aufirst%3DS.%26aulast%3DHerdegen%26aufirst%3DT.%26aulast%3DCourtney%26aufirst%3DM.%2BJ.%26atitle%3Dc-Jun%2520N-terminal%2520protein%2520kinase%2520%2528JNK%2529%25202%252F3%2520is%2520specifically%2520activated%2520by%2520stress%252C%2520mediating%2520c-Jun%2520activation%252C%2520in%2520the%2520presence%2520of%2520constitutive%2520JNK1%2520activity%2520in%2520cerebellar%2520neurons%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D4335%26epage%3D4345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Huntwork-Rodriguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozniak, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bustos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1083/jcb.201303066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1083%2Fjcb.201303066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2013&pages=747-763&author=S.+Huntwork-Rodriguezauthor=B.+Wangauthor=T.+Watkinsauthor=A.+S.+Ghoshauthor=C.+D.+Pozniakauthor=D.+Bustosauthor=K.+Newtonauthor=D.+S.+Kirkpatrickauthor=J.+W.+Lewcock&title=JNK-mediated+phosphorylation+of+DLK+suppresses+its+ubiquitination+to+promote+neuronal+apoptosis&doi=10.1083%2Fjcb.201303066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201303066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201303066%26sid%3Dliteratum%253Aachs%26aulast%3DHuntwork-Rodriguez%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWatkins%26aufirst%3DT.%26aulast%3DGhosh%26aufirst%3DA.%2BS.%26aulast%3DPozniak%26aufirst%3DC.%2BD.%26aulast%3DBustos%26aufirst%3DD.%26aulast%3DNewton%26aufirst%3DK.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DJNK-mediated%2520phosphorylation%2520of%2520DLK%2520suppresses%2520its%2520ubiquitination%2520to%2520promote%2520neuronal%2520apoptosis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2013%26volume%3D202%26spage%3D747%26epage%3D763%26doi%3D10.1083%2Fjcb.201303066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E.</span><span> </span><span class="NLM_article-title">Rational use of plasma protein and tissue binding data in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8238</span><span class="NLM_x">–</span> <span class="NLM_lpage">8248</span><span class="refDoi"> DOI: 10.1021/jm5007935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5007935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8238-8248&author=X.+Liuauthor=M.+Wrightauthor=C.+E.+Hop&title=Rational+use+of+plasma+protein+and+tissue+binding+data+in+drug+design&doi=10.1021%2Fjm5007935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design</span></div><div class="casAuthors">Liu, Xingrong; Wright, Matthew; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8238-8248</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is a commonly accepted assumption that only unbound drug mols. are available to interact with their targets.  Therefore, one of the objectives in drug design is to optimize the compd. structure to increase in vivo unbound drug concn.  In this review, theor. analyses and exptl. observations are presented to illustrate that low plasma protein binding does not necessarily lead to high in vivo unbound plasma concn.  Similarly, low brain tissue binding does not lead to high in vivo unbound brain tissue concn.  Instead, low intrinsic clearance leads to high in vivo unbound plasma concn., and low efflux transport activity at the blood-brain barrier leads to high unbound brain concn.  Plasma protein and brain tissue binding are very important parameters in understanding pharmacokinetics, pharmacodynamics, and toxicities of drugs, but these parameters should not be targeted for optimization in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiYUz9ljIDrVg90H21EOLACvtfcHk0lhDrtZyXSXz5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M&md5=53ffbdb88ddf500a90a0eee14b0e641f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm5007935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5007935%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DHop%26aufirst%3DC.%2BE.%26atitle%3DRational%2520use%2520of%2520plasma%2520protein%2520and%2520tissue%2520binding%2520data%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8238%26epage%3D8248%26doi%3D10.1021%2Fjm5007935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">The free fraction in the cell culture medium containing 10% serum was calculated based on a method reported in this reference assuming the serum binding is similar to measured human plasma protein binding of 84% for compound <b>14</b>.</p></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Cohen, F.; Huestis, M.; Ly, C.; Patel, S.; Siu, M.; Zhao, X.</span><span> </span><span class="NLM_article-title">Preparation of Substituted Dipyridines as DLK Iinhibitors for Treating Neurodegeneration</span>. PCT Int. Appl., WO 2013174780,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=F.+Cohen&author=M.+Huestis&author=C.+Ly&author=S.+Patel&author=M.+Siu&author=X.+Zhao&title=Preparation+of+Substituted+Dipyridines+as+DLK+Iinhibitors+for+Treating+Neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DF.%26atitle%3DPreparation%2520of%2520Substituted%2520Dipyridines%2520as%2520DLK%2520Iinhibitors%2520for%2520Treating%2520Neurodegeneration%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallop, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminker, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weimer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span> </span><span class="NLM_article-title">Spatially coordinated kinase signaling regulates local axon degeneration</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">13439</span><span class="NLM_x">–</span> <span class="NLM_lpage">13453</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2039-12.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1523%2FJNEUROSCI.2039-12.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=23015435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKhsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=13439-13453&author=M.+Chenauthor=J.+A.+Maloneyauthor=D.+Y.+Kallopauthor=J.+K.+Atwalauthor=S.+J.+Tamauthor=K.+Baerauthor=H.+Kisselauthor=J.+S.+Kaminkerauthor=J.+W.+Lewcockauthor=R.+M.+Weimerauthor=R.+J.+Watts&title=Spatially+coordinated+kinase+signaling+regulates+local+axon+degeneration&doi=10.1523%2FJNEUROSCI.2039-12.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Spatially coordinated kinase signaling regulates local axon degeneration</span></div><div class="casAuthors">Chen, Mark; Maloney, Janice A.; Kallop, Dara Y.; Atwal, Jasvinder K.; Tam, Stephen J.; Baer, Kristin; Kissel, Holger; Kaminker, Joshua S.; Lewcock, Joseph W.; Weimer, Robby M.; Watts, Ryan J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">13439-13453</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">In addn. to being a hallmark of neurodegenerative disease, axon degeneration is used during development of the nervous system to prune unwanted connections.  In development, axon degeneration is tightly regulated both temporally and spatially.  Here, we provide evidence that degeneration cues are transduced through various kinase pathways functioning in spatially distinct compartments to regulate axon degeneration.  Intriguingly, glycogen synthase kinase-3 (GSK3) acts centrally, likely modulating gene expression in the cell body to regulate distally restricted axon degeneration.  Through a combination of genetic and pharmacol. manipulations, including the generation of an analog-sensitive kinase allele mutant mouse for GSK3β, we show that the β isoform of GSK3, not the α isoform, is essential for developmental axon pruning in vitro and in vivo.  Addnl., we identify the dleu2/mir15a/16-1 cluster, previously characterized as a regulator of B-cell proliferation, and the transcription factor tbx6, as likely downstream effectors of GSK3β in axon degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1FqsdLaQoI7Vg90H21EOLACvtfcHk0lhDrtZyXSXz5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKhsrzJ&md5=b961d768ebb4ed59b947269bc095871a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2039-12.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2039-12.2012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DM.%26aulast%3DMaloney%26aufirst%3DJ.%2BA.%26aulast%3DKallop%26aufirst%3DD.%2BY.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DTam%26aufirst%3DS.%2BJ.%26aulast%3DBaer%26aufirst%3DK.%26aulast%3DKissel%26aufirst%3DH.%26aulast%3DKaminker%26aufirst%3DJ.%2BS.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26aulast%3DWeimer%26aufirst%3DR.%2BM.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26atitle%3DSpatially%2520coordinated%2520kinase%2520signaling%2520regulates%2520local%2520axon%2520degeneration%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D13439%26epage%3D13453%26doi%3D10.1523%2FJNEUROSCI.2039-12.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_publisher-name">ThermoFisher Scientific</span>, <span class="NLM_publisher-loc">Waltham, MA</span>, <a href="https://www.thermofisher.com/us/en/home/products-and-services/services/custom-services/screening-and-profiling-services/selectscreen-profiling-service/selectscreen-kinase-profiling-service.html" class="extLink">https://www.thermofisher.com/us/en/home/products-and-services/services/custom-services/screening-and-profiling-services/selectscreen-profiling-service/selectscreen-kinase-profiling-service.html</a> (accessed August 2,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ThermoFisher+Scientific%2C+Waltham%2C+MA%2C+https%3A%2F%2Fwww.thermofisher.com%2Fus%2Fen%2Fhome%2Fproducts-and-services%2Fservices%2Fcustom-services%2Fscreening-and-profiling-services%2Fselectscreen-profiling-service%2Fselectscreen-kinase-profiling-service.html+%28accessed+August+2%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26pub%3DThermoFisher%2520Scientific%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_publisher-name">DiscoverX</span>, <span class="NLM_publisher-loc">Fremont, CA</span>, <a href="https://www.discoverx.com/technologies-platforms/competitive-binding-technology/kinomescan-technology-platform" class="extLink">https://www.discoverx.com/technologies-platforms/competitive-binding-technology/kinomescan-technology-platform</a> (Accessed August 2,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DiscoverX%2C+Fremont%2C+CA%2C+https%3A%2F%2Fwww.discoverx.com%2Ftechnologies-platforms%2Fcompetitive-binding-technology%2Fkinomescan-technology-platform+%28Accessed+August+2%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26pub%3DDiscoverX%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 23 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alexander
S. Filatov, Siqi Wang, Olesya V. Khoroshilova, Stanislav V. Lozovskiy, Anna G. Larina, Vitali M. Boitsov, <span class="NLM_string-name hlFld-ContribAuthor">Alexander V. Stepakov</span>. </span><span class="cited-content_cbyCitation_article-title">Stereo- and Regioselective 1,3-Dipolar Cycloaddition of the Stable Ninhydrin-Derived Azomethine Ylide to Cyclopropenes: Trapping of Unstable Cyclopropene Dipolarophiles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (11)
                                     , 7017-7036. <a href="https://doi.org/10.1021/acs.joc.9b00753" title="DOI URL">https://doi.org/10.1021/acs.joc.9b00753</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b00753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b00753%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStereo-%252Band%252BRegioselective%252B1%25252C3-Dipolar%252BCycloaddition%252Bof%252Bthe%252BStable%252BNinhydrin-Derived%252BAzomethine%252BYlide%252Bto%252BCyclopropenes%25253A%252BTrapping%252Bof%252BUnstable%252BCyclopropene%252BDipolarophiles%26aulast%3DFilatov%26aufirst%3DAlexander%2BS.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D16032019%26date%3D22052019%26date%3D08052019%26volume%3D84%26issue%3D11%26spage%3D7017%26epage%3D7036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Illia
O. Feskov, Anton V. Chernykh, Yuliya O. Kuchkovska, Constantin G. Daniliuc, Ivan S. Kondratov, <span class="NLM_string-name hlFld-ContribAuthor">Oleksandr O. Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">3-((Hetera)cyclobutyl)azetidines, “Stretched” Analogues of Piperidine, Piperazine, and Morpholine: Advanced Building Blocks for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (3)
                                     , 1363-1371. <a href="https://doi.org/10.1021/acs.joc.8b02822" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02822%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D3-%252528%252528Hetera%252529cyclobutyl%252529azetidines%25252C%252B%2525E2%252580%25259CStretched%2525E2%252580%25259D%252BAnalogues%252Bof%252BPiperidine%25252C%252BPiperazine%25252C%252Band%252BMorpholine%25253A%252BAdvanced%252BBuilding%252BBlocks%252Bfor%252BDrug%252BDiscovery%26aulast%3DFeskov%26aufirst%3DIllia%2BO.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D05112018%26date%3D08012019%26date%3D24122018%26volume%3D84%26issue%3D3%26spage%3D1363%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Masha
G. Savelieff, Geewoo Nam, Juhye Kang, Hyuck Jin Lee, Misun Lee, <span class="NLM_string-name hlFld-ContribAuthor">Mi Hee Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (2)
                                     , 1221-1322. <a href="https://doi.org/10.1021/acs.chemrev.8b00138" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00138%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DDevelopment%252Bof%252BMultifunctional%252BMolecules%252Bas%252BPotential%252BTherapeutic%252BCandidates%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25252C%252BParkinson%2525E2%252580%252599s%252BDisease%25252C%252Band%252BAmyotrophic%252BLateral%252BSclerosis%252Bin%252Bthe%252BLast%252BDecade%26aulast%3DSavelieff%26aufirst%3DMasha%2BG.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D02032018%26date%3D10082018%26volume%3D119%26issue%3D2%26spage%3D1221%26epage%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael Siu, Arundhati Sengupta Ghosh, <span class="NLM_string-name hlFld-ContribAuthor">Joseph W. Lewcock</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Leucine Zipper Kinase Inhibitors for the Treatment of Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (18)
                                     , 8078-8087. <a href="https://doi.org/10.1021/acs.jmedchem.8b00370" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00370</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00370%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252BLeucine%252BZipper%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNeurodegeneration%26aulast%3DSiu%26aufirst%3DMichael%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D08032018%26date%3D04062018%26volume%3D61%26issue%3D18%26spage%3D8078%26epage%3D8087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robert J. Young, <span class="NLM_string-name hlFld-ContribAuthor">Paul D. Leeson</span>. </span><span class="cited-content_cbyCitation_article-title">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6421-6467. <a href="https://doi.org/10.1021/acs.jmedchem.8b00180" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMapping%252Bthe%252BEfficiency%252Band%252BPhysicochemical%252BTrajectories%252Bof%252BSuccessful%252BOptimizations%26aulast%3DYoung%26aufirst%3DRobert%2BJ.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03022018%26date%3D25042018%26date%3D05042018%26volume%3D61%26issue%3D15%26spage%3D6421%26epage%3D6467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hua Deng, Wu-Lin Yang, Fei Tian, Wenjun Tang, <span class="NLM_string-name hlFld-ContribAuthor">Wei-Ping Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Construction of 3-Azabicyclo[3.1.0]hexane Skeleton with Five Contiguous Stereogenic Centers by Cu-Catalyzed 1,3-Dipolar Cycloaddition of Trisubstituted Cyclopropenes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (13)
                                     , 4121-4125. <a href="https://doi.org/10.1021/acs.orglett.8b01686" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01686</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01686%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAsymmetric%252BConstruction%252Bof%252B3-Azabicyclo%25255B3.1.0%25255Dhexane%252BSkeleton%252Bwith%252BFive%252BContiguous%252BStereogenic%252BCenters%252Bby%252BCu-Catalyzed%252B1%25252C3-Dipolar%252BCycloaddition%252Bof%252BTrisubstituted%252BCyclopropenes%26aulast%3DDeng%26aufirst%3DHua%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D29052018%26date%3D26062018%26volume%3D20%26issue%3D13%26spage%3D4121%26epage%3D4125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyemin  Kim</span>, <span class="hlFld-ContribAuthor ">Jinyoung  Lee</span>, <span class="hlFld-ContribAuthor ">Yongcheol  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">PDK1 is a negative regulator of axon regeneration. </span><span class="cited-content_cbyCitation_journal-name">Molecular Brain</span><span> <strong>2021,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13041-021-00748-z" title="DOI URL">https://doi.org/10.1186/s13041-021-00748-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13041-021-00748-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13041-021-00748-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Brain%26atitle%3DPDK1%252Bis%252Ba%252Bnegative%252Bregulator%252Bof%252Baxon%252Bregeneration%26aulast%3DKim%26aufirst%3DHyemin%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siqi  Wang</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Filatov</span>, <span class="hlFld-ContribAuthor ">Stanislav V.  Lozovskiy</span>, <span class="hlFld-ContribAuthor ">Stanislav V.  Shmakov</span>, <span class="hlFld-ContribAuthor ">Olesya V.  Khoroshilova</span>, <span class="hlFld-ContribAuthor ">Anna G.  Larina</span>, <span class="hlFld-ContribAuthor ">Stanislav I.  Selivanov</span>, <span class="hlFld-ContribAuthor ">Vitali M.  Boitsov</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Stepakov</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of Spiro[3-azabicyclo[3.1.0]hexanes] via 1,3-Dipolar Cycloaddition of 1,2-Diphenylcyclopropenes to Ninhydrin-Derived Azomethine Ylides. </span><span class="cited-content_cbyCitation_journal-name">Synthesis</span><span> <strong>2021,</strong> <em>53 </em>
                                    (12)
                                     , 2114-2132. <a href="https://doi.org/10.1055/a-1360-9716" title="DOI URL">https://doi.org/10.1055/a-1360-9716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/a-1360-9716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fa-1360-9716%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthesis%26atitle%3DConstruction%252Bof%252BSpiro%25255B3-azabicyclo%25255B3.1.0%25255Dhexanes%25255D%252Bvia%252B1%25252C3-Dipolar%252BCycloaddition%252Bof%252B1%25252C2-Diphenylcyclopropenes%252Bto%252BNinhydrin-Derived%252BAzomethine%252BYlides%26aulast%3DWang%26aufirst%3DSiqi%26date%3D2021%26date%3D2021%26volume%3D53%26issue%3D12%26spage%3D2114%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuefei  Li</span>, <span class="hlFld-ContribAuthor ">Yanbo  Yu</span>, <span class="hlFld-ContribAuthor ">Zhude  Tu</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazole Scaffold Synthesis, Functionalization, and Applications in Alzheimer’s Disease and Parkinson’s Disease Treatment (2011–2020). </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (5)
                                     , 1202. <a href="https://doi.org/10.3390/molecules26051202" title="DOI URL">https://doi.org/10.3390/molecules26051202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26051202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26051202%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPyrazole%252BScaffold%252BSynthesis%25252C%252BFunctionalization%25252C%252Band%252BApplications%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BParkinson%2525E2%252580%252599s%252BDisease%252BTreatment%252B%2525282011%2525E2%252580%2525932020%252529%26aulast%3DLi%26aufirst%3DXuefei%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D5%26spage%3D1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Xu</span>, <span class="hlFld-ContribAuthor ">Diane E.  Carrera</span>, <span class="hlFld-ContribAuthor ">Danial  Beaudry</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Malcolm P.  Huestis</span>, <span class="hlFld-ContribAuthor ">Wendy  Liu</span>, <span class="hlFld-ContribAuthor ">Rémy  Angelaud</span>, <span class="hlFld-ContribAuthor ">Francis  Gosselin</span>. </span><span class="cited-content_cbyCitation_article-title">Fit-for-purpose synthesis of dual leucine zipper kinase (DLK) inhibitor GNE-834. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (43)
                                     , 152430. <a href="https://doi.org/10.1016/j.tetlet.2020.152430" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.152430</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.152430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.152430%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DFit-for-purpose%252Bsynthesis%252Bof%252Bdual%252Bleucine%252Bzipper%252Bkinase%252B%252528DLK%252529%252Binhibitor%252BGNE-834%26aulast%3DXu%26aufirst%3DJie%26date%3D2020%26volume%3D61%26issue%3D43%26spage%3D152430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caroline L.  Benn</span>, <span class="hlFld-ContribAuthor ">Lee A.  Dawson</span>. </span><span class="cited-content_cbyCitation_article-title">Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Aging Neuroscience</span><span> <strong>2020,</strong> <em>12 </em><a href="https://doi.org/10.3389/fnagi.2020.00242" title="DOI URL">https://doi.org/10.3389/fnagi.2020.00242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnagi.2020.00242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnagi.2020.00242%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Aging%2520Neuroscience%26atitle%3DClinically%252BPrecedented%252BProtein%252BKinases%25253A%252BRationale%252Bfor%252BTheir%252BUse%252Bin%252BNeurodegenerative%252BDisease%26aulast%3DBenn%26aufirst%3DCaroline%2BL.%26date%3D2020%26date%3D2020%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sunil  Goodwani</span>, <span class="hlFld-ContribAuthor ">Celia  Fernandez</span>, <span class="hlFld-ContribAuthor ">Paul J.  Acton</span>, <span class="hlFld-ContribAuthor ">Virginie  Buggia-Prevot</span>, <span class="hlFld-ContribAuthor ">Morgan L.  McReynolds</span>, <span class="hlFld-ContribAuthor ">Jiacheng  Ma</span>, <span class="hlFld-ContribAuthor ">Cheng Hui  Hu</span>, <span class="hlFld-ContribAuthor ">Mary E.  Hamby</span>, <span class="hlFld-ContribAuthor ">Yongying  Jiang</span>, <span class="hlFld-ContribAuthor ">Kang  Le</span>, <span class="hlFld-ContribAuthor ">Michael J.  Soth</span>, <span class="hlFld-ContribAuthor ">Philip  Jones</span>, <span class="hlFld-ContribAuthor ">William J.  Ray</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Leucine Zipper Kinase Is Constitutively Active in the Adult Mouse Brain and Has Both Stress-Induced and Homeostatic Functions. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (14)
                                     , 4849. <a href="https://doi.org/10.3390/ijms21144849" title="DOI URL">https://doi.org/10.3390/ijms21144849</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21144849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21144849%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDual%252BLeucine%252BZipper%252BKinase%252BIs%252BConstitutively%252BActive%252Bin%252Bthe%252BAdult%252BMouse%252BBrain%252Band%252BHas%252BBoth%252BStress-Induced%252Band%252BHomeostatic%252BFunctions%26aulast%3DGoodwani%26aufirst%3DSunil%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D14%26spage%3D4849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Ge</span>, <span class="hlFld-ContribAuthor ">Wenlin  Chen</span>, <span class="hlFld-ContribAuthor ">Peter  Axerio-Cilies</span>, <span class="hlFld-ContribAuthor ">Yu Tian  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">NMDARs in Cell Survival and Death: Implications in Stroke Pathogenesis and Treatment. </span><span class="cited-content_cbyCitation_journal-name">Trends in Molecular Medicine</span><span> <strong>2020,</strong> <em>26 </em>
                                    (6)
                                     , 533-551. <a href="https://doi.org/10.1016/j.molmed.2020.03.001" title="DOI URL">https://doi.org/10.1016/j.molmed.2020.03.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molmed.2020.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molmed.2020.03.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Molecular%2520Medicine%26atitle%3DNMDARs%252Bin%252BCell%252BSurvival%252Band%252BDeath%25253A%252BImplications%252Bin%252BStroke%252BPathogenesis%252Band%252BTreatment%26aulast%3DGe%26aufirst%3DYang%26date%3D2020%26volume%3D26%26issue%3D6%26spage%3D533%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dale D. O.  Martin</span>, <span class="hlFld-ContribAuthor ">Prasad S.  Kanuparthi</span>, <span class="hlFld-ContribAuthor ">Sabrina M.  Holland</span>, <span class="hlFld-ContribAuthor ">Shaun S.  Sanders</span>, <span class="hlFld-ContribAuthor ">Hey-Kyeong  Jeong</span>, <span class="hlFld-ContribAuthor ">Margret B.  Einarson</span>, <span class="hlFld-ContribAuthor ">Marlene A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Gareth M.  Thomas</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Inhibitors of DLK Palmitoylation and Signaling by High Content Screening. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-39968-8" title="DOI URL">https://doi.org/10.1038/s41598-019-39968-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-39968-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-39968-8%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DIdentification%252Bof%252BNovel%252BInhibitors%252Bof%252BDLK%252BPalmitoylation%252Band%252BSignaling%252Bby%252BHigh%252BContent%252BScreening%26aulast%3DMartin%26aufirst%3DDale%2BD.%2BO.%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marlies  Verschuuren</span>, <span class="hlFld-ContribAuthor ">Peter  Verstraelen</span>, <span class="hlFld-ContribAuthor ">Gerardo  García-Díaz Barriga</span>, <span class="hlFld-ContribAuthor ">Ines  Cilissen</span>, <span class="hlFld-ContribAuthor ">Emma  Coninx</span>, <span class="hlFld-ContribAuthor ">Mieke  Verslegers</span>, <span class="hlFld-ContribAuthor ">Peter H.  Larsen</span>, <span class="hlFld-ContribAuthor ">Rony  Nuydens</span>, <span class="hlFld-ContribAuthor ">Winnok H.  De Vos</span>. </span><span class="cited-content_cbyCitation_article-title">High-throughput microscopy exposes a pharmacological window in which dual leucine zipper kinase inhibition preserves neuronal network connectivity. </span><span class="cited-content_cbyCitation_journal-name">Acta Neuropathologica Communications</span><span> <strong>2019,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40478-019-0741-3" title="DOI URL">https://doi.org/10.1186/s40478-019-0741-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40478-019-0741-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40478-019-0741-3%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Neuropathologica%2520Communications%26atitle%3DHigh-throughput%252Bmicroscopy%252Bexposes%252Ba%252Bpharmacological%252Bwindow%252Bin%252Bwhich%252Bdual%252Bleucine%252Bzipper%252Bkinase%252Binhibition%252Bpreserves%252Bneuronal%252Bnetwork%252Bconnectivity%26aulast%3DVerschuuren%26aufirst%3DMarlies%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yishi  Jin</span>, <span class="hlFld-ContribAuthor ">Binhai  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Multitasking: Dual Leucine Zipper–Bearing Kinases in Neuronal Development and Stress Management. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Cell and Developmental Biology</span><span> <strong>2019,</strong> <em>35 </em>
                                    (1)
                                     , 501-521. <a href="https://doi.org/10.1146/annurev-cellbio-100617-062644" title="DOI URL">https://doi.org/10.1146/annurev-cellbio-100617-062644</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-cellbio-100617-062644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-cellbio-100617-062644%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DMultitasking%25253A%252BDual%252BLeucine%252BZipper%2525E2%252580%252593Bearing%252BKinases%252Bin%252BNeuronal%252BDevelopment%252Band%252BStress%252BManagement%26aulast%3DJin%26aufirst%3DYishi%26date%3D2019%26volume%3D35%26issue%3D1%26spage%3D501%26epage%3D521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra  Russo</span>, <span class="hlFld-ContribAuthor ">Aaron  DiAntonio</span>. </span><span class="cited-content_cbyCitation_article-title">Wnd/DLK Is a Critical Target of FMRP Responsible for Neurodevelopmental and Behavior Defects in the Drosophila Model of Fragile X Syndrome. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2019,</strong> <em>28 </em>
                                    (10)
                                     , 2581-2593.e5. <a href="https://doi.org/10.1016/j.celrep.2019.08.001" title="DOI URL">https://doi.org/10.1016/j.celrep.2019.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2019.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2019.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DWnd%25252FDLK%252BIs%252Ba%252BCritical%252BTarget%252Bof%252BFMRP%252BResponsible%252Bfor%252BNeurodevelopmental%252Band%252BBehavior%252BDefects%252Bin%252Bthe%252BDrosophila%252BModel%252Bof%252BFragile%252BX%252BSyndrome%26aulast%3DRusso%26aufirst%3DAlexandra%26date%3D2019%26volume%3D28%26issue%3D10%26spage%3D2581%26epage%3D2593.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I. N.  Bardasov</span>, <span class="hlFld-ContribAuthor ">A. U.  Alekseeva</span>, <span class="hlFld-ContribAuthor ">O. V.  Ershov</span>. </span><span class="cited-content_cbyCitation_article-title">Hydrolysis of 6-Aryl-2-amino-4-(dicyanomethylidene)-3-azabicyclo[3.1.0]hex-2-ene-1,5-dicarbonitriles. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>55 </em>
                                    (8)
                                     , 1077-1080. <a href="https://doi.org/10.1134/S1070428019080025" title="DOI URL">https://doi.org/10.1134/S1070428019080025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428019080025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428019080025%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DHydrolysis%252Bof%252B6-Aryl-2-amino-4-%252528dicyanomethylidene%252529-3-azabicyclo%25255B3.1.0%25255Dhex-2-ene-1%25252C5-dicarbonitriles%26aulast%3DBardasov%26aufirst%3DI.%2BN.%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D8%26spage%3D1077%26epage%3D1080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elham  Asghari Adib</span>, <span class="hlFld-ContribAuthor ">Laura J  Smithson</span>, <span class="hlFld-ContribAuthor ">Catherine A  Collins</span>. </span><span class="cited-content_cbyCitation_article-title">An axonal stress response pathway: degenerative and regenerative signaling by DLK. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Neurobiology</span><span> <strong>2018,</strong> <em>53 </em>, 110-119. <a href="https://doi.org/10.1016/j.conb.2018.07.002" title="DOI URL">https://doi.org/10.1016/j.conb.2018.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.conb.2018.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.conb.2018.07.002%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Neurobiology%26atitle%3DAn%252Baxonal%252Bstress%252Bresponse%252Bpathway%25253A%252Bdegenerative%252Band%252Bregenerative%252Bsignaling%252Bby%252BDLK%26aulast%3DAsghari%2BAdib%26aufirst%3DElham%26date%3D2018%26volume%3D53%26spage%3D110%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Simon</span>, <span class="hlFld-ContribAuthor ">Trent A.  Watkins</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic opportunities and pitfalls in the treatment of axon degeneration. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Neurology</span><span> <strong>2018,</strong> <em>31 </em>
                                    (6)
                                     , 693-701. <a href="https://doi.org/10.1097/WCO.0000000000000621" title="DOI URL">https://doi.org/10.1097/WCO.0000000000000621</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/WCO.0000000000000621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FWCO.0000000000000621%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Neurology%26atitle%3DTherapeutic%252Bopportunities%252Band%252Bpitfalls%252Bin%252Bthe%252Btreatment%252Bof%252Baxon%252Bdegeneration%26aulast%3DSimon%26aufirst%3DDavid%2BJ.%26date%3D2018%26volume%3D31%26issue%3D6%26spage%3D693%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James S.  Scott</span>, <span class="hlFld-ContribAuthor ">Michael J.  Waring</span>. </span><span class="cited-content_cbyCitation_article-title">Practical application of ligand efficiency metrics in lead optimisation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (11)
                                     , 3006-3015. <a href="https://doi.org/10.1016/j.bmc.2018.04.004" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPractical%252Bapplication%252Bof%252Bligand%252Befficiency%252Bmetrics%252Bin%252Blead%252Boptimisation%26aulast%3DScott%26aufirst%3DJames%2BS.%26date%3D2018%26volume%3D26%26issue%3D11%26spage%3D3006%26epage%3D3015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Shi</span>, <span class="hlFld-ContribAuthor ">Mary  Mader</span>. </span><span class="cited-content_cbyCitation_article-title">Brain penetrant kinase inhibitors: Learning from kinase neuroscience discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (11)
                                     , 1981-1991. <a href="https://doi.org/10.1016/j.bmcl.2018.05.007" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.05.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.05.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBrain%252Bpenetrant%252Bkinase%252Binhibitors%25253A%252BLearning%252Bfrom%252Bkinase%252Bneuroscience%252Bdiscovery%26aulast%3DShi%26aufirst%3DYuan%26date%3D2018%26volume%3D28%26issue%3D11%26spage%3D1981%26epage%3D1991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Two-dimensional representation of the hydrogen bonds of compound <b>1</b> with the hinge residues of DLK (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CEQ">5CEQ</a>). Two-dimensional representation of proposed hydrogen bonds of 3-substituted-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlay of two crystallographic structures of piperidine <b>7</b> (protein/ligand/waters in dark green/bright green/pale green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5VO2">5VO2</a>) and azabicyclo[3.1.0]hexane <b>10</b> (ivory/brown/ivory, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5VO1">5VO1</a>) bound to the DLK kinase domain. (a) Viewed down into the ATP-binding pocket with the glycine-rich P loop removed from the foreground. The kinase “hinge” is at the upper left, providing a canonical kinase binding motif of hydrogen bonds with the small molecule ligand. The core 5-(pyrazol-3-yl)pyridin-2-amines maintain a consistent position, while the solvent-oriented oxetane differs between piperidine (<b>7</b>) or the azabicyclo[3.1.0]hexane (<b>10</b>). (b) A rotated view of the overlay with the hinge at the rear, highlighting the proximity of the azabicyclo[3.1.0]hexane moiety to carbonyl groups of DLK residues 194 and 195 and showing the slight shift of the isopropyl moiety of the ligand at the center of the image.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Kinase selectivity of compounds <b>14</b> and <b>24</b> @ 1 μM (333 × and 250 × DLK <i>K</i><sub>i</sub>, respectively). Values are reported as percent inhibition and determined in a 220 kinase panel at Life Technologies. EGFR* = EGFR(T790M, L858R), RAF1* = RAF1(Y340D, Y341D), MYLK* = MYLK(smMLCK), MYLK3* = MYLK3(caMLCK), and p38_alpha* = p38_alpha(direct). Kinases with ≥50% inhibition for compound <b>14</b> are Flt3 (IC<sub>50</sub> = 0.709 μM), PAK4 (IC<sub>50</sub> = 0.673 μM), STK16 (IC<sub>50</sub> = 1.52 μM), and TrkA (IC<sub>50</sub> = 1.55 μM). Kinases with ≥50% inhibition for compound <b>24</b> are Axl (IC<sub>50</sub> = 0.448 μM), CSF1R (IC<sub>50</sub> = 1.22 μM), DMPK (IC<sub>50</sub> = 1.38 μM), EphA7 (IC<sub>50</sub> = 0.665 μM), Flt3 (IC<sub>50</sub> = 0.238 μM), and TrkA (IC<sub>50</sub> = 0.383 μM). Biochemical IC<sub>50</sub> values were determined at Life Technologies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Evaluation of compounds using an in vitro axon degeneration assay. Representative curves for compound <b>14</b> (red) and compound <b>24</b> (blue) show EC<sub>50</sub> values of 0.574 μM and 0.457 μM, respectively. Max activity reflects the extent of axonal protection relative to a positive control where degeneration was not induced as measured by high content imaging of axons followed by automated quantification. Each data point represents averages from three independent assays ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Single dose of compound <b>14</b> reduces p-c-Jun in the PS2APP model of Alzheimer’s disease. (A) Representative Western blot images of p-MKK4, p-JNK, p-c-Jun, and a GAPDH control from cortical lysates of PS2APP mice treated with vehicle (MCT) or compound <b>14</b> at 15 or 50 mg/kg PO (<i>n</i> = 7–8 animals per group). (B–D) Quantification of p-MKK4, p-JNK, and p-c-Jun following compound <b>14</b> dosing. A significant treatment effect was observed for p-c-Jun at both dose levels while p-MKK4 levels were significantly reduced only at the 50 mg/kg dose as compared to vehicle (****<i>p</i> < 0.0001, **<i>p</i> < 0.01 versus vehicle by Dunnett’s post hoc test, #<i>p</i> < 0.05 by Student’s <i>t</i> test) (C) Total concentration of <b>14</b> in brain 6 h postdose. (D) In vivo PK/PD relationship for brain exposure versus p-c-Jun reduction in individual animals from both dose groups determined an IC<sub>50</sub> = 0.190 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaI, NaNO<sub>2</sub>, <i>p</i>-toluenesulfonic acid, CH<sub>3</sub>CN, H<sub>2</sub>O, 0 °C, 0.5 h, 60% yield; (b) (i) HCl, 1,4-dioxane, CH<sub>3</sub>OH, 0–23 °C, 2 h; (ii) 3-oxetanone, NaBH<sub>3</sub>CN, CH<sub>3</sub>OH, 50 °C, 3 h, 95% yield; (c) R–(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl), Pd(dppf)Cl<sub>2,</sub> 1,4-dioxane, H<sub>2</sub>O, Cs<sub>2</sub>CO<sub>3</sub>, 110 °C microwave, 0.5 h.</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>3</sub>CN, <i>t</i>-BuOK, THF, 23 °C, 1 h, 94% crude yield; (b) hydrazine monohydrate, <i>i-</i>PrOH, 80 °C, 16 h, 80% yield (2-steps); (c) NaI, NaNO<sub>2</sub>, <i>p</i>-toluenesulfonic acid monohydrate, CH<sub>3</sub>CN, H<sub>2</sub>O, 23 °C, 1 h, 26% yield; (d) 2-bromopropane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 23 °C, 10–16 h, 23% yield; (e) R-I, R-Br, or R-OSO<sub>2</sub>CF<sub>3</sub>, Cs<sub>2</sub>CO<sub>3</sub> or K<sub>2</sub>CO<sub>3</sub>, DMF or CH<sub>3</sub>CN, 23 °C, 10–16 h; (f) 2,2-dimethyloxirane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 16 h, 47% yield; (g) (TFA, CH<sub>2</sub>Cl<sub>2</sub>) or (HCl, EtOAc) or (HCl, 1,4-dioxane, CH<sub>3</sub>OH), 23 °C, 1–3 h; (h) 3-oxetanone, NaBH<sub>3</sub>CN, CH<sub>3</sub>OH, 23–60 °C, 1–3 h; (i) R-Br or R-OSO<sub>2</sub>Me, (<i>i</i>-Pr)<sub>2</sub>NEt, THF or DMF, 40–50 °C, 16 h; (j) Ac<sub>2</sub>O, (<i>i</i>-Pr)<sub>2</sub>NEt, 25 °C, 1 h, 75% yield; (k) 2-methyloxirane, CH<sub>3</sub>OH, 23 °C, 16 h, 55% yield; (l) R-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl), Pd(dppf)Cl<sub>2,</sub> Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 100–120 °C microwave, 0.5 h.</p></p></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/medium/jm-2017-008438_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-19/acs.jmedchem.7b00843/20171006/images/large/jm-2017-008438_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00843&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N,O</i>-dimethylhydroxylamine hydrochloride, HATU, Et<sub>3</sub>N, DMF, 23 °C, 2 h, 84% yield; (b) MeMgBr, THF, Et<sub>2</sub>O, 23 °C, 2 h, 89% yield; (c) (i) (CO<sub>2</sub>Et)<sub>2</sub>, LiHMDS, 25 °C, 3 h; (ii) isopropylhydrazine or ethylhydrazine or cyclopropylmethylhydrazine, EtOH, 50 °C, 0.3 h; (d) aq. NaOH, EtOH, 23 °C, 2 h; (e) diphenylphosphoryl azide, BnOH, (<i>i</i>-Pr)<sub>2</sub>NEt, toluene, 90 °C, 4 h; (f) H<sub>2</sub> (1 atm), CH<sub>3</sub>OH, 10% Pd/C, 23 °C, 1.5 h; (g) NaI, NaNO<sub>2</sub>, <i>p</i>-toluenesulfonic acid, CH<sub>3</sub>CN, H<sub>2</sub>O, 0–23 °C, 3 h; (h) (i) (TFA, CH<sub>2</sub>Cl<sub>2</sub>) or (HCl, EtOAc), 23 °C, 1 h; (ii) 3-oxetanone, acetic acid, NaBH<sub>3</sub>CN, CH<sub>3</sub>OH, 40–60 °C, 2 h; (i) R-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub> or Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN or 1,4-dioxane, H<sub>2</sub>O, 105 °C microwave or reflux, 0.25–3.5 h.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i106">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46514" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46514" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Watkins, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntwork-Rodriguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastham-Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modrusan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminker, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessier-Lavigne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">4039</span><span class="NLM_x">–</span> <span class="NLM_lpage">4044</span><span class="refDoi"> DOI: 10.1073/pnas.1211074110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1073%2Fpnas.1211074110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=4039-4044&author=T.+A.+Watkinsauthor=B.+Wangauthor=S.+Huntwork-Rodriguezauthor=J.+Yangauthor=Z.+Jiangauthor=J.+Eastham-Andersonauthor=Z.+Modrusanauthor=J.+S.+Kaminkerauthor=M.+Tessier-Lavigneauthor=J.+W.+Lewcock&title=DLK+initiates+a+transcriptional+program+that+couples+apoptotic+and+regenerative+responses+to+axonal+injury&doi=10.1073%2Fpnas.1211074110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1211074110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1211074110%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DT.%2BA.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHuntwork-Rodriguez%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DEastham-Anderson%26aufirst%3DJ.%26aulast%3DModrusan%26aufirst%3DZ.%26aulast%3DKaminker%26aufirst%3DJ.%2BS.%26aulast%3DTessier-Lavigne%26aufirst%3DM.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DDLK%2520initiates%2520a%2520transcriptional%2520program%2520that%2520couples%2520apoptotic%2520and%2520regenerative%2520responses%2520to%2520axonal%2520injury%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D4039%26epage%3D4044%26doi%3D10.1073%2Fpnas.1211074110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Shin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beirowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milbrandt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiAntonio, A.</span><span> </span><span class="NLM_article-title">Dual leucine zipper kinase is required for retrograde injury signaling and axonal regeneration</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span><span class="refDoi"> DOI: 10.1016/j.neuron.2012.04.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1016%2Fj.neuron.2012.04.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2012&pages=1015-1022&author=J.+E.+Shinauthor=Y.+Choauthor=B.+Beirowskiauthor=J.+Milbrandtauthor=V.+Cavalliauthor=A.+DiAntonio&title=Dual+leucine+zipper+kinase+is+required+for+retrograde+injury+signaling+and+axonal+regeneration&doi=10.1016%2Fj.neuron.2012.04.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2012.04.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2012.04.028%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DJ.%2BE.%26aulast%3DCho%26aufirst%3DY.%26aulast%3DBeirowski%26aufirst%3DB.%26aulast%3DMilbrandt%26aufirst%3DJ.%26aulast%3DCavalli%26aufirst%3DV.%26aulast%3DDiAntonio%26aufirst%3DA.%26atitle%3DDual%2520leucine%2520zipper%2520kinase%2520is%2520required%2520for%2520retrograde%2520injury%2520signaling%2520and%2520axonal%2520regeneration%26jtitle%3DNeuron%26date%3D2012%26volume%3D74%26spage%3D1015%26epage%3D1022%26doi%3D10.1016%2Fj.neuron.2012.04.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Sengupta Ghosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozniak, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">DLK induces developmental neuronal degeneration via selective regulation of proapoptotic JNK activity</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">194</span><span class="NLM_x">, </span> <span class="NLM_fpage">751</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span><span class="refDoi"> DOI: 10.1083/jcb.201103153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1083%2Fjcb.201103153" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2011&pages=751-764&author=A.+Sengupta+Ghoshauthor=B.+Wangauthor=C.+D.+Pozniakauthor=M.+Chenauthor=R.+J.+Wattsauthor=J.+W.+Lewcock&title=DLK+induces+developmental+neuronal+degeneration+via+selective+regulation+of+proapoptotic+JNK+activity&doi=10.1083%2Fjcb.201103153"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201103153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201103153%26sid%3Dliteratum%253Aachs%26aulast%3DSengupta%2BGhosh%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DPozniak%26aufirst%3DC.%2BD.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DDLK%2520induces%2520developmental%2520neuronal%2520degeneration%2520via%2520selective%2520regulation%2520of%2520proapoptotic%2520JNK%2520activity%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2011%26volume%3D194%26spage%3D751%26epage%3D764%26doi%3D10.1083%2Fjcb.201103153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Larhammar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntwork-Rodriguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanoy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta Ghosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminker, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastham-Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modrusan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farley, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessier-Lavigne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, T. A.</span><span> </span><span class="NLM_article-title">Dual leucine zipper kinase-dependent PERK activation contributes to neuronal degeneration following insult</span> <span class="citation_source-journal">eLife</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e20725</span><span class="refDoi"> DOI: 10.7554/eLife.20725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.7554%2FeLife.20725" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=e20725&author=M.+Larhammarauthor=S.+Huntwork-Rodriguezauthor=Z.+Jiangauthor=H.+Solanoyauthor=A.+Sengupta+Ghoshauthor=B.+Wangauthor=J.+S.+Kaminkerauthor=K.+Huangauthor=J.+Eastham-Andersonauthor=M.+Siuauthor=Z.+Modrusanauthor=M.+M.+Farleyauthor=M.+Tessier-Lavigneauthor=J.+W.+Lewcockauthor=T.+A.+Watkins&title=Dual+leucine+zipper+kinase-dependent+PERK+activation+contributes+to+neuronal+degeneration+following+insult&doi=10.7554%2FeLife.20725"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.7554%2FeLife.20725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.20725%26sid%3Dliteratum%253Aachs%26aulast%3DLarhammar%26aufirst%3DM.%26aulast%3DHuntwork-Rodriguez%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DSolanoy%26aufirst%3DH.%26aulast%3DSengupta%2BGhosh%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DKaminker%26aufirst%3DJ.%2BS.%26aulast%3DHuang%26aufirst%3DK.%26aulast%3DEastham-Anderson%26aufirst%3DJ.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DModrusan%26aufirst%3DZ.%26aulast%3DFarley%26aufirst%3DM.%2BM.%26aulast%3DTessier-Lavigne%26aufirst%3DM.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26aulast%3DWatkins%26aufirst%3DT.%2BA.%26atitle%3DDual%2520leucine%2520zipper%2520kinase-dependent%2520PERK%2520activation%2520contributes%2520to%2520neuronal%2520degeneration%2520following%2520insult%26jtitle%3DeLife%26date%3D2017%26volume%3D6%26spage%3De20725%26doi%3D10.7554%2FeLife.20725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Tedeschi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradke, F.</span><span> </span><span class="NLM_article-title">The DLK signalling pathway--a double-edged sword in neural development and regeneration</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span><span class="refDoi"> DOI: 10.1038/embor.2013.64</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1038%2Fembor.2013.64" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=605-614&author=A.+Tedeschiauthor=F.+Bradke&title=The+DLK+signalling+pathway%2D%2Da+double-edged+sword+in+neural+development+and+regeneration&doi=10.1038%2Fembor.2013.64"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fembor.2013.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fembor.2013.64%26sid%3Dliteratum%253Aachs%26aulast%3DTedeschi%26aufirst%3DA.%26aulast%3DBradke%26aufirst%3DF.%26atitle%3DThe%2520DLK%2520signalling%2520pathway--a%2520double-edged%2520sword%2520in%2520neural%2520development%2520and%2520regeneration%26jtitle%3DEMBO%2520Rep.%26date%3D2013%26volume%3D14%26spage%3D605%26epage%3D614%26doi%3D10.1038%2Fembor.2013.64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pozniak, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta Ghosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogineni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanoy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bustos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jubb, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayalon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weimer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degeneration</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">2553</span><span class="NLM_x">–</span> <span class="NLM_lpage">2567</span><span class="refDoi"> DOI: 10.1084/jem.20122832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1084%2Fjem.20122832" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=2553-2567&author=C.+D.+Pozniakauthor=A.+Sengupta+Ghoshauthor=A.+Gogineniauthor=J.+E.+Hansonauthor=S.+H.+Leeauthor=J.+L.+Larsonauthor=H.+Solanoyauthor=D.+Bustosauthor=H.+Liauthor=H.+Nguauthor=A.+M.+Jubbauthor=G.+Ayalonauthor=J.+Wuauthor=K.+Scearce-Levieauthor=Q.+Zhouauthor=R.+M.+Weimerauthor=D.+S.+Kirkpatrickauthor=J.+W.+Lewcock&title=Dual+leucine+zipper+kinase+is+required+for+excitotoxicity-induced+neuronal+degeneration&doi=10.1084%2Fjem.20122832"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1084%2Fjem.20122832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20122832%26sid%3Dliteratum%253Aachs%26aulast%3DPozniak%26aufirst%3DC.%2BD.%26aulast%3DSengupta%2BGhosh%26aufirst%3DA.%26aulast%3DGogineni%26aufirst%3DA.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLarson%26aufirst%3DJ.%2BL.%26aulast%3DSolanoy%26aufirst%3DH.%26aulast%3DBustos%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DNgu%26aufirst%3DH.%26aulast%3DJubb%26aufirst%3DA.%2BM.%26aulast%3DAyalon%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DWeimer%26aufirst%3DR.%2BM.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DDual%2520leucine%2520zipper%2520kinase%2520is%2520required%2520for%2520excitotoxicity-induced%2520neuronal%2520degeneration%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D2553%26epage%3D2567%26doi%3D10.1084%2Fjem.20122832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Miller, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Press, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milbrandt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiAntonio, A.</span><span> </span><span class="NLM_article-title">A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1038/nn.2290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1038%2Fnn.2290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=19287387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtFCisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=387-389&author=B.+R.+Millerauthor=C.+Pressauthor=R.+W.+Danielsauthor=Y.+Sasakiauthor=J.+Milbrandtauthor=A.+DiAntonio&title=A+dual+leucine+kinase-dependent+axon+self-destruction+program+promotes+Wallerian+degeneration&doi=10.1038%2Fnn.2290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration</span></div><div class="casAuthors">Miller, Bradley R.; Press, Craig; Daniels, Richard W.; Sasaki, Yo; Milbrandt, Jeffrey; DiAntonio, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-389</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Axon degeneration underlies many common neurol. disorders, but the signaling pathways that orchestrate axon degeneration are unknown.  We found that dual leucine kinase promoted degeneration of severed axons in Drosophila and mice, and that its target, c-Jun N-terminal kinase, promoted degeneration locally in axons as they committed to degenerate.  This pathway also promoted degeneration after chemotherapy exposure and may be a component of a general axon self-destruction program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWn57Z1aoqF7Vg90H21EOLACvtfcHk0liw2yOkpDzRMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtFCisrs%253D&md5=8565d1f74e199f63e29c411454003ec4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnn.2290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2290%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DB.%2BR.%26aulast%3DPress%26aufirst%3DC.%26aulast%3DDaniels%26aufirst%3DR.%2BW.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DMilbrandt%26aufirst%3DJ.%26aulast%3DDiAntonio%26aufirst%3DA.%26atitle%3DA%2520dual%2520leucine%2520kinase-dependent%2520axon%2520self-destruction%2520program%2520promotes%2520Wallerian%2520degeneration%26jtitle%3DNat.%2520Neurosci.%26date%3D2009%26volume%3D12%26spage%3D387%26epage%3D389%26doi%3D10.1038%2Fnn.2290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Welsbie, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlinicke, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackler, L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auld, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simard-Bisson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blouin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enke, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boye, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merbs, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh-Armstrong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauswirth, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiAntonio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickells, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yau, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quigley, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, D. J.</span><span> </span><span class="NLM_article-title">Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">4045</span><span class="NLM_x">–</span> <span class="NLM_lpage">4050</span><span class="refDoi"> DOI: 10.1073/pnas.1211284110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1073%2Fpnas.1211284110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=4045-4050&author=D.+S.+Welsbieauthor=Z.+Yangauthor=Y.+Geauthor=K.+L.+Mitchellauthor=X.+Zhouauthor=S.+E.+Martinauthor=C.+A.+Berlinickeauthor=L.+Hacklerauthor=J.+Fullerauthor=J.+Fuauthor=L.+H.+Caoauthor=B.+Hanauthor=D.+Auldauthor=T.+Xueauthor=S.+Hiraiauthor=L.+Germainauthor=C.+Simard-Bissonauthor=R.+Blouinauthor=J.+V.+Nguyenauthor=C.+H.+Davisauthor=R.+A.+Enkeauthor=S.+L.+Boyeauthor=S.+L.+Merbsauthor=N.+Marsh-Armstrongauthor=W.+W.+Hauswirthauthor=A.+DiAntonioauthor=R.+W.+Nickellsauthor=J.+Ingleseauthor=J.+Hanesauthor=K.+W.+Yauauthor=H.+A.+Quigleyauthor=D.+J.+Zack&title=Functional+genomic+screening+identifies+dual+leucine+zipper+kinase+as+a+key+mediator+of+retinal+ganglion+cell+death&doi=10.1073%2Fpnas.1211284110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1211284110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1211284110%26sid%3Dliteratum%253Aachs%26aulast%3DWelsbie%26aufirst%3DD.%2BS.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DMitchell%26aufirst%3DK.%2BL.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DMartin%26aufirst%3DS.%2BE.%26aulast%3DBerlinicke%26aufirst%3DC.%2BA.%26aulast%3DHackler%26aufirst%3DL.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DL.%2BH.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DAuld%26aufirst%3DD.%26aulast%3DXue%26aufirst%3DT.%26aulast%3DHirai%26aufirst%3DS.%26aulast%3DGermain%26aufirst%3DL.%26aulast%3DSimard-Bisson%26aufirst%3DC.%26aulast%3DBlouin%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DJ.%2BV.%26aulast%3DDavis%26aufirst%3DC.%2BH.%26aulast%3DEnke%26aufirst%3DR.%2BA.%26aulast%3DBoye%26aufirst%3DS.%2BL.%26aulast%3DMerbs%26aufirst%3DS.%2BL.%26aulast%3DMarsh-Armstrong%26aufirst%3DN.%26aulast%3DHauswirth%26aufirst%3DW.%2BW.%26aulast%3DDiAntonio%26aufirst%3DA.%26aulast%3DNickells%26aufirst%3DR.%2BW.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DHanes%26aufirst%3DJ.%26aulast%3DYau%26aufirst%3DK.%2BW.%26aulast%3DQuigley%26aufirst%3DH.%2BA.%26aulast%3DZack%26aufirst%3DD.%2BJ.%26atitle%3DFunctional%2520genomic%2520screening%2520identifies%2520dual%2520leucine%2520zipper%2520kinase%2520as%2520a%2520key%2520mediator%2520of%2520retinal%2520ganglion%2520cell%2520death%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D4045%26epage%3D4050%26doi%3D10.1073%2Fpnas.1211284110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Valakh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babetto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiAntonio, A.</span><span> </span><span class="NLM_article-title">Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/j.nbd.2015.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1016%2Fj.nbd.2015.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=25726747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1yitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2015&pages=13-25&author=V.+Valakhauthor=E.+Freyauthor=E.+Babettoauthor=L.+J.+Walkerauthor=A.+DiAntonio&title=Cytoskeletal+disruption+activates+the+DLK%2FJNK+pathway%2C+which+promotes+axonal+regeneration+and+mimics+a+preconditioning+injury&doi=10.1016%2Fj.nbd.2015.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury</span></div><div class="casAuthors">Valakh, Vera; Frey, Erin; Babetto, Elisabetta; Walker, Lauren J.; DiAntonio, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-25</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Nerve injury can lead to axonal regeneration, axonal degeneration, and/or neuronal cell death.  Remarkably, the MAP3K dual leucine zipper kinase, DLK, promotes each of these responses, suggesting that DLK is a sensor of axon injury.  In Drosophila, mutations in proteins that stabilize the actin and microtubule cytoskeletons activate the DLK pathway, suggesting that DLK may be activated by cytoskeletal disruption.  Here we test this model in mammalian sensory neurons.  We find that pharmacol. agents designed to disrupt either the actin or microtubule cytoskeleton activate the DLK pathway, and that activation is independent of calcium influx or induction of the axon degeneration program.  Moreover, activation of the DLK pathway by targeting the cytoskeleton induces a pro-regenerative state, enhancing axon regeneration in response to a subsequent injury in a process akin to preconditioning.  This highlights the potential utility of activating the DLK pathway as a method to improve axon regeneration.  Moreover, DLK is required for these responses to cytoskeletal perturbations, suggesting that DLK functions as a key neuronal sensor of cytoskeletal damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop9lR4GkX5prVg90H21EOLACvtfcHk0liw2yOkpDzRMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1yitb4%253D&md5=1d76b9e4aa3bbdc42d5b43f04e48aef7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2015.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2015.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DValakh%26aufirst%3DV.%26aulast%3DFrey%26aufirst%3DE.%26aulast%3DBabetto%26aufirst%3DE.%26aulast%3DWalker%26aufirst%3DL.%2BJ.%26aulast%3DDiAntonio%26aufirst%3DA.%26atitle%3DCytoskeletal%2520disruption%2520activates%2520the%2520DLK%252FJNK%2520pathway%252C%2520which%2520promotes%2520axonal%2520regeneration%2520and%2520mimics%2520a%2520preconditioning%2520injury%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2015%26volume%3D77%26spage%3D13%26epage%3D25%26doi%3D10.1016%2Fj.nbd.2015.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meilandt, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanoy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogineni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta Ghosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandham, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozniak, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modrusan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudhard, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carano, R. A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weimer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">Loss of dual leucine zipper kinase signaling is protective in multiple neurodegenerative disease models</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">eaag0394</span><span class="refDoi"> DOI: 10.1126/scitranslmed.aag0394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1126%2Fscitranslmed.aag0394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=28814543" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=eaag0394&author=C.+E.+Le+Pichonauthor=W.+J.+Meilandtauthor=S.+Dominguezauthor=H.+Solanoyauthor=H.+Linauthor=H.+Nguauthor=A.+Gogineniauthor=A.+Sengupta+Ghoshauthor=Z.+Jiangauthor=S.-H.+Leeauthor=J.+Maloneyauthor=V.+D.+Gandhamauthor=C.+D.+Pozniakauthor=B.+Wangauthor=S.+Leeauthor=M.+Siuauthor=S.+Patelauthor=Z.+Modrusanauthor=X.+Liuauthor=Y.+Rudhardauthor=M.+Bacaauthor=A.+Gustafsonauthor=J.+Kaminkerauthor=R.+A.+D.+Caranoauthor=E.+J.+Huangauthor=O.+Foremanauthor=R.+Weimerauthor=K.+Scearce-Levieauthor=J.+W.+Lewcock&title=Loss+of+dual+leucine+zipper+kinase+signaling+is+protective+in+multiple+neurodegenerative+disease+models&doi=10.1126%2Fscitranslmed.aag0394"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aag0394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aag0394%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DMeilandt%26aufirst%3DW.%2BJ.%26aulast%3DDominguez%26aufirst%3DS.%26aulast%3DSolanoy%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DNgu%26aufirst%3DH.%26aulast%3DGogineni%26aufirst%3DA.%26aulast%3DSengupta%2BGhosh%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DS.-H.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DGandham%26aufirst%3DV.%2BD.%26aulast%3DPozniak%26aufirst%3DC.%2BD.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DModrusan%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DRudhard%26aufirst%3DY.%26aulast%3DBaca%26aufirst%3DM.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DKaminker%26aufirst%3DJ.%26aulast%3DCarano%26aufirst%3DR.%2BA.%2BD.%26aulast%3DHuang%26aufirst%3DE.%2BJ.%26aulast%3DForeman%26aufirst%3DO.%26aulast%3DWeimer%26aufirst%3DR.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DLoss%2520of%2520dual%2520leucine%2520zipper%2520kinase%2520signaling%2520is%2520protective%2520in%2520multiple%2520neurodegenerative%2520disease%2520models%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26spage%3Deaag0394%26doi%3D10.1126%2Fscitranslmed.aag0394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ferraris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsbie, D.</span><span> </span><span class="NLM_article-title">Dual leucine zipper kinase as a therapeutic target for neurodegenerative conditions</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1923</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span><span class="refDoi"> DOI: 10.4155/fmc.13.150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.4155%2Ffmc.13.150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=24175744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislyntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1923-1934&author=D.+Ferrarisauthor=Z.+Yangauthor=D.+Welsbie&title=Dual+leucine+zipper+kinase+as+a+therapeutic+target+for+neurodegenerative+conditions&doi=10.4155%2Ffmc.13.150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Dual leucine zipper kinase as a therapeutic target for neurodegenerative conditions</span></div><div class="casAuthors">Ferraris, Dana; Yang, Zhiyong; Welsbie, Derek</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1923-1934</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Dual leucine zipper kinase (DLK) is a serine/threonine protein kinase that is a member of the mixed lineage kinase subfamily.  Mixed lineage kinases are upstream MAP3Ks that activate the JNK pathway.  DLK is primarily responsible for activating JNK and mediating the apoptotic stress response in various cell types, specifically neurons.  Inhibition and knockdown of DLK has been demonstrated to have neuroprotective effects in cellular and animal models of Alzheimer's disease, glaucoma, Parkinson's disease and other neurodegenerative conditions.  Several series of ATP-binding site inhibitors have been identified through profiling efforts providing launch points for future medicinal chem. programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp30bZGinlt2bVg90H21EOLACvtfcHk0ljxMpm3Ac4wOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislyntg%253D%253D&md5=b233930ced57264fedae91bafacb6585</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.150%26sid%3Dliteratum%253Aachs%26aulast%3DFerraris%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWelsbie%26aufirst%3DD.%26atitle%3DDual%2520leucine%2520zipper%2520kinase%2520as%2520a%2520therapeutic%2520target%2520for%2520neurodegenerative%2520conditions%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D1923%26epage%3D1934%26doi%3D10.4155%2Ffmc.13.150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Oetjen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemcke, T.</span><span> </span><span class="NLM_article-title">Dual leucine zipper kinase (MAP3K12) modulators: a patent review (2010–2015)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span><span class="refDoi"> DOI: 10.1517/13543776.2016.1170810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1517%2F13543776.2016.1170810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=27043251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Gis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=607-616&author=E.+Oetjenauthor=T.+Lemcke&title=Dual+leucine+zipper+kinase+%28MAP3K12%29+modulators%3A+a+patent+review+%282010%E2%80%932015%29&doi=10.1517%2F13543776.2016.1170810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Dual leucine zipper kinase (MAP3K12) modulators: a patent review (2010-2015)</span></div><div class="casAuthors">Oetjen, Elke; Lemcke, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">607-616</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: The dual leucine zipper kinase (DLK, MAP3K12) is essential for neuronal development and has been shown to mediate axon regeneration.  On the other hand, DLK is involved in the pathogenesis of neurodegenerative disease and diabetes mellitus.  Several patents have been published claiming to modulate or inhibit DLK by various approaches including ATP competitive inhibitors.  In addn., two publications describe SAR of highly selective DLK inhibitors with efficacy in distinct mouse models of neurodegeneration.: This review summarized patents claiming to modulate DLK activity published between 2010 and 2015.  Peer-reviewed publications related to the patents and addnl. peer-reviewed publications are included.  This article describes 18 patents from three pharmaceutical companies and three academic research groups.: Several methods are proposed to modulate DLK activity, some of them very exptl. and not suitable for easy application in patients.  ATP competitive kinase inhibitors exert high affinity, but for the majority, no information about their selectivity is available.  To date, two inhibitors have been tested in mice.  Given the controversial findings that DLK is required for neurodegeneration and for axon regeneration, more research is needed to further elucidate the regulation and the function of this kinase in diverse organs/tissues and under physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW_r7JJP42xrVg90H21EOLACvtfcHk0ljxMpm3Ac4wOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Gis7w%253D&md5=6457f83dc7ff008a774eee2a934f3f64</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1517%2F13543776.2016.1170810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2016.1170810%26sid%3Dliteratum%253Aachs%26aulast%3DOetjen%26aufirst%3DE.%26aulast%3DLemcke%26aufirst%3DT.%26atitle%3DDual%2520leucine%2520zipper%2520kinase%2520%2528MAP3K12%2529%2520modulators%253A%2520a%2520patent%2520review%2520%25282010%25E2%2580%25932015%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D607%26epage%3D616%26doi%3D10.1517%2F13543776.2016.1170810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De La Torre, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huestis, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanoy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span> </span><span class="NLM_article-title">Discovery of dual leucine zipper kinase (DLK, MAP3K12) inhibitors with activity in neurodegeneration models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span><span class="refDoi"> DOI: 10.1021/jm5013984</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5013984" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSjsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=401-418&author=S.+Patelauthor=F.+Cohenauthor=B.+J.+Deanauthor=K.+De+La+Torreauthor=G.+Deshmukhauthor=A.+A.+Estradaauthor=A.+S.+Ghoshauthor=P.+Gibbonsauthor=A.+Gustafsonauthor=M.+P.+Huestisauthor=C.+E.+Le+Pichonauthor=H.+Linauthor=W.+Liuauthor=X.+Liuauthor=Y.+Liuauthor=C.+Q.+Lyauthor=J.+P.+Lyssikatosauthor=C.+Maauthor=K.+Scearce-Levieauthor=Y.+G.+Shinauthor=H.+Solanoyauthor=K.+L.+Starkauthor=J.+Wangauthor=B.+Wangauthor=X.+Zhaoauthor=J.+W.+Lewcockauthor=M.+Siu&title=Discovery+of+dual+leucine+zipper+kinase+%28DLK%2C+MAP3K12%29+inhibitors+with+activity+in+neurodegeneration+models&doi=10.1021%2Fjm5013984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Dual Leucine Zipper Kinase (DLK, MAP3K12) Inhibitors with Activity in Neurodegeneration Models</span></div><div class="casAuthors">Patel, Snahel; Cohen, Frederick; Dean, Brian J.; De La Torre, Kelly; Deshmukh, Gauri; Estrada, Anthony A.; Ghosh, Arundhati Sengupta; Gibbons, Paul; Gustafson, Amy; Huestis, Malcolm P.; Le Pichon, Claire E.; Lin, Han; Liu, Wendy; Liu, Xingrong; Liu, Yichin; Ly, Cuong Q.; Lyssikatos, Joseph P.; Ma, Changyou; Scearce-Levie, Kimberly; Shin, Young G.; Solanoy, Hilda; Stark, Kimberly L.; Wang, Jian; Wang, Bei; Zhao, Xianrui; Lewcock, Joseph W.; Siu, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">401-418</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dual leucine zipper kinase (DLK, MAP3K12) was recently identified as an essential regulator of neuronal degeneration in multiple contexts.  Here the authors describe the generation of potent and selective DLK inhibitors starting from a high-throughput screening hit.  Using proposed hinge-binding interactions to infer a binding mode and specific design parameters to optimize for CNS druglike mols., the authors came to focus on the di(pyridin-2-yl)amines because of their combination of desirable potency and good brain penetration following oral dosing.  The lead inhibitor GNE-3511 I displayed concn.-dependent protection of neurons from degeneration in vitro and demonstrated dose-dependent activity in two different animal models of disease.  These results suggest that specific pharmacol. inhibition of DLK may have therapeutic potential in multiple indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBLUV7fJcY-rVg90H21EOLACvtfcHk0ljYbsW8girXow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSjsr3P&md5=8f4ebdbfb0d324a4253bcd832e690a18</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm5013984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5013984%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DDean%26aufirst%3DB.%2BJ.%26aulast%3DDe%2BLa%2BTorre%26aufirst%3DK.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DGhosh%26aufirst%3DA.%2BS.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DHuestis%26aufirst%3DM.%2BP.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DShin%26aufirst%3DY.%2BG.%26aulast%3DSolanoy%26aufirst%3DH.%26aulast%3DStark%26aufirst%3DK.%2BL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26aulast%3DSiu%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520dual%2520leucine%2520zipper%2520kinase%2520%2528DLK%252C%2520MAP3K12%2529%2520inhibitors%2520with%2520activity%2520in%2520neurodegeneration%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D401%26epage%3D418%26doi%3D10.1021%2Fjm5013984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanoy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">Scaffold-hopping and structure-based discovery of potent, selective, and brain penetrant N-(1H-pyrazol-3-yl)pyridin-2-amine inhibitors of dual leucine zipper kinase (DLK, MAP3K12)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8182</span><span class="NLM_x">–</span> <span class="NLM_lpage">8199</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01072</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Kit7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8182-8199&author=S.+Patelauthor=S.+F.+Harrisauthor=P.+Gibbonsauthor=G.+Deshmukhauthor=A.+Gustafsonauthor=T.+Kellarauthor=H.+Linauthor=X.+Liuauthor=Y.+Liuauthor=Y.+Liuauthor=C.+Maauthor=K.+Scearce-Levieauthor=A.+S.+Ghoshauthor=Y.+G.+Shinauthor=H.+Solanoyauthor=J.+Wangauthor=B.+Wangauthor=J.+Yinauthor=M.+Siuauthor=J.+W.+Lewcock&title=Scaffold-hopping+and+structure-based+discovery+of+potent%2C+selective%2C+and+brain+penetrant+N-%281H-pyrazol-3-yl%29pyridin-2-amine+inhibitors+of+dual+leucine+zipper+kinase+%28DLK%2C+MAP3K12%29&doi=10.1021%2Facs.jmedchem.5b01072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold-Hopping and Structure-Based Discovery of Potent, Selective, And Brain Penetrant N-(1H-Pyrazol-3-yl)pyridin-2-amine Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12)</span></div><div class="casAuthors">Patel, Snahel; Harris, Seth F.; Gibbons, Paul; Deshmukh, Gauri; Gustafson, Amy; Kellar, Terry; Lin, Han; Liu, Xingrong; Liu, Yanzhou; Liu, Yichin; Ma, Changyou; Scearce-Levie, Kimberly; Ghosh, Arundhati Sengupta; Shin, Young G.; Solanoy, Hilda; Wang, Jian; Wang, Bei; Yin, Jianping; Siu, Michael; Lewcock, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8182-8199</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent data suggest that inhibition of dual leucine zipper kinase (DLK, MAP3K12) has therapeutic potential for treatment of a no. of indications ranging from acute neuronal injury to chronic neurodegenerative disease.  Thus, high demand exists for selective small mol. DLK inhibitors with favorable drug-like properties and good CNS penetration.  Herein the authors describe a shape-based scaffold hopping approach to convert pyrimidine 1 to a pyrazole core with improved physicochem. properties.  The authors also present the first crystal structures of DLK.  By utilizing a combination of property and structure-based design, the authors identified inhibitor I, a potent, selective, and brain-penetrant inhibitor of DLK with activity in an in vivo nerve injury model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJzgZkA0g77bVg90H21EOLACvtfcHk0ljYbsW8girXow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Kit7fN&md5=e7b850d7c7d2eac3317b573ace2c6fab</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01072%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DKellar%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DGhosh%26aufirst%3DA.%2BS.%26aulast%3DShin%26aufirst%3DY.%2BG.%26aulast%3DSolanoy%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DScaffold-hopping%2520and%2520structure-based%2520discovery%2520of%2520potent%252C%2520selective%252C%2520and%2520brain%2520penetrant%2520N-%25281H-pyrazol-3-yl%2529pyridin-2-amine%2520inhibitors%2520of%2520dual%2520leucine%2520zipper%2520kinase%2520%2528DLK%252C%2520MAP3K12%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8182%26epage%3D8199%26doi%3D10.1021%2Facs.jmedchem.5b01072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Heffron, T. P.</span><span> </span><span class="NLM_article-title">Small molecule kinase inhibitors for the treatment of brain cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">10030</span><span class="NLM_x">–</span> <span class="NLM_lpage">10066</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00618</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00618" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOjt77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10030-10066&author=T.+P.+Heffron&title=Small+molecule+kinase+inhibitors+for+the+treatment+of+brain+cancer&doi=10.1021%2Facs.jmedchem.6b00618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer</span></div><div class="casAuthors">Heffron, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10030-10066</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In addn. to each of the factors that govern the identification of a successful oncol. drug candidate, drug discovery aimed at treating neurol. cancer must also consider the presence of the blood-brain barrier (BBB).  The high level of expression of efflux transporters (e.g., P-glycoprotein (P-gp) and breast cancer resistance protein (Bcrp)) at the BBB limits many small mols. from freely reaching the brain, where neurooncol. malignancies reside.  Furthermore, many of the targets identified for the potential treatment of central nervous system (CNS) malignancies suggest that kinase inhibitors, capable of penetrating the BBB to reach their target, would be desirable.  This Perspective discusses the unmet need for neurooncol. treatments, the appeal of kinase targets in this space, and a summary of what is known about free brain penetration of clin. inhibitors of kinases that are of interest for the treatment of brain cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqij86WIpk16LVg90H21EOLACvtfcHk0ljYbsW8girXow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOjt77E&md5=7e184f17a60658174cb44a9fbadc8dfd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26atitle%3DSmall%2520molecule%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520brain%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10030%26epage%3D10066%26doi%3D10.1021%2Facs.jmedchem.6b00618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgYM7UvI3APWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB%282%29+agonists+using+parallel+synthesis+protocols%3A+A+Lipophilic+Efficiency+%28LipE%29+analysis&doi=10.1016%2Fj.bmcl.2009.05.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0lgYM7UvI3APWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB%25282%2529%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520A%2520Lipophilic%2520Efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409%26doi%3D10.1016%2Fj.bmcl.2009.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Merour, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buron, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ple, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span> </span><span class="NLM_article-title">The azaindole framework in the design of kinase inhibitors</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">19935</span><span class="NLM_x">–</span> <span class="NLM_lpage">19979</span><span class="refDoi"> DOI: 10.3390/molecules191219935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.3390%2Fmolecules191219935" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=19935-19979&author=J.+Y.+Merourauthor=F.+Buronauthor=K.+Pleauthor=P.+Bonnetauthor=S.+Routier&title=The+azaindole+framework+in+the+design+of+kinase+inhibitors&doi=10.3390%2Fmolecules191219935"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3390%2Fmolecules191219935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules191219935%26sid%3Dliteratum%253Aachs%26aulast%3DMerour%26aufirst%3DJ.%2BY.%26aulast%3DBuron%26aufirst%3DF.%26aulast%3DPle%26aufirst%3DK.%26aulast%3DBonnet%26aufirst%3DP.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DThe%2520azaindole%2520framework%2520in%2520the%2520design%2520of%2520kinase%2520inhibitors%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D19935%26epage%3D19979%26doi%3D10.3390%2Fmolecules191219935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.07.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+Decrescenzoauthor=R.+V.+Devrajauthor=E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes&doi=10.1016%2Fj.bmcl.2008.07.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0lgYM7UvI3APWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDecrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875%26doi%3D10.1016%2Fj.bmcl.2008.07.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker-Glenn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9416</span><span class="NLM_x">–</span> <span class="NLM_lpage">9433</span><span class="refDoi"> DOI: 10.1021/jm301020q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301020q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9416-9433&author=A.+A.+Estradaauthor=X.+Liuauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=B.+K.+Chanauthor=H.+Chenauthor=X.+Dingauthor=A.+G.+DiPasqualeauthor=S.+L.+Dominguezauthor=J.+Dotsonauthor=J.+Drummondauthor=M.+Flagellaauthor=S.+Flynnauthor=R.+Fujiauthor=A.+Gillauthor=J.+Gunzner-Tosteauthor=S.+F.+Harrisauthor=T.+P.+Heffronauthor=T.+Kleinheinzauthor=D.+W.+Leeauthor=C.+E.+Le+Pichonauthor=J.+P.+Lyssikatosauthor=A.+D.+Medhurstauthor=J.+G.+Moffatauthor=S.+Mukundauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=T.+Tranauthor=N.+Trivediauthor=S.+Wangauthor=S.+Zhangauthor=X.+Zhangauthor=G.+Zhaoauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+highly+potent%2C+selective%2C+and+brain-penetrable+leucine-rich+repeat+kinase+2+%28LRRK2%29+small+molecule+inhibitors&doi=10.1021%2Fjm301020q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors</span></div><div class="casAuthors">Estrada, Anthony A.; Liu, Xingrong; Baker-Glenn, Charles; Beresford, Alan; Burdick, Daniel J.; Chambers, Mark; Chan, Bryan K.; Chen, Huifen; Ding, Xiao; DiPasquale, Antonio G.; Dominguez, Sara L.; Dotson, Jennafer; Drummond, Jason; Flagella, Michael; Flynn, Sean; Fuji, Reina; Gill, Andrew; Gunzner-Toste, Janet; Harris, Seth F.; Heffron, Timothy P.; Kleinheinz, Tracy; Lee, Donna W.; Le Pichon, Claire E.; Lyssikatos, Joseph P.; Medhurst, Andrew D.; Moffat, John G.; Mukund, Susmith; Nash, Kevin; Scearce-Levie, Kimberly; Sheng, Zejuan; Shore, Daniel G.; Tran, Thuy; Trivedi, Naimisha; Wang, Shumei; Zhang, Shuo; Zhang, Xiaolin; Zhao, Guiling; Zhu, Haitao; Sweeney, Zachary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9416-9433</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a high demand for potent, selective, and brain-penetrant small mol. inhibitors of leucine-rich repeat kinase 2 (LRRK2) to test whether inhibition of LRRK2 kinase activity is a potentially viable treatment option for Parkinson's disease patients.  Herein we disclose the use of property and structure-based drug design for the optimization of highly ligand efficient aminopyrimidine lead compds.  High throughput in vivo rodent cassette pharmacokinetic studies enabled rapid validation of in vitro-in vivo correlations.  Guided by this data, optimal design parameters were established.  Effective incorporation of these guidelines into our mol. design process resulted in the discovery of small mol. inhibitors such as GNE-7915 (18, I) and 19, which possess an ideal balance of LRRK2 cellular potency, broad kinase selectivity, metabolic stability, and brain penetration across multiple species.  Advancement of GNE-7915 into rodent and higher species toxicity studies enabled risk assessment for early development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptu1BnxYNJQrVg90H21EOLACvtfcHk0lh-oe4xPaQOSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktbfO&md5=9fc7ccca9c973a960e7393c79c1255fa</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm301020q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301020q%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DMukund%26aufirst%3DS.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DTrivedi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520highly%2520potent%252C%2520selective%252C%2520and%2520brain-penetrable%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520small%2520molecule%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9416%26epage%3D9433%26doi%3D10.1021%2Fjm301020q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Muller, K.</span><span> </span><span class="NLM_article-title">Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span><span class="refDoi"> DOI: 10.2533/chimia.2014.356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.2533%2Fchimia.2014.356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=25198745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1emsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2014&pages=356-362&author=K.+Muller&title=Simple+vector+considerations+to+assess+the+polarity+of+partially+fluorinated+alkyl+and+alkoxy+groups&doi=10.2533%2Fchimia.2014.356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups</span></div><div class="casAuthors">Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Chimia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">356-362</span>CODEN:
                <span class="NLM_cas:coden">CHIMAD</span>;
        ISSN:<span class="NLM_cas:issn">0009-4293</span>.
    
            (<span class="NLM_cas:orgname">Swiss Chemical Society</span>)
        </div><div class="casAbstract">A review.  While H/F exchange at aryl groups or introduction of CF3 units have dominated medicinal chem. for decades, the use of partially fluorinated alkyl and alkoxy groups has come into focus more recently.  A simple bond vector anal. scheme, based on the assumption of context-independent bond polarities as well as idealized configurational and conformational geometries, is applied to small alkyl and alkoxy groups with prototypic fluorination patterns for qual. assessments of relative polarities as well as polarity modulation by conformational change.  Combined with a const. vol. increase for each hydrogen/fluorine exchange these polarity ests. can be translated into expected lipophilicity shifts (ΔlogP), using a simple parameterization scheme derived from exptl. logP values.  While terminal monofluoro- and gem-difluoromethyl groups in small aliph. units are correctly predicted to show lower lipophilicity compared to their tri- or non-fluorinated congeners, vicinal difluoro and bis-vicinal trifluoro patterns are identified to exhibit significantly lower lipophilicities than their resp. geminal di- and trifluoro substituted counterparts.  The trifluoromethoxy group is diagnosed as an intrinsically lipophilic unit compared to the parent methoxy group.  The difluoromethoxy group is of particular interest as it can easily interconvert between a highly lipophilic and a polar conformation, thus enabling this unit to adjust to polarity changes of the mol. environment.  For di- and trifluoroalkoxy groups, again the vic-difluoro and bis-vic-trifluoro substitution patterns stand out as most promising to keep lipophilicity low.  The 1,3-difluoro pattern next to an ether moiety shows an interesting conformational dependence of polarity, similar to the difluoromethoxy group.  While very qual. in nature, the simple bond vector anal. promises to be a useful tool for the identification of lipophilicity-lowering fluorinated alkyl or alkoxy groups and particularly those groups that display marked conformation-dependent lipophilicity and thus potentially serve as 'environmental adaptors'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6yZ2IogEjkrVg90H21EOLACvtfcHk0lh-oe4xPaQOSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1emsLrI&md5=073bd4a2d1d9dcc5f1540296263dda62</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2533%2Fchimia.2014.356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2533%252Fchimia.2014.356%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DSimple%2520vector%2520considerations%2520to%2520assess%2520the%2520polarity%2520of%2520partially%2520fluorinated%2520alkyl%2520and%2520alkoxy%2520groups%26jtitle%3DChimia%26date%3D2014%26volume%3D68%26spage%3D356%26epage%3D362%26doi%3D10.2533%2Fchimia.2014.356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Rudhard, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta Ghosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedaran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">Identification of 12/15-lipoxygenase as a regulator of axon degeneration through high-content screening</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2927</span><span class="NLM_x">–</span> <span class="NLM_lpage">2941</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2936-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1523%2FJNEUROSCI.2936-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=25698732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSjs77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=2927-2941&author=Y.+Rudhardauthor=A.+Sengupta+Ghoshauthor=B.+Lippertauthor=A.+Bockerauthor=M.+Pedaranauthor=J.+Kramerauthor=H.+Nguauthor=O.+Foremanauthor=Y.+Liuauthor=J.+W.+Lewcock&title=Identification+of+12%2F15-lipoxygenase+as+a+regulator+of+axon+degeneration+through+high-content+screening&doi=10.1523%2FJNEUROSCI.2936-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 12/15-lipoxygenase as a regulator of axon degeneration through high-content screening</span></div><div class="casAuthors">Rudhard, York; Ghosh, Arundhati Sengupta; Lippert, Beatrix; Boecker, Alexander; Pedaran, Mehdi; Kraemer, Joachim; Ngu, Hai; Foreman, Oded; Liu, Yichin; Lewcock, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2927-2941</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Axon degeneration is a programed process that takes place during development, in response to neuronal injury, and as a component of neurodegenerative disease pathol., yet the mol. mechanisms that drive this process remain poorly defined.  In this study, we have developed a semi-automated, 384-well format axon degeneration assay in rat dorsal root ganglion (DRG) neurons using a trophic factor withdrawal paradigm.  Using this setup, we have screened a library of known drugs and bioactives to identify several previously unappreciated regulators of axon degeneration, including lipoxygenases.  Multiple structurally distinct lipoxygenase inhibitors as well as mouse DRG neurons lacking expression of 12/15-lipoxygenase display protection of axons in this context.  Retinal ganglion cell axons from 12/15-lipoxygenase-null mice were similarly protected from degeneration following nerve crush injury.  Through addnl. mechanistic studies, we demonstrate that lipoxygenases act cell autonomously within neurons to regulate degeneration, and are required for mitochondrial permeabilization and caspase activation in the axon.  These findings suggest that these enzymes may represent an attractive target for treatment of neuropathies and provide a potential mechanism for the neuroprotection obsd. in various settings following lipoxygenase inhibitor treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4GvHK9fLzwLVg90H21EOLACvtfcHk0lh-oe4xPaQOSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSjs77I&md5=0bce092fa10b6fbc1861328e67d82f1c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2936-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2936-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DRudhard%26aufirst%3DY.%26aulast%3DSengupta%2BGhosh%26aufirst%3DA.%26aulast%3DLippert%26aufirst%3DB.%26aulast%3DBocker%26aufirst%3DA.%26aulast%3DPedaran%26aufirst%3DM.%26aulast%3DKramer%26aufirst%3DJ.%26aulast%3DNgu%26aufirst%3DH.%26aulast%3DForeman%26aufirst%3DO.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DIdentification%2520of%252012%252F15-lipoxygenase%2520as%2520a%2520regulator%2520of%2520axon%2520degeneration%2520through%2520high-content%2520screening%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D2927%26epage%3D2941%26doi%3D10.1523%2FJNEUROSCI.2936-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Welsbie, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaskula-Ranga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluch, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buehler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamed, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamling, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, I. D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronai, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlinicke, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, D. J.</span><span> </span><span class="NLM_article-title">Enhanced functional genomic screening identifies novel mediators of dual leucine zipper kinase-dependent injury signaling in neurons</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1154</span><span class="refDoi"> DOI: 10.1016/j.neuron.2017.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1016%2Fj.neuron.2017.06.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2017&pages=1142-1154&author=D.+S.+Welsbieauthor=K.+L.+Mitchellauthor=V.+Jaskula-Rangaauthor=V.+M.+Sluchauthor=Z.+Yangauthor=J.+Kimauthor=E.+Buehlerauthor=A.+Patelauthor=S.+E.+Martinauthor=P.+W.+Zhangauthor=Y.+Geauthor=Y.+Duanauthor=J.+Fullerauthor=B.+J.+Kimauthor=E.+Hamedauthor=X.+Chamlingauthor=L.+Leiauthor=I.+D.+C.+Fraserauthor=Z.+A.+Ronaiauthor=C.+A.+Berlinickeauthor=D.+J.+Zack&title=Enhanced+functional+genomic+screening+identifies+novel+mediators+of+dual+leucine+zipper+kinase-dependent+injury+signaling+in+neurons&doi=10.1016%2Fj.neuron.2017.06.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2017.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2017.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DWelsbie%26aufirst%3DD.%2BS.%26aulast%3DMitchell%26aufirst%3DK.%2BL.%26aulast%3DJaskula-Ranga%26aufirst%3DV.%26aulast%3DSluch%26aufirst%3DV.%2BM.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DBuehler%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DS.%2BE.%26aulast%3DZhang%26aufirst%3DP.%2BW.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DB.%2BJ.%26aulast%3DHamed%26aufirst%3DE.%26aulast%3DChamling%26aufirst%3DX.%26aulast%3DLei%26aufirst%3DL.%26aulast%3DFraser%26aufirst%3DI.%2BD.%2BC.%26aulast%3DRonai%26aufirst%3DZ.%2BA.%26aulast%3DBerlinicke%26aufirst%3DC.%2BA.%26aulast%3DZack%26aufirst%3DD.%2BJ.%26atitle%3DEnhanced%2520functional%2520genomic%2520screening%2520identifies%2520novel%2520mediators%2520of%2520dual%2520leucine%2520zipper%2520kinase-dependent%2520injury%2520signaling%2520in%2520neurons%26jtitle%3DNeuron%26date%3D2017%26volume%3D94%26spage%3D1142%26epage%3D1154%26doi%3D10.1016%2Fj.neuron.2017.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Richards, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouagazzal, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kew, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohrmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockhaus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loetscher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czech, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bluethmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J. A.</span><span> </span><span class="NLM_article-title">PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">8989</span><span class="NLM_x">–</span> <span class="NLM_lpage">9003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=14523101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFOnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=8989-9003&author=J.+G.+Richardsauthor=G.+A.+Higginsauthor=A.+M.+Ouagazzalauthor=L.+Ozmenauthor=J.+N.+Kewauthor=B.+Bohrmannauthor=P.+Malherbeauthor=M.+Brockhausauthor=H.+Loetscherauthor=C.+Czechauthor=G.+Huberauthor=H.+Bluethmannauthor=H.+Jacobsenauthor=J.+A.+Kemp&title=PS2APP+transgenic+mice%2C+coexpressing+hPS2mut+and+hAPPswe%2C+show+age-related+cognitive+deficits+associated+with+discrete+brain+amyloid+deposition+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation</span></div><div class="casAuthors">Richards, J. Grayson; Higgins, Guy A.; Ouagazzal, Abdel-Mouttalib; Ozmen, Laurence; Kew, James N. C.; Bohrmann, Bernd; Malherbe, Pari; Brockhaus, Manfred; Loetscher, Hansruedi; Czech, Christian; Huber, Gerda; Bluethmann, Horst; Jacobsen, Helmut; Kemp, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">8989-9003</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Transgenic mice, expressing mutant β-amyloid precursor proteins (βAPPs), have lead to a better understanding of the pathophysiol. processes in Alzheimer's disease (AD).  In many of these models, however, the temporal development of cognitive decline and the relationship to Aβ deposition and inflammation are unclear.  We now report a novel transgenic mouse line, PS2APP (PS2N141I × APPswe), which develops a severe cerebral amyloidosis in discrete brain regions, and present a cross-sectional anal. of these mice at 4, 8, 12, and 16 mo of age.  Each age cohort was investigated for changes in behavior, electrophysiol. of synapse efficacy, ELISA-detd. Aβ load, histopathol., and in immunoelectron microscopy.  Cognitive deficits were first obsd. at 8 mo when Aβ deposits and inflammation were restricted to discrete brain regions, namely the subiculum and frontolateral (motor and orbital) cortex.  As early as 5 mo, electron microscopy revealed the presence, in these regions, of pre-plaque, immunogold-labeled extracellular fibrillar Aβ.  At the same age, increased levels of insol. Aβ were detected by ELISA, with Aβ1-40 levels exceeding those of Aβ1-42.  Further cognitive decline occurred in an age-related manner, and this was accompanied by the spread of amyloidosis to ultimately affect not only neo- and limbic cortices, but also thalamic and pontine nuclei.  Dentate gyrus post-tetanic potentiation was significantly attenuated at 17 mo, and there were also significant differences in paired-pulse parameters.  This systematic cross-sectional study of the behavioral and pathol. changes in the PS2APP mouse indicates that it develops age-related cognitive decline assocd. with severe amyloidosis and inflammation in discrete brain regions and therefore is suitable for testing a range of potential symptomatic and disease-modifying therapies for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDKdVZTi_SV7Vg90H21EOLACvtfcHk0lgXE4AqpQnXpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFOnu78%253D&md5=0cd756fe7367e67cf38e6c64a34a6e14</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DJ.%2BG.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DOuagazzal%26aufirst%3DA.%2BM.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DKew%26aufirst%3DJ.%2BN.%26aulast%3DBohrmann%26aufirst%3DB.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DBrockhaus%26aufirst%3DM.%26aulast%3DLoetscher%26aufirst%3DH.%26aulast%3DCzech%26aufirst%3DC.%26aulast%3DHuber%26aufirst%3DG.%26aulast%3DBluethmann%26aufirst%3DH.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DKemp%26aufirst%3DJ.%2BA.%26atitle%3DPS2APP%2520transgenic%2520mice%252C%2520coexpressing%2520hPS2mut%2520and%2520hAPPswe%252C%2520show%2520age-related%2520cognitive%2520deficits%2520associated%2520with%2520discrete%2520brain%2520amyloid%2520deposition%2520and%2520inflammation%26jtitle%3DJ.%2520Neurosci.%26date%3D2003%26volume%3D23%26spage%3D8989%26epage%3D9003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Coffey, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiciene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hongisto, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brecht, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdegen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, M. J.</span><span> </span><span class="NLM_article-title">c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4335</span><span class="NLM_x">–</span> <span class="NLM_lpage">4345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=12040039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFWgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=4335-4345&author=E.+T.+Coffeyauthor=G.+Smicieneauthor=V.+Hongistoauthor=J.+Caoauthor=S.+Brechtauthor=T.+Herdegenauthor=M.+J.+Courtney&title=c-Jun+N-terminal+protein+kinase+%28JNK%29+2%2F3+is+specifically+activated+by+stress%2C+mediating+c-Jun+activation%2C+in+the+presence+of+constitutive+JNK1+activity+in+cerebellar+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons</span></div><div class="casAuthors">Coffey, Eleanor T.; Smiciene, Giedre; Hongisto, Vesa; Cao, Jiong; Brecht, Stephan; Herdegen, Thomas; Courtney, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4335-4345</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">C-Jun is considered a major regulator of both neuronal death and regeneration.  Stress in primary cultured CNS neurons induces phosphorylation of c-Jun serines 63 and 73 and increased c-Jun protein level.  However, total c-Jun N-terminal protein kinase (JNK) activity does not increase, and no satisfactory explanation for this paradox has been available.  Here we demonstrate that neuronal stress induces strong activation of JNK2/3 in the presence of constitutively and highly active JNK1.  Correspondingly, neurons from JNK1-/- mice show lower constitutive activity and considerably higher responsiveness to stress.  P38 activity can be completely inhibited without effect on c-Jun phosphorylation, whereas 10 μM SB203580 strongly inhibits neuronal JNK2/3, stress-induced c-Jun phosphorylation, induced c-Jun activity, and neuronal death in response to trophic withdrawal stress.  Neither constitutive JNK1 activity nor total neuronal JNK activity were significantly affected by this concn. of drug.  Thus, neuronal stress selectively activates JNK2/3 in the presence of mechanisms maintaining constitutive JNK1 activity, and this JNK2/3 activity selectively targets c-Jun, which is isolated from constitutive JNK1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUUBvsE-JyObVg90H21EOLACvtfcHk0ljx7-2U2AQf6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksFWgtb4%253D&md5=2472f44b2c6a531cfc2601999c2fbcde</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoffey%26aufirst%3DE.%2BT.%26aulast%3DSmiciene%26aufirst%3DG.%26aulast%3DHongisto%26aufirst%3DV.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DBrecht%26aufirst%3DS.%26aulast%3DHerdegen%26aufirst%3DT.%26aulast%3DCourtney%26aufirst%3DM.%2BJ.%26atitle%3Dc-Jun%2520N-terminal%2520protein%2520kinase%2520%2528JNK%2529%25202%252F3%2520is%2520specifically%2520activated%2520by%2520stress%252C%2520mediating%2520c-Jun%2520activation%252C%2520in%2520the%2520presence%2520of%2520constitutive%2520JNK1%2520activity%2520in%2520cerebellar%2520neurons%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D4335%26epage%3D4345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Huntwork-Rodriguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozniak, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bustos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1083/jcb.201303066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1083%2Fjcb.201303066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2013&pages=747-763&author=S.+Huntwork-Rodriguezauthor=B.+Wangauthor=T.+Watkinsauthor=A.+S.+Ghoshauthor=C.+D.+Pozniakauthor=D.+Bustosauthor=K.+Newtonauthor=D.+S.+Kirkpatrickauthor=J.+W.+Lewcock&title=JNK-mediated+phosphorylation+of+DLK+suppresses+its+ubiquitination+to+promote+neuronal+apoptosis&doi=10.1083%2Fjcb.201303066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201303066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201303066%26sid%3Dliteratum%253Aachs%26aulast%3DHuntwork-Rodriguez%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWatkins%26aufirst%3DT.%26aulast%3DGhosh%26aufirst%3DA.%2BS.%26aulast%3DPozniak%26aufirst%3DC.%2BD.%26aulast%3DBustos%26aufirst%3DD.%26aulast%3DNewton%26aufirst%3DK.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DJNK-mediated%2520phosphorylation%2520of%2520DLK%2520suppresses%2520its%2520ubiquitination%2520to%2520promote%2520neuronal%2520apoptosis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2013%26volume%3D202%26spage%3D747%26epage%3D763%26doi%3D10.1083%2Fjcb.201303066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E.</span><span> </span><span class="NLM_article-title">Rational use of plasma protein and tissue binding data in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8238</span><span class="NLM_x">–</span> <span class="NLM_lpage">8248</span><span class="refDoi"> DOI: 10.1021/jm5007935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5007935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8238-8248&author=X.+Liuauthor=M.+Wrightauthor=C.+E.+Hop&title=Rational+use+of+plasma+protein+and+tissue+binding+data+in+drug+design&doi=10.1021%2Fjm5007935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design</span></div><div class="casAuthors">Liu, Xingrong; Wright, Matthew; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8238-8248</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is a commonly accepted assumption that only unbound drug mols. are available to interact with their targets.  Therefore, one of the objectives in drug design is to optimize the compd. structure to increase in vivo unbound drug concn.  In this review, theor. analyses and exptl. observations are presented to illustrate that low plasma protein binding does not necessarily lead to high in vivo unbound plasma concn.  Similarly, low brain tissue binding does not lead to high in vivo unbound brain tissue concn.  Instead, low intrinsic clearance leads to high in vivo unbound plasma concn., and low efflux transport activity at the blood-brain barrier leads to high unbound brain concn.  Plasma protein and brain tissue binding are very important parameters in understanding pharmacokinetics, pharmacodynamics, and toxicities of drugs, but these parameters should not be targeted for optimization in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiYUz9ljIDrVg90H21EOLACvtfcHk0ljx7-2U2AQf6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M&md5=53ffbdb88ddf500a90a0eee14b0e641f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm5007935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5007935%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DHop%26aufirst%3DC.%2BE.%26atitle%3DRational%2520use%2520of%2520plasma%2520protein%2520and%2520tissue%2520binding%2520data%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8238%26epage%3D8248%26doi%3D10.1021%2Fjm5007935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">The free fraction in the cell culture medium containing 10% serum was calculated based on a method reported in this reference assuming the serum binding is similar to measured human plasma protein binding of 84% for compound <b>14</b>.</p></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Cohen, F.; Huestis, M.; Ly, C.; Patel, S.; Siu, M.; Zhao, X.</span><span> </span><span class="NLM_article-title">Preparation of Substituted Dipyridines as DLK Iinhibitors for Treating Neurodegeneration</span>. PCT Int. Appl., WO 2013174780,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=F.+Cohen&author=M.+Huestis&author=C.+Ly&author=S.+Patel&author=M.+Siu&author=X.+Zhao&title=Preparation+of+Substituted+Dipyridines+as+DLK+Iinhibitors+for+Treating+Neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DF.%26atitle%3DPreparation%2520of%2520Substituted%2520Dipyridines%2520as%2520DLK%2520Iinhibitors%2520for%2520Treating%2520Neurodegeneration%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallop, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminker, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weimer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span> </span><span class="NLM_article-title">Spatially coordinated kinase signaling regulates local axon degeneration</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">13439</span><span class="NLM_x">–</span> <span class="NLM_lpage">13453</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2039-12.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=10.1523%2FJNEUROSCI.2039-12.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=23015435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKhsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=13439-13453&author=M.+Chenauthor=J.+A.+Maloneyauthor=D.+Y.+Kallopauthor=J.+K.+Atwalauthor=S.+J.+Tamauthor=K.+Baerauthor=H.+Kisselauthor=J.+S.+Kaminkerauthor=J.+W.+Lewcockauthor=R.+M.+Weimerauthor=R.+J.+Watts&title=Spatially+coordinated+kinase+signaling+regulates+local+axon+degeneration&doi=10.1523%2FJNEUROSCI.2039-12.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Spatially coordinated kinase signaling regulates local axon degeneration</span></div><div class="casAuthors">Chen, Mark; Maloney, Janice A.; Kallop, Dara Y.; Atwal, Jasvinder K.; Tam, Stephen J.; Baer, Kristin; Kissel, Holger; Kaminker, Joshua S.; Lewcock, Joseph W.; Weimer, Robby M.; Watts, Ryan J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">13439-13453</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">In addn. to being a hallmark of neurodegenerative disease, axon degeneration is used during development of the nervous system to prune unwanted connections.  In development, axon degeneration is tightly regulated both temporally and spatially.  Here, we provide evidence that degeneration cues are transduced through various kinase pathways functioning in spatially distinct compartments to regulate axon degeneration.  Intriguingly, glycogen synthase kinase-3 (GSK3) acts centrally, likely modulating gene expression in the cell body to regulate distally restricted axon degeneration.  Through a combination of genetic and pharmacol. manipulations, including the generation of an analog-sensitive kinase allele mutant mouse for GSK3β, we show that the β isoform of GSK3, not the α isoform, is essential for developmental axon pruning in vitro and in vivo.  Addnl., we identify the dleu2/mir15a/16-1 cluster, previously characterized as a regulator of B-cell proliferation, and the transcription factor tbx6, as likely downstream effectors of GSK3β in axon degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1FqsdLaQoI7Vg90H21EOLACvtfcHk0lgLGhlP1de9BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKhsrzJ&md5=b961d768ebb4ed59b947269bc095871a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2039-12.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2039-12.2012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DM.%26aulast%3DMaloney%26aufirst%3DJ.%2BA.%26aulast%3DKallop%26aufirst%3DD.%2BY.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DTam%26aufirst%3DS.%2BJ.%26aulast%3DBaer%26aufirst%3DK.%26aulast%3DKissel%26aufirst%3DH.%26aulast%3DKaminker%26aufirst%3DJ.%2BS.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26aulast%3DWeimer%26aufirst%3DR.%2BM.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26atitle%3DSpatially%2520coordinated%2520kinase%2520signaling%2520regulates%2520local%2520axon%2520degeneration%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D13439%26epage%3D13453%26doi%3D10.1523%2FJNEUROSCI.2039-12.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_publisher-name">ThermoFisher Scientific</span>, <span class="NLM_publisher-loc">Waltham, MA</span>, <a href="https://www.thermofisher.com/us/en/home/products-and-services/services/custom-services/screening-and-profiling-services/selectscreen-profiling-service/selectscreen-kinase-profiling-service.html" class="extLink">https://www.thermofisher.com/us/en/home/products-and-services/services/custom-services/screening-and-profiling-services/selectscreen-profiling-service/selectscreen-kinase-profiling-service.html</a> (accessed August 2,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ThermoFisher+Scientific%2C+Waltham%2C+MA%2C+https%3A%2F%2Fwww.thermofisher.com%2Fus%2Fen%2Fhome%2Fproducts-and-services%2Fservices%2Fcustom-services%2Fscreening-and-profiling-services%2Fselectscreen-profiling-service%2Fselectscreen-kinase-profiling-service.html+%28accessed+August+2%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26pub%3DThermoFisher%2520Scientific%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_publisher-name">DiscoverX</span>, <span class="NLM_publisher-loc">Fremont, CA</span>, <a href="https://www.discoverx.com/technologies-platforms/competitive-binding-technology/kinomescan-technology-platform" class="extLink">https://www.discoverx.com/technologies-platforms/competitive-binding-technology/kinomescan-technology-platform</a> (Accessed August 2,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DiscoverX%2C+Fremont%2C+CA%2C+https%3A%2F%2Fwww.discoverx.com%2Ftechnologies-platforms%2Fcompetitive-binding-technology%2Fkinomescan-technology-platform+%28Accessed+August+2%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26pub%3DDiscoverX%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CEQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CEQ','PDB','5CEQ'); return false;">PDB: 5CEQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5VO2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5VO2','PDB','5VO2'); return false;">PDB: 5VO2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5VO1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5VO1','PDB','5VO1'); return false;">PDB: 5VO1</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d59e6366-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i97"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00843">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82178"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00843">10.1021/acs.jmedchem.7b00843</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">CEREP Receptor panel data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00843/suppl_file/jm7b00843_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00843/suppl_file/jm7b00843_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00843/suppl_file/jm7b00843_si_001.pdf">jm7b00843_si_001.pdf (96.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00843/suppl_file/jm7b00843_si_002.csv">jm7b00843_si_002.csv (2.55 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors for DLK kinase domain complexes are available in the PDB with accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5VO1">5VO1</a> (<b>7</b>) and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5VO2">5VO2</a> (<b>10</b>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-19%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00843" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00843" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677aa104abfc3d00","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
